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è tempo di comprendere di più, cosi possiamo temere di meno.  
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 Abstract 
ABSTRACT 
   Milk is the most widely consumed beverage in the world, not counting 
water, which provides high-quality nutrition to infants, children, and adults, 
due to its high content of micro- and macronutrients. Despite the benefits 
that milk provides from a nutritional point of view, it may also be a vehicle 
of food contaminants, such as mycotoxins and veterinary drug residues 
(VDs), due to nasty agricultural practices or improper usage of these drugs. 
In this sense, the first part of my project includes the studies regarding the 
topics mentioned above. 
   Hence, a multi-residue method based on a QuEChERS extraction for the 
simultaneous determination of veterinary drug residues (n=61) and 
mycotoxins (n=46) in milk was developed by using ultra high performance 
liquid chromatography coupled with high resolution mass spectrometry 
(UHPLC Q-Exactive Orbitrap HRMS). The recoveries were in a range of 72-
93% at three spiking levels, with repeatability and reproducibility results 
expressed as relative standard deviations (RSDs) lower than 7% and 14%, 
respectively. The limits of quantification (LOQs) were in the range of 0.01-50 
pg/mL. Matrix effects obtained were in the range of 75-97%. The results 
obtained from the study showed that none of the analyzed samples (n=56) 
were contaminated with mycotoxins, whereas the presence of up to seven 
veterinary drug residues in 50% of analyzed samples was detected (range of 
0.007-4.53 ng/mL). None of the analyzed VDs had a concentration level 
higher than their permitted limits, except for benzylpenicillin procain (4.53 
ng/mL). In the post-target screening, 53 contaminants were tentatively 
identified. Regarding the incidence of mycotoxins, AFM2 contamination was 
displayed in >70% of analyzed samples. A significant percentage (>80%) has 
been shown by betamethasone, prednisolone and oxfendazole. Special focus 
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should be paid to the latter, considering that the maximum residue limit 
permitted in EC 37/2010 is really low, 0.3; 6; 10 μg/Kg, respectively. In 
addition, other eleven VDs identified in analyzed milk samples are 
prohibited in milk by the regulation in force (EC 37/2010).  From the obtained 
values seems to be clear the necessity of a continuous monitoring of 
contaminants in the milk production chain. 
   The second part of my Ph.D. project was based on the re-evaluation of 
whey, one of the highest polluting liquid wastes of the dairy industry. 
Environmental and economic problems associated with food waste have 
induced industries to reuse these materials in order to minimize food waste. 
In this sense, I have evaluated the bioactivity of two typologies of whey 
(freeze-dried cow’s and liquid goat’s whey) after subjecting these by-
products to the fermentation process by lactic acid bacteria (Lactobacillus 
plantarum CECT 220, 221, 223, 748). Antifungal activity performed against 30 
mycotoxigenic fungi belonging to the Penicillium, Aspergillus and Fusarium 
genera has shown a satisfying inhibitory effect. The value of MIC for 
Aspergillus and Fusarium genera was included in a range from 1.95 to 62.5 g/L 
whereas for Penicillium genera was included in a range from 3.9 to 125 g/L.  
The value of MFC was contained between 15.6 and 250 g/L for Aspergillus, 
62.5 and 250 g/L for Penicillium, 3.9 and 250 g/L for Fusarium. The antifungal 
activity could be correlated to the presence of phenolic compounds identified 
in cell-free-supernatant. Based on previously performed experiments, 
mycotoxigenic strains of P.  expansum and P. brevicompactum were employed 
for studying the shelf-life improvement of bread.  
  A valuable increase in the shelf-life was obtained for pita bread prepared 
with fermented whey. In particular, after the inoculation of bread with 
Penicillium, a rise of 1-2 and 7-8 days for the two typologies of assayed whey 
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 Abstract 
was compared to a positive control. Through a natural contamination, an 
increase in the preservation period of bread (until the 20th day) was observed. 
  Regarding the antimicrobial activity,  by adding the 1% of freeze-dried 
fermented whey in bread preparation, a percentage reduction ranged 
between 12-23% was obtained, whereas with the replacement of 100% of 
water used in bread preparation with whey fermented by LAB, the 
percentage of reduction has the highest peak of increase ranged from 42 to 
92% for the different typologies of test performed. 
   In addition, concerning freeze-dried whey, I have evaluated the 
antioxidant, antihypertensive, and iron binding activity of the permeate, 
consisting of small bioactive compounds purified on Centricon Amicon with 
a cut-off of 3 kDa.  The results highlighted a radical cation scavenging 
activity ranging from 1.415 to 2.083 mmol trolox equivalents TE/per kg of dry 
weight, a percentage of iron binding capacity ranging between 23–55% and a 
percentage of ACE inhibitory activity ranging between 67–85%. The optimal 
biological activity was obtained from whey fermented by L. plantarum 220 for 
all the assays performed, except for the iron chelating activity. These results 
confirm the interesting use of lactic acid bacteria as a source of new natural 
preservatives, which can contribute to the maintenance of food quality and 
safety. The obtained results support the hypothesis of using whey as a 
functional ingredient to improve food preservation and its potential use in 
nutraceutical formulation. 
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 Introduction 
INTRODUCTION  
 Objectives of the project  
 
   The overall goals of this Ph.D. project were: (i) the development a multi-
residue method for the simultaneous determination of milk contaminants 
including mycotoxins and veterinary drug residues, throughout a 
UHPLC Q-Orbitrap HRMS analysis, to investigate the occurrence in milk 
samples; (ii) a study regarding the potential bioactivity of dairy waste 
products, particularly the whey, in order to reuse this by-products in the 
bread preparation replacing it with the chemical preservatives. 
 
 Brief description of the outline of the thesis 
         A brief description of my Ph.D. project and its main objectives was 
reported in this paragraph. The thesis is subdivided in two section; in the 
first part, the SECTION I, I have reported the experiments performed on 
milk to optimize a method for the simultaneous investigation of 
veterinary drug residues and mycotoxins which occurrence in milk. In 
this section, there are two chapters; chapter 1, in which there is an 
introduction about the production and the consumption of milk and the 
contaminants that could be found in it, such as mycotoxins and 
veterinary drug residues. Furthermore, I have reported the settlement in 
which was estabilished the maximum amounts of these contaminants in 
milk permitted in EU. Finally, I have described the selected extraction 
procedure and the technique that I have used to identify and quantify the 
contaminants in milk; in this case, I have employed a recent development 
of mass spectrometry: Q-Exactive Orbitrap. Chapter 2 of this section 
contains the general and specific objectives that I have reached in this 
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first part. The latter chapter is subdivided in four subsections. The first 
specific objective includes the optimization of the chromatography and 
mass spectrometry conditions. The second specific objective considers 
the various test performed to obtain the optimization in the extraction 
process. The third specific objective describes the validation of method, 
and finally, the last specific objective includes the application of the 
validated method to 56 milk samples purchased in a supermarket in 
Naples, Campania. The last part of the first section contains the 
conclusions of the first section. 
 
   The second part, SECTION II of my project includes the study of whey 
in order to re-evaluate this by-product. I studied two types of whey: 
freeze-dried commercial cow’s whey and liquid sweet goat’s whey. I 
started my experiments evaluating the antifungal activity and the 
bioactivity of a commercial freeze-dried cow’s whey and then, 
considering the promising results obtained, I decided to continue my 
experiments on whey coming from goat’s milk. Also SECTION II is 
subdivided into two chapters. Chapter 1 begins with a brief description of 
whey, its impact on the environment and the possibility to reuse this by-
product after its fermentation by lactic acid bacteria. In this introductory 
part, I have described the potential biological activities awarded to the 
bioactive compounds derived from fermented whey (proteins, phenolic 
compounds, etc) and their possible application to increase the shelf-life of 
food. Chapter 2 includes the general and specific objectives that I wanted 
to reach. Chapter 2 is divided in turn in four subsections. The first specific 
objective of section II has been concerned the sample preparation for the 
experimental part, the evaluation of the macronutrients content of the 
two types of whey, the pasteurization of the liquid sweet whey adopted 
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to remove the microorganisms growth, and finally the further 
fermentation procedure was reported. In the specific objective 2, various 
assays of antifungal activity of fermented whey by four strains of L. 
plantarum (220, 221, 223 and 748) against thirty mycotoxigenic fungi were 
performed. In addition, the identification of phenolic compounds 
deriving from the fermentation process was carried out. The inhibition 
fungal growth assays on fermented whey gave us an initial overview on 
the antifungal activity of the different typologies of studied whey, 
confirming the interest in continuing the investigation on sweet whey 
fermented with L. plantarum 220, 221, and 223, given their effectiveness as 
antifungal agents. On the other hand, whey fermented by L. plantarum 748 
was not taken into account, having shown a strongly inferior activity 
compared to the other ones. So, I decided to text the antifungal activity on 
a typical greek bread namely “pita bread”. In specific objective 3, I have 
reported my experiments concerning the application of whey in bread 
preparation. I explained the contamination with two mycotoxigenic fungi 
(P.expansum and P.brevicompactum) given its recurrence in the 
contamination of bread, and I compared the results obtained by artificial 
contamination of bread with a natural contamination due to the normal 
environment. Finally, a microbiological assay on three typologies of bread 
was performed alongwith the evaluation of pH after the preservation 
period. In the last part of this section, the evaluation of the biological 
activity of freeze-dried whey including antioxidant, iron-binding and 
ACE inhibitory activity was presented. The conclusions were reported at 
the end of the section. 
  An increase of the shelf-life of pita bread was obtained replacing liquid 
whey in the fermentation process. Furthermore, whey could be a great 
candidate for the formulation of a potentially new nutraceutical. 
 4  
 
Section I Chapter 1-Milk 
 SECTION I 
 
CHAPTER 1 - Milk  
 
   Milk is a beverage widely consumed in the world, not counting water, 
which provides high-quality nutrition to infants, children, and adults due to 
its high content of micro- and macronutrients. Generally, the intake of milk 
in most of the species concludes at the end of the weaning period, except in 
humans, in which milk consumption ongoing even during adulthood (Chon 
et al. 2016). 
   The Regulation (CE) No. 853/2004 of the European Parliament and of the 
Council of 29 April 2004, which establishes specific rules on hygiene for food 
of animal origin, defines: 
"raw milk" as milk produced by the secretion of the mammary gland of farmed 
animals which has not been heated to more than 40°C and has not undergone any 
treatment having an equivalent effect; 
"Dairy products" are defined as products resulting from the processing of raw milk 
or further processing of those products; 
"Milk production holding" means an establishment where one or more farmed 
animals are kept to produce milk with a view to placing it on the market as food (EC 
No 853/2004). 
   According to the latest data reported by Food and Agriculture 
Organization of the United Nations (FAO), the European population has a 
significantly higher milk and dairy consumption than the global population, 
with an annual per capita data of 236.4 kg and 90 kg, respectively. Among 
the European countries, Italy is one of the highest milk and dairy consumers, 
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with an annual per capita consumption of 246.9 kg. In 2016 worldwide milk 
production was around 659 million tonnes, with an increase compared to 
2006 of 14.7%. Italy milk production in 2016 was about 10 million tons, a 
constant value over the past 10 years (FAO, 2013). Cows' milk production 
and consumption are reported in table 1. 
Table 1. Cows' milk production in the world and in Italy and milk consumption in Europe 
and Italy from 2006 to 2016 (FAOSTAT, 2018). 
  Production    
(million tonnes) 
Consumption         
(kg/per capite) 
Year World Italy UE Italy 
2006 562.3 10.9 239.29 269.29 
2007 574.7 10.6 240.51 258.15 
2008 587.7 11.3 238.16 268.07 
2009 591.7 10.6 238.34 258.28 
2010 602.9 10.5 236.77 257.59 
2011 617.3 10.5 238.2 260.78 
2012 631.4 10.6 235.47 255.44 
2013 636.6 10.4 236.41 246.88 
2014 656.7 11.0 n.d. n.d. 
2015 666.7 11.1 n.d. n.d. 
2016 659.1 10.8 n.d. n.d. 
n.d. not reported    
 
   The most commonly consumed types of milk is represented by bovine milk 
corresponding at 85% of the worldwide milk production, and the remaining 
part is divided between buffalo milk (11%), followed by goat (2.3%), sheep 
(1.4%) and camel milk (0.2%). The consumption of goat, sheep, buffalo, and 
camel milk are prevalent popular in other countries (Gerosa & Skoet, 2012). 
The nutritional composition of different types of milk is shown in table 2 and 
detailed composition of cow’s milk is reported in table 3. Note that, several 
factors can influence the chemical composition of milk including 
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environmental conditions, animal nutritional status, lactation stage and 
animal species (Schwendel et al. 2015). 
 
Table 2. Milk composition of selected animals' average % of whole milk. 
 
Composition Cattle Buffalo Sheep Camel Goat Yat Horse 
Water 86.4 83 81.25 87 86.9 82 90 
Fat  4.36 9.2 6.7 4.51 4.4 7.25 1.25 
Proteins 3.37 4.86 5.17 3.64 3.4 6.2 2.15 
Lactose 4.86 4.52 4.45 4.3 4.58 4.86 6.4 
Minerals 2.15 0.8 0.9 0.77 0.8 0.8 0.4 
Source: Compilated from multiple source 
 
Table 3: Macro and micronutrient composition of cow's milk (CREA, 2018). 
Composition Values / 100 g 
Energy (kcal) 63 
Water (g) 87.6 
Proteins (g) 3.3 
of which:  
Casein (%) 80 
Serum proteins (%) 20 
Fat (g) 3.6 
of which:  
Total saturated (g) 2.11 
Total monounsaturated (g) 1.1 
Total polyunsaturated (g) 0.12 
Cholesterol (mg) 11 
Carbohydrates (g) 4.7 
Calcium (mg) 120 
Potassium (mg) 150 
Phosphorus (mg) 95 
Iron (mg) 0.2 
Magnesium (mg) 11 
Zinc (mg) 0.3 
Vitamin C (mg) 1 
Vitamin B1 (mg) 0.04 
Vitamin A (μg) 50 
Vitamin E (mg) 0.07 
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   Nowadays, the demand for milk protein and its products has risen 
substantially due to the impact on health and high biological effect. Milk 
protein may prevent bone breakdown, improve muscle movement, build-up 
muscles, raise satiety, control blood sugar, decrease the risk of some cancers 
and act on several biological disorder (Haug et al. 2007; Durazzo, 2017). 
1.1 The main milk contaminants 
    Despite the benefits that milk provides from a nutritional point of view, it 
may also be a vehicle of food contaminants, such as mycotoxins and 
veterinary drug residues (VDs) due to nasty agricultures practices or 
improper usage of these drugs. In this sense, the first part of my project 
include the studies regarding the topics mentioned above. 
1.1.1. Mycotoxigenic fungi  
   Toxigenic fungi are ubiquitous in nature and are considered to be among 
the most notable contaminants in foods concerning the impact on food 
safety, public health, and the national economy of several countries 
(Milićević et al. 2010, Adeyeye et al. 2016). The natural fungal flora related 
with foods is dominated by three genera of fungi: Aspergillus, Fusarium, and 
Penicillium which may be contaminated foods, feeds or the raw materials 
used to produce them, lead to the loss of food products. Foods contamination 
depends on different environmental factors such as moisture, temperature, 
and a matrix that favours the growth of a particular mould (Bhat et al. 2010). 
These three genera of filamentous fungi produce mycotoxins, secondary 
metabolites, capable of having acute toxic, carcinogenic, mutagenic, 
teratogenic, immunotoxic, and estrogenic effects in humans and animals 
(Sweeney et al. 1998; Pitt et al. 2000; Calvo et al. 2002; Richard, 2007). 
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Penicillium species  
   Penicillium represents a huge genus of fungi of which belonging to 150 
different species, and about 50 or more common occurrence (Pitt et al. 1988). 
The variety of mycotoxins produced by Penicillium species is broader than 
other fungal genera. Several Penicillium species are among the most common 
agents of postharvest diseases affecting a wide range of fruits and vegetables. 
The major agent causing the blue mould rot of apples, pears and other fruits, 
is an example of the destructive postharvest pathogens of Penicillium 
expansum, that cause a large part of the economic losses that occur during 
storage and shipment. In addition to losses that are involved in postharvest, 
various Penicillium species may produce a variety of mycotoxins (Barkai-
Golan & Paster, 2001). The Penicillium mycotoxins of importance in fruits and 
vegetables include patulin, ochratoxin A, citrinin, penicillic acid, 
cyclopiazonic acid, citreovirdin, penitrem; and other secondary metabolites, 
such as chaetoglobosins, communesins, roquefortine C, expansolides, 
janthitrems, paxillines, which may cause toxic responses in humans and 
animals. The most common mycotoxin of P. expansum is patulin, a relatively 
small molecule which may be produced by other Penicillium or by different 
Aspergillus species (Barkai-Golan, 2008).  
Aspergillus species 
   Aspergillus is a group of moulds common in worldwide having a particular 
importance as organisms responsible for spoilage food and represent a large 
proportion of moulds found in industrial food (Yu et al. 2002, Taniwaki et al. 
2018). Aspergillus species are more important in tropical and subtropical 
areas. Under favourable environmental conditions, Aspergillus species bring 
to changes in sensorial, nutritional and qualitative nature such as 
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pigmentation, discolouration, development of off odours and off flavours in 
foodstuffs and animal feeds (Perrone et al. 2007). As it has been reported by 
different recent papers, almost 50 species of Aspergillus genus showing the 
capacity to produce mycotoxins. Mycotoxins produced by Aspergillus species 
are able to grow up in whatsoever conditions, for example, Aspergillus niger, 
the most common species of Aspergillus responsible for post-harvest 
deterioration, occurring on a great variety of substrates. Aspergillus flavus, an 
opportunistic pathogen, is more frequently encountered in warm climates 
between 16 and 35 degree latitudes, and it is uncommon above 45 degree 
latitudes (Amaike and Keller, 2011; Ashiq, 2015; Pitt et al. 2000; William, 
2018). As it is well-Known, the strains of Aspergillus are able to produce 
aflatoxins. The strains of A. flavus, A. parasiticus are producers of more than 
one aflatoxins like aflatoxins B1, B2, G1, and G2 and therefore these toxins 
can often be found in foods as mixtures, whereas closely related fungi such 
as A. oryzae and A. sojae, have never been shown to produce aflatoxins 
(Krishnan et al .2009). Aspergillus is responsible for a spectrum of disease, 
including allergic bronchopulmonary aspergillosis (ABPA), aspergilloma, 
chronic aspergillosis, and various forms of invasive aspergillosis, caused 
principally by A. fumigatus specifically for pulmonary, sinus, and central 
nervous system infection (Mwanda et al. 2005). 
Fusarium species 
   Fusarium is regarded as one of the most important mycotoxigenic fungi 
genera. The Fusarium species are the most common fungi found on cereals 
grown in the temperate regions of America, Europe and Asia (EFSA, 2002a). 
Fusarium species can produce three of the most important classes of 
mycotoxins ones based on occurrence and toxicity: fumonisins (FBs), 
zearalenone (ZEA), and trichothecenes (deoxynivalenol (DON), nivalenol 
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(NIV), T-2 and HT-2 toxins), whereas Fusarium genera are also able to 
produce emerging mycotoxins, like fusaproliferin (FUS), beauvericin (BEA), 
enniatins (ENNs) and moniliformin (MON), which are more recently 
discovered and less studied (Summerell and Leslie, 2011; Escrivá et al. 2015). 
Fusarium mycotoxins are widely distributed in the food chain, showing a 
high occurrence especially in corn and wheat, the main sources of food 
intake of these toxins, but they can also found in other products including 
rice, barley, oats, potato and fodder (Cendoya et al. 2018).  Generally, infect of 
Fusarium in cereals occurs in the field mainly before harvest. To this end, 
various actions must be carried out during the cultivation, harvesting and 
storage step and the application of agreeable agricultural practices, collection 
and storage (Nesic et al. 2014). As regarding the toxicity, DON, the most 
commonly detected Fusarium mycotoxin in cereal grains, was related to 
deleterious health effects such as malnutrition, endocrine dysfunction, 
anorexia, weight loss, and immune alterations (Pestka, 2010) but is non-
classifiable as carcinogenic to humans (IARC, 1993). 
1.1.2. Mycotoxins  
   Mycotoxins are secondary toxic low weight metabolites which are 
produced by several species of fungi, including Aspergillus, Penicillium, and 
Fusarium genera, but also Trichoderma, Trichothecium and Alternaria are 
important as food contaminants or pathogens for plants (Flores-Flores et al. 
2015; Bhat et al. 2010). These fungi are able to contaminate agricultural 
products and to produce mycotoxins under favourable conditions, during 
pre- and post-harvest practices, processing and storage steps. The production 
of mycotoxins is stimulated by certain environmental factors: therefore the 
extent of contamination will differ with geographic location, agricultural 
methods and the susceptibility of commodities to the penetration of fungi 
 11  
 
Section I Chapter 1 - Milk 
during storage and processing periods (Alshannaq et al. 2017). 
Contamination of food and feed with mycotoxins is a worldwide problem. In 
fact, the Food and Agriculture Organization (FAO) has estimated that a 
quarter of the world’s crops are contaminated with mycotoxins, and it has a 
major economic impact (FAO, 2003). Moreover, mycotoxins are of significant 
public health concern, based on their high toxic profile. Mycotoxins may 
cause different toxic effects in animal and humans including carcinogenic, 
mutagenic, teratogenic, immunotoxic, estrogenic effects and mycotoxicoses 
(Schatzmayret al  2013; Streit et al. 2013; Urusov et al. 2015). Some of the most 
important mycotoxins are aflatoxins, fumonisins, trichothecenes, ochratoxins, 
sterigmatocystins (STCs), and zearalenones (ZEAs) which will be further 
described in the next paragraph (Wu et al. 2014a). 
Aflatoxins 
   Aflatoxins are a subgroup of toxins produced by different Aspergillus strains 
includes: Aspergillus flavus, Aspergillus parasiticus, Aspergillus nomius, 
Aspergillus pseudotamarii, and Aspergillus bombycis (Amaike and Keller, 2011; 
Becker-Algeri et al. 2016).  Structurally, are a group of 20 related polycyclic 
structures belonging to the furanocoumarin class of compounds.  Aflatoxins 
are classified in four major group: B1, B2, G1, and G2 with respect to the 
structural difference on their blue (B) or green (G) fluorescence under UV 
light and their relative chromatographic mobility (Yu, 2012). Apart from 
these, in mammals that consumed a diet contaminated with mycotoxins, the 
metabolism of aflatoxins B1 and B2 bring to the production of aflatoxins M1 
and M2, which are metabolized and then transferred to animal-derived food. 
Aflatoxin B1 conversion to aflatoxin M1 involves the hydroxylation of the 
tertiary carbon of the difuranocoumarin ring, and the hydroxyl group 
increases water solubility, allowing a rapid excretion in urine, milk, and 
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feces. The rate of transformation of aflatoxin B1 in their metabolite M1 was 
up to 6 %, and this value is influenced by various factors including season, 
environmental conditions, geographic location, and diversity of the farming 
systems (Becker-Algeri et al. 2016). In fact, several studies reported that milk 
produced during the cold season was more contaminated than milk 
produced during the warm season, owing to the favourable conditions for 
fungal growth in cattle feed that had been stored for longer times during the 
cold season (Meat et al. 2008, Pleadin et al. 2015; Gnonlonfin et. al 2013). 
Generally, aflatoxin M1 can be detected within 12 h after animals are fed an 
aflatoxin B1-contaminated feed, whereas in humans, the exposure to 
aflatoxin M1 is correlated to the milk consumed in the diet (Giovati et al. 
2015). 
Toxicity 
   Aflatoxins are one of the most potent toxic substances that occur naturally. 
The adverse effects of aflatoxins can be classified into acute and chronic 
toxicity. Acute toxicity is caused when large doses of aflatoxins are ingested 
through the feed. Chronic toxicity occurs after a long-term exposure to low 
or moderate concentrations of aflatoxins. Adverse effects of this class of 
toxins include various forms of aflatoxicosis after aflatoxin exposure in 
humans. Acute aflatoxicosis which results from a few exposures may result 
in death, whereas chronic aflatoxicosis causes immune suppression, 
undersides growth, and hepatocellular carcinoma (Kamala et al. 2018, 
Guterres et al. 2017; Klich, 2007). Among the mycotoxins identified so far, 
aflatoxins (AFs), are the most extensively studied and one of most important 
classes from a public health perspective and are classified as carcinogenic to 
humans (Group 1) by the International Agency for Research on Cancer, the 
specialized cancer agency of the World Health Organization (IARC, 2012).         
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   Aflatoxins cause immunogenic, highly teratogenic, and mutagenic effects in 
humans and animals, retard the growth in experimental animals and have 
been reported to provoke hepatic cancer in humans (Do et al. 2007; Kew, 
2013; Yu, 2012, Luzardo et al. 2016). The toxicity of the aflatoxins increases in 
the order G2, B2, G1 and B1. Extensive research on various animal species 
has shown that aflatoxins, especially aflatoxin B1, are potential carcinogens 
(De Ruyck et al. 2015; Wu et al. 2009; Liu et al. 2012). In particular, the 
aflatoxin metabolite that exerts the carcinogenic effects is aflatoxin B1-8,9-
epoxide (AFBO), which is able to form adducts with proteins and DNA, and 
produce mutations (Woo et al. 2011). One of the most studied mutational 
effects of aflatoxin B1 involves the human p53 gene. In fact, is reported 
mutations in this gene in 50% of the people with hepatocellular carcinoma  
(Aguilar et al. 1993; De Giorgi et al. 2015). Other studies reported the 
correlation between hepatocellular carcinoma and aflatoxin exposure up to 
about 25% (Magnussen et al. 2013; Liu and Wu, 2010).  
Ochratoxins 
   Ochratoxins are secondary fungal metabolites produced by two genera of 
fungi, Aspergillus and Penicillium. Chemically, they consist of an isocoumarin 
and a phenylalanine moiety linked by an amide bond. Ochratoxin comes in 
three secondary metabolite forms, A, B, and C. Ochratoxin A (OTA) is a 
chlorinated toxin, first described in 1965 (van der Merwe et al. 1965). The 
Ochratoxin B (OTB) is a nonchlorinated form of Ochratoxin A (OTA) and 
Ochratoxin C (OTC) is an ethyl ester form Ochratoxin A (Bayman and Baker 
et al. 2006; Marin et al. 2013; Jeswal & Kumar, 2015). OTA is concentrated in 
the grain husks, in barley, wheat, rye, maize and rice, legumes, cacao, spices, 
wines, and raisins, and it has also been described in cows’ milk and pork 
products (Duarte et al. 2010). Due to it stability, OTA is not destroyed by 
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common food preparation procedures. Based on its high affinity for proteins 
like albumin, OTA accumulates in animal organs and may cause carryover of 
the contamination (Bayman and Baker et al. 2006). 
Toxicity  
   Ochratoxins have been labelled as a carcinogen, nephrotoxic, hepatotoxic, 
teratogenic, and immunotoxic compounds, and have been linked to cancer in 
the human urinary tract. In humans, renal cancer can occur when the diet 
contains more than 70 μg/kg OTA per day (Reddy and Bhoola et al. 2010).  
Teratogenic effects have been documented in several animal models, 
including mouse, rat, hamster, rabbit, and chick, and reduced birth weight 
and craniofacial abnormalities were the most common manifestations 
(Heussner and Bingle et al .2015; Malir et al. 2013). In this sense, IARC has 
classified OTA in 2B group (possibly carcinogenic agent). 
Exposure  
   The Committee established a PTWI of 112 ng/kg bw/week, based on the 
deterioration of renal function in pigs, for which the LOEL was 8 μg/kg 
bw/day, and application of a safety factor of 500 (FAO, 2003). 
Fumonisins  
   Fumonisins were discovered in 1988, through their isolation from cultures 
of Fusarium verticillioides, a frequent worldwide contaminant of maize 
particularly in warm and wet regions. In addition to corn and corn-based 
foods, the occurrance of FB1 was also described  in beer, beans, soybeans, 
rice, sorghum, and asparagus (Scott, 2012).  Structurally,  they contain a long 
hydroxylated hydrocarbon chain and tricarballylic acid, methyl, and amino 
groups, of which the amino group is important for biological activity 
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(Stockmann-Juvala and Savolainen, 2008). Fumonisins have been grouped 
into four major categories, the A, B, C, and P. The predominant molecular 
form produced by Fusarium moniliforme is namely fumonisin B1, which is 
also able to produce FB2 (the 10-deoxy FB1) and FB3 (the 5-deoxy FB1) in 
significantly lower quantities (Soriano et al. 2005). Even though various 
studies did not find FB1 contamination in milk (Scott et al. 1994; Richard and 
others, 1996), the transfer of these contaminants to milk has been previously 
confirmed (Maragos and Richard 1994; Gazzotti et al. 2009; Gonzalez-Peñas et 
al. 2015).  
Toxicity  
   Fumonisins exposure has been linked to carcinogenic effects in human and 
animals including liver, esophageal and kidney cancer. In addition, 
pulmonary artery hypertrophy and porcine pulmonary edema in swine, 
equine leukoencephalomalacia in horses, and atherosclerosis in monkeys 
were reported(Marasas et al. 2004; Domijan, 2012; Raiola et al. 2015, 
Ahangarkani et al. 2014; Escrivá et al. 2015). As regarding the toxicity, the 
most toxic compound FB1 is classified by the IARC as a Group 2B possible 
carcinogen to humans (IARC, 2012). 
Exposure  
   The Joint FAO/WHO Expert Committee on Food Additives established the 
maximum tolerable daily intake of fumonisins as 2 μg/kg body weight for 
FB1, FB2, and FB3, alone or in combination (Marasas et al. 2004, WHO, 2002). 
Trichothecenes 
   Trichothecenes (TCs) are a complex group of mycotoxins, structurally 
related to sesquiterpenoids. Based on their structural features, they are 
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divided into four groups (A, B, C and D); among these classification type A is 
more toxic than type B. Several genera of fungi belonging to the Fusarium, 
Stachybotrys, Myrothecium, Trichothecium, Trichoderma, Cephalosporium, 
Cylindrocarpon, Verticimonosporium, and Phomopsis genera can produce 
trichothecenes (Scott, 1989).  Generally, TCs type A are producing by F. 
sporotrichioidies, F. poae and F. equiseti and TCs type B are produced by species 
of F. graminearum and F. culmorum. Structurally, trichothecenes can be 
macrocyclic and nonmacrocyclic due to the presence of macrocylic ester or of 
an ester–ether bridge between C-4 and C-15.  The principal TCs type A 
includes: toxins T-2 and HT-2, diacetoxyscirpenol (DAS), neosolaniol (NEO) 
which do not possess a ketone group in position C-8. TCs type B are 
characterized by the presence of a ketone group in this position. In the latter 
group are included deoxynivalenol (DON), nivalenol (NIV), and their 
acetylated derivatives: 3-acetyldeoxynivalenol (3-ADON), 15-
acetyldeoxynivalenol (15-ADON) and X-fusrenone (FUS-X) (Krska et al. 
2007). Even though milk is not considered a significant source of 
trichothecene toxins, high levels of feed and silage contamination can also 
result in significant levels present in milk. Recent studies have reported that 
animals ingesting feed contaminated by type A or B trichothecenes (DON or 
T-2 toxin) showed mycotoxin biotransformation and excretion in fluids such 
as milk, thus classifying these as a risk to human health (Danicke and 
Brezina, 2013). However, there are few reports of the natural occurrence of 
these toxic compounds and their metabolites in milk samples intended for 
human consumption (Signorini et al. 2012).  
Toxicity  
   The main adverse effects of TCs are classified in acute and chronic 
disorders. An acute toxicity can result in nausea, vomiting, loss of appetite, 
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growth retardation, and diarrhea. Systemic toxic effects include remarkable 
immunosuppressive activity and cytotoxicity attributed to the strong 
inhibition of protein, RNA and DNA synthesis (Cope, 2018; McLaughlin et al. 
2017; Konigs et al. 2009; Wan et al. 2015; Sobrova et al. 2010). Within the TCs, 
the HT-2 and T-2 toxins are known to produce the Food Poisonous Aleukia 
(ATA), characterized by sepsis, haemorrhages and general pancytopenia. 
The TCs have been classified as non-carcinogenic for humans (Group 3) 
according to the IARC (1993).  
Exposure 
   The Joint FAO/WHO Expert Committee on Food Additives established the 
maximum tolerable daily intake of DON (including its acetylated forms 3-
DON and 15-DON) as 1 μg/kg per body weight  and 60 ng/kg bw/day for T2 
and HT-2 toxins alone or in combination  (FAO, 2004). 
Zearalenone 
   Zearalenone (ZEA) is a toxin produced from fungi of the genus Fusarium 
like F. graminearum, F. culmorum and F. equiseti. Structurally, is a lactone 
mycotoxin similar to 17β-estradiol, and its main metabolites are alpha and 
beta Zearalenol. ZEA is mainly present in corn but the toxin has also been 
detected in wheat, barley, oats, sorghum, rye, rice, and soybean products 
(Minervini et al. 2005, Zinedine et al. 2007; Summerell et al.  2012). 
Toxicity  
   ZEA possesses pronounced estrogenic effects and various studies have 
hypothesized its ability to competitively bind estrogen receptors, explaining 
the alterations of reproductive tract observed and its ability to impair fertility 
in mice, rats, guinea pigs, hamsters and rabbits, and domestic animals (De 
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Ruyck et al. 2015; Escriva et al. 2015; Zinedine et al. 2007). The Agency 
International for Cancer Research has classified Zearalenone in Group 3 as 
"not classifiable as a carcinogenic agent for humans ". 
Exposure 
   The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has 
established a temporary tolerable maximum level of daily intake for 
Zearalenone and its metabolites (including alpha Zearalenol) of  0.25 μg/kg 
per body weight (EFSA, 2016).  
Enniatins 
   ENs (A, A1, B and B1) and BEA are cyclohexadepsipeptides composed of 
alternating residues of three N-methyl amino acids, commonly leucine, 
isoleucine and valine, and three hydroxy acids, typically hydroxyisovaleric 
acid. ENs are produced by F. trincinctum, F. poae, F. sporotrichioides, and F. 
langsethiae species, whereas BEA producers include  F. poae, F. langsethiae, F. 
verticillioides, F. sporotrichioides, F. sambucinum, F. proliferatum, and F. 
subglutinans. Finally, the strains of F. avenaceum can produce both ENs and 
small amounts of BEA (Logrieco et al. 1998; Thrane, 2001). ENNs possess 
antifungal, antimicrobial, anthelmintic, herbicide phytotoxic and cytotoxic 
potential activity. BEA has demonstrated insecticidal activity against a broad 
spectrum of microorganisms and an antibacterial activity against human, 
animal and plants pathogenic bacteria with no selectivity between Gram-
positive and Gram-negative bacteria (Ruiz et al. 2011). 
Toxicity  
   The mycotoxins mentioned above have demonstrated cytotoxic effects and 
are also able to change the intracellular ionic homeostasis. The principal toxic 
action of ENNs is related to their ionophoric properties, by which ENNs are 
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capable of promoting the formation of stable lipophilic complexes with 
essential cations mono and divalent (Ca2+, Na+, K+) and their transport 
through biological membranes, disrupting normal physiological 
concentrations (Uhlig et al. 2006; Firakova et al. 2007, Wang & Xu, 2012). 
1.1.3. Classification of veterinary drugs 
1.1.3.1. Antibiotics 
   Antibiotics are drugs extensively used in the treatment and prevention of 
bacterial diseases, which can kill microorganisms or inhibit their growth. 
Generally, this class of drugs was used for therapeutic purposes to protect 
animal health but also to prevent economic loss, ensuring the safe food 
supply (Sarmah et al. 2006; Du and Liu, 2012). To treat or prevent infections 
of animals, they are applied as drugs or feed additives. The use of antibiotics 
in food producing animals is widely adopted worldwide, despite their use 
for growth promotion in livestock production was banned in EU (EU, 2003; 
Tang et al. 2018, Hao et al. 2014; Courtheyn et al. 2002; Serratosa et al. 2006). 
   The widespread use of antibiotics is often employed for no-therapeutic 
purposes. The main concern of extended antibiotics use is the promotion of 
bacterial resistance, which can enhance the formation of single, cross- and 
multiple resistance in pathogens, commensal and environmental bacteria 
(Laxminarayan et al. 2013). The most frequently used antibiotics are 
tetracyclines, sulphonamides, β-lactams and macrolides (Etebu et al. 2016; 
Sarmah et al. 2006). Among veterinary drugs can be found compounds with 
growth promoting activities which are substances improving the growth rate 
and feed efficiency of domestic animals when are added to animal feed in 
sub-therapeutic doses over an extended period of time (Kools et al. 2008; 
Bártíková et al. 2016; Lozano and Trujillo, 2012; Ronquillo et al. 2017).  
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Penicillins  
   Penicillin was one of the first widely available antibiotics, coming into use 
in the early 1940s. Despite its remarkably nontoxic effects to humans, it has 
shown immunogenicity reactions, in its early versions. Approximately 4-11% 
of the human population are believed to be allergic to penicillin and 
correlated drugs, thus exposure to this class of drug via food animal residues 
puts them at risk for developing allergic reactions which may range from 
minor reactions, like a skin rash, to severe anaphylaxis (Dayan, 1993). In 
particular, 6 ng/mL corresponding to 10 IU (0.6 mg), of drug in milk can 
cause anaphylaxis (EMA, 2008; Baynes et al. 2016). In this sense, the MRL and 
tolerance for this drug in milk is less than this concentration in many 
jurisdictions such EU and Codex, having an MRL <of 4 ng/mL (JECFA, 2015). 
Tetracyclines   
   Tetracyclines, in addition to bacterial infections usage, have been also 
approved in various cases to treat Mycoplasma in poultry. Generally, are 
used for as few as 3-5 days or as long as several weeks in feed or water in 
order to control or treat bacterial enteritis or pneumonia. Anaphylaxis to 
tetracyclines is uncommon compared to the beta-lactam drugs.  Human 
exposure to minocycline, a subgroup of tetracycline, has been correlated to 
approximately 13% adverse effects of which a small number results in 
anaphylactic reactions (Winckler & Grafe, 2001; Kemper, 2008; Jamalet al. 
2017).  
Aminoglycosides 
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   As regard aminoglycosides, gentamicin and neomycin were usually used in 
livestock. Predominantly, they were used for treatment of infectious 
keratoconjunctivitis caused by Moraxella bovis in cattle, or to treat or control 
bacterial enteritis in piglets or young chickens and turkeys. To date, there is 
no reported evidence of human consumption of meat or milk products 
containing tetracyclines or aminoglycosides having resulted in adverse 
reactions associated with aminoglycoside or tetracycline toxicity (Krause et 
al. 2016). 
Sulfonamides 
   One of the oldest groups of antimicrobials used in food animal production 
for over 60 years were represented by sulfonamides, the third most 
commonly antimicrobial used in food animals behind tetracyclines and 
penicillins. The main reasons for the occurrence of sulfonamide residues 
could be improper feed mixing, failure to observe the proper withdrawal 
time, and improper cleaning of feed mixing equipment. In addition, 
excretion of sulfamethazine in the feces and urine could also cause 
recontamination of the environment in swine and poultry houses and results 
in residues in the next group of animals when cleaning was not properly 
done (Barani et al. 2015). Oral sulfachlorpyridazine and sulfamethazine are 
commonly administered to calves to treat diarrhea, although there are 
restricted efficacy data that support this use (Riviere and Papich, 2009). 
Occasionally, sulfonamides are utilized in the poultry industry to control 
coccidiosis. The use of sulfonamide drugs can bring to the adverse drug 
reactions such as skin reactions which can range from a mild rash to a severe 
toxidermia or epidermal toxic necrolysis. Acute liver injuries associated with 
cotrimoxazole are also frequently reported in humans (Choquet-
Kastylevskey et al. 2002). However, blood dyscrasias including neutropenia, 
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hemolytic anemia, thrombocytopenia and pancytopenia have been 
associated with sulfonamide use in humans. Another concern associated 
with the ingestion of sulfonamides is thyroid cancer, in fact, sulfamethazine 
produced a dose-dependent increase in follicular cell adenomas of the 
thyroid gland in both male and female mice (Tijani et al. 2016).  
Chloramphenicol  
   Chloramphenicol is an older antibiotic widely used in pet animals. This 
antibiotic has a broad-spectrum antimicrobial activity against Gram-positive 
and negative microorganisms, anaerobes and rickettsiae. Several animal-
derived food products including milk, honey, and meat have been 
contaminated with chloramphenicol after the use of this at therapeutic doses 
(Hanekamp et al. 2003). Adverse effects include bone marrow suppression 
resulting in aplastic anemia and genotoxic, and possible carcinogen effects 
due to  exposure of the mentioned drug (Lai et al. 2009). The restricted 
studies available on the carcinogenicity do not allow a definitive 
classification of the drug. Since only a small exposure to chloramphenicol 
may lead to aplastic anemia, of particular importance in veterinary medicine, 
people handling and administering the drug may also be at risk (Hanekamp 
et al. 2015). In this sense, Codex indicated in its risk management the 
following recommendations “there is no safe level of residues of 
chloramphenicol or its metabolites in food that represents an acceptable risk 
to consumers, competent authorities should prevent residues of 
chloramphenicol in food by not using chloramphenicol in food producing 
animals” (CAC, 2014). For this reason, chloramphenicol is listed in Table 2 of 
EU document  No. 37/2010 as a list of prohibited substances. Based on EFSA  
reported data, the exposure to animal-derived food products contaminated 
with chloramphenicol at or below 0.3 mg/kg are unlikely to be a health 
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concern for aplastic anemia or reproductive or hepatotoxic effects (EFSA, 
2014). 
1.1.3.2. Antiprotozoals and anticoccidial drugs 
   The antiprotozoals are drugs that kills or inhibits the growth of organisms 
known as protozoans. Protozoans cause a variety of diseases, including 
malaria and Chagas’ disease (Zamboni et al. 2015). Members of this drug 
class include: metronidazole, ipronidazole, ronidazole, dimetridazole, and 
tinidazole. Metronidazole is the most commonly studied compound of this 
group which is used extensively in companion animal veterinary medicine 
for a variety of indications (Stock et al. 2018; Riviere and Papich, 2013). 
Antiprotozoals and anticoccidial drugs are often employed in protozoal 
infections of farm livestock such as babesiosis, cryptosporidiosis, giardiasis, 
toxoplasmosis, trypanosomosis, coccidiosis. They are often incorporated into 
feedstuff to prevent or treat various diseases (Boxall et al. 2002). Generally, 
were labelled for the treatment of swine dysentery, histomoniasis in turkeys 
and recommended as a treatment for trichomoniasis in bulls (Larina et al. 
2009). As regards the toxicity, there is enough evidence to consider 
metronidazole as an animal carcinogen, but insufficient for assert the same to 
humans (Bendensky et al. 2002). Protozoan parasites are able to cause 
abortion and infertility in domestic ruminants (Kaltungo and Musa, 2013). 
1.1.3.3. Antiparasitic drugs 
   Ectoparasiticides and endectocides have a huge range of application in 
livestock and companion animals.  The first class of antiparasitic veterinary 
drugs was used to control external parasites. Animals are infected by several 
arachnids and insects, like various ticks, keds, flies, lice and mites. These 
latter can cause important irritation leading to inadequate conditions such as 
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weight decrease or reduced milk yield, resulting in major economic losses 
(Rajput et al. 2006). Based on the chemical structure, ectoparasiticides can be 
classified into various groups: amidines, carbamate, nitroguanidines, 
organochlorines, organophosphates, pyrethroids, macrocyclic lactones. The 
endectocide class was applied for treatment of diseases caused by both 
internal and external parasites (Taylor et al. 2005).  Generally, various 
parasitic species are vectors of diseases to humans, due to the transmission of 
infections to animals themselves, increasing the necessity to an effective 
control (Patz et al. 2000).  
1.1.3.4. Anthelmintics 
   Anthelmintic drugs are a class of drugs used for the treatment of a broad 
range of infections caused by parasitic worms include flatworms (flukes and 
tapeworms) and roundworms which result in a considerable animals 
morbidity and mortality. Based on similar chemical structure and 
mechanism of action, anthelmintics are classified in different classes: 
macrocyclic lactones, pyrazinoisoquinolines, benzimidazoles, 
imidazothiazoles, tetrahydropyrimidines, salicylanilides, nitrophenolic, 
organophospates (Coles et al. 2002; Kaczala et al. 2016). The most important 
drug is represented by praziquantel, belonging to the pyrazinoisoquinolines 
sub-group (Doenhoff et al. 2008). Niclosamide, classified as salicylanilides, is 
effective against tapeworms, whereas closantel associated with rafoxanide 
acting against flukes (Lateefet al. 2008). The use of anthelmintics frequently 
leads to drug resistance development, due to the amino-acetonitrile 
derivatives of which monepantel is a member (Kaminsky et al. 2008). 
1.1.3.5. NSAIDs 
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   NSAIDs are non-steroidal anti-inflammatory drugs. Generally, they are 
employed in practical therapy to treat inflammatory conditions, fever, 
osteoarthritis and rheumatoid arthritis in domestic animals (Crofford et al. 
2013; Lamano-Carvalho, 2007).  The NSAID drugs used in veterinary 
medicine include acetylsalicylic acid, paracetamol, phenylbutazone, flunixin 
meglumine, ketoprofen, meloxicam, tolfenamic acid, carprofen, etodolac, 
meloxicam, deracoxib and firocoxib (Bergh and Budsberg, 2005; Chen et al. 
2008). 
1.1.3.6. Benzodiazepnes 
   Anxiolytic and sedative drugs called benzodiazepines are used to treat 
insomnia, behaviour problems and associated conditions in companion 
animals (Licata et al. 2008). The most common drug employed in the 
veterinary field is diazepam, used as sedative and anxiolytic in animals 
transport to prevent stress. Other drugs, prescibed especially to dogs and 
cats, are represented by alprazolam, chlordiazepoxide, clonazepam, 
lorazepam, oxazepam, and triazolam (Mota-Rojas et al. 2011). 
1.1.3.7. Hormones 
   Hormones represent a class of drugs extensively employed in animals 
diseases. Corticosteroids are divided in nature, such as cortisol and cortisone, 
and synthetic drug including dexamethasone, prednisolone, 
methylprednisone, betamethasone. The main applications of this class of 
drugs are: asthma, rheumatoid disease, gastrointestinal, renal, cardiac, 
reproductive disorders, the treatment of sick animals control and the 
improvement of  the growth rate of animals, serving as growth promoters, 
although this application was banned (Courtheyn et al. 2002; Hughes & 
Heritage, 2004; Castanon et al. 2007; Casewell et al. 2003). Therapeutic use of 
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hormones also includes treatment of companion animals suffering from 
endocrine dysfunction including diabetes and hypothyroidism (Rees et al. 
2005). 
1.2. Legislation of mycotoxins and veterinary drug residues in milk 
   Hence, to protect consumers’ health, EU has set both the maximum residue 
limits (MRLs) for veterinary drugs and the maximum limit (MLs) for 
mycotoxins in Commission Regulation (EC) No. 37/2010 and Commission 
Regulation (EC), No. 165/2010, which amending Regulation (EC), No. 
1881/2006, respectively (EU 165/2010; EU 37/2010). MRLs of veterinary drug 
residues permitted in milk are in the range from 0.05 μg/kg to 1500 μg/kg. As 
regards mycotoxins, AFM1, the principal hydroxylated AFB1 metabolite, is 
the only mycotoxin regulated for animal-derived products. The maximum 
limit of AFM1 in raw milk, heat-treated milk and milk for the manufacture of 
milk-based products was set at 0.05 μg/kg and restricted of up to 0.025 μg/kg 
for infant formulae and follow-on formulae, including infant milk and 
follow-on milk. 
1.3. Analysis of food contaminants 
   Nowadays, food security is a growing concern for consumers, governments 
and producers due to the globalization of markets in which food is produced 
and distributed worldwide. Food alarms in recent years have generated great 
interest and concern leading to provide suitable protective measures to 
ensure consumers safety. Nowadays, food contaminants analysis is still a 
challenge due to the heterogeneity of the different dietary matrices, the 
different chemical structures of the analysed compounds and the low 
detection required levels. The use of a single analysis technique which 
includes a huge group of contaminants is an objective to be achieved, 
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however, the simultaneous extraction of a wide range of compounds is a 
critical step. Advances in the analysis of contaminants are based on the 
development of faster methods, able to detect different analytes at once, 
respectful of the environment, economic and adequate to achieve the 
proposed objectives in food, feed, tissues and biological fluids (De Saeger et 
al. 2016). Most of the analytical methods reported in literature consist of 
sampling, homogenization, extraction steps followed by a purification of the 
sample to eliminate unwanted matrix components, and finally, the 
separation and detection steps, usually carried out by means of a 
chromatographic technique in combination with a variety of detectors 
(Pereira et al. 2014). In this sense, several analytical methodologies were 
applied and tested for the efficient determination of a simultaneous huge 
group of contaminants such as QuEChERS (Quick, Easy, Cheap, Effective, 
Rugged and Safe) or dispersive liquid-liquid microextraction (DLLME); 
however, more conventional techniques such as solid phase extraction (SPE) 
or solid-liquid extraction (SLE) are still widely used. 
1.3.1. QuEChERS 
   Currently, one of the most used solid-liquid extraction methods is the 
QuEChERS procedure, which allows the extraction and purification in the 
presence of inorganic salts. This method was initially used for the 
determination of pesticides (Anastassiades, 2003), but in recent years it is also 
being used for the extraction and purification of other compounds (Sospedra 
et al. 2010; Rodríguez-Carrasco et al. 2012; Azaiez et al. 2014). The QuEChERS 
sample preparation method has a number of advantages over traditional 
techniques, such as a high yield, the use of small amounts of organic solvent 
(non-chlorinated), which makes it a fast and economical method for the 
extraction of food contaminants (Arroyo-Manzanares et al. 2014a). This 
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methodology consists of an extraction based on the distribution of the 
analytes between an aqueous phase and a solvent, followed by a  purification 
step of the organic phase through a dispersion process in solid phase (d-
SPE). In the extraction phase, an organic solvent, usually acetonitrile, is used, 
and subsequently, a series of salts, magnesium sulfate or sodium sulphate 
and sodium chloride or sodium acetate are added to remove moisture from 
the sample and promote the distribution of the samples analytes towards the 
organic phase. The purification step is carried out by the addition of PSA 
(Primary and Secondary Amine) to remove polar pigments, organic acids 
and other products present in the matrix that could interfere with the 
analytes. Generally, PSA is used in combination with C18 to remove lipids, 
sterols and pigments. The QuEChERS method has been suffering 
modifications from your first application regarding the reagents used and 
their proportions, depending on the analytes and the matrices to study. It is 
currently a preparation technique samples widely used for a wide variety of 
compounds as residues of veterinary drug (Stubbings and Bigwood, 2009; 
Aguilera-Luiz et al. 2008), pesticide residues (Wilkowska and Biziuk, 2011; 
Hou et al. 2013), or mycotoxins (Cunha and Fernandes, 2010, Ferreira et al. 
2012; Rodríguez-Carrasco et al. 2013). 
1.4. Identification and quantification of contaminants  
    For the identification and quantification of contaminants, the 
chromatographic separation of the different analytes coupled to different 
types of detectors are required, particularly mass spectrometers because of 
the analysis of food and feed requires the use of sensitive and selective 
methods. The different chemical structure of compounds, as well as the 
variety of matrices analyzed, hinders the development of multi-compounds 
analytical methods. Therefore, the development of analytical methods which 
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use a single sample preparation and a single final determination is, 
nowadays, the goal to achieve. 
 
1.4.1. Chromatographic techniques 
   Today, it is well recognized that liquid chromatography (LC) coupled to 
mass spectrometry (MS) detectors are the most widely applied instrumental 
technique for contaminants residue analysis in food for their ability to 
separate mycotoxins from similar and different chemical structures (Hird et 
al. 2014). Generally, immunochemical methods are specific for a single 
compound or a small group of structurally related compounds (Emon, 2011). 
During the last decade several methods based on LC-MS/MS for the 
identification and quantification of mycotoxins and veterinary drug residues 
in different matrices have been published (Zachariasova et al. 2010, 
Rasmussen et al. 2010, Zhao et al. 2015; Stanciuet al. 2017b). 
1.4.2. Mass spectrometry techniques 
   Mass spectrometry is a powerful analytical tool used in the identification of 
compounds, to elucidate the molecular weight, chemical structure of 
molecules and quantify contaminants in complex matrices. It allows us to 
obtain the distribution of the molecules in accordance with its mass/charge 
ratio (m/z). In recent years the traditional acquisition in HRMS has evolved, 
allowing a wide range of tools to identify or quantify compounds. This 
evolution has been made possible by improvements in HRMS 
instrumentation with the introduction of new instruments including Q-TOF, 
Q-IMS-TOF, IT-TOF, Q-Orbitrap.  
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   Nowadays, different types of mass spectrometers are available: mass 
spectrometers with triple quadrupole and linear ion trap, which have a 
resolution power lower than 10,000 (mass accuracy> 5 ppm) while a high 
resolution (HRMS) it can be defined as a resolution power of 10,000-100,000 
with a mass accuracy of <5 ppm (Holčapek et al. 2012). High-resolution mode 
is recommended for qualitative analysis,  whereas low-resolution mode 
achieves the best results in terms of sensitivity and dynamic range. Thus, 
selection between both operation modes depends on the objective of the 
analysis. 
   The Orbitrap mass analyzer is the first high-performance mass analyzer 
which employs trapping of ions in electrostatic fields, together with a 
sophisticated ion injection process, which enables high resolution, mass 
accuracy, and excellent sensitivity for addressing numerous analytical 
applications in both research and routine analysis. Orbitrap mass analyzers 
allow selection of different resolution values, typically corresponding to 
17,500; 35,000; 70,000; 100,000; or up to 140,000 FWHM in modern 
instruments.  The principle of Orbitrap is based on the Kingdon ion trap 
described in 1923, and commercially at the first time in 2005 (Eliuk & 
Makarov, 2015). The development of screening methods that include the 
analysis of a large number of mycotoxins simultaneously are currently 
carried out by the use of LC-HRMS. 
   HRMS has been employed for a long time as a screening tool in food and 
feed for the analysis of veterinary drug residues, pesticide residues and 
natural toxins.  HRMS instruments present several advantages with respect 
to conventional systems in residue analysis, providing an unequivocal 
identification mainly based on the accurate mass measurements and the 
capability to increase selectivity. This is one of the most important 
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characteristics when trace amounts of hundreds of analytes have to be 
determined in complex samples, as in my experiment. 
   Thus, HRMS provides a robust, sensitive and selective analysis by allowing 
the exploration of mass spectra in full scan mode, obtaining more complete, 
detailed and accurate information about the composition of a sample. 
Consequently, this characteristic allows the analysis of unknown 
compounds, as well as the possibility of retrospective data analysis without 
the need to re-inject the sample and the ability to carry out structural 
elucidations of unknown or suspicious compounds when a standard with 
which to compare is not available (Senyuva et al. 2015).  Given this 
assumption, the latter described technique has been selected to achieve the 
simultaneous determination of mycotoxins and veterinary drug residues in 
milk. 
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CHAPTER 2 - Objectives section I 
 
2.1.General Objective 
   The aim of this part of my thesis work was to develop a multi-residue 
method for the simultaneous determination of mycotoxins (n=46) and 
veterinary drug residues (n=61) in milk to investigate the occurrence of the 
before mentioned compounds in 56 milk samples in order to monitor the 
exposure in the global population, as well as in susceptible groups such as 
children. 
2.2. Specific Objectives: 
1. Optimization of spectrometric (Q-Exactive Orbitrap HRMS) 
and chromatographic (UHPLC) conditions for the simultaneous 
determination of mycotoxins and veterinary drug residues in 
milk; 
2. Development of a multi-residue method based on QuEChERS 
procedure for the extraction and purification of veterinary 
drugs  and mycotoxins in milk; 
3. Validation of the analytical method in accordance with the 
regulation 2002/657/CE on the performance of analytical 
methods; 
4. Application of validated method to investigate the occurrence 
of the before mentioned compounds in 56 milk samples 
purchased in Campania, Italy. 
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Section I Chapter 2 - Specific objectives 1 
SPECIFIC OBJECTIVES 1 
   Optimization of spectrometric (Q-Exactive Orbitrap HRMS) and 
chromatographic (UHPLC) conditions for the simultaneous determination of 
mycotoxins and veterinary drug residues in milk. 
Materials and Methods 
Chemicals and materials 
   Methanol (MeOH), acetonitrile (AcN) and (LC-MS grade) were acquired 
from Merk (Darmstadt, Germany). Formic water acid (mass spectrometry 
grade) and ammonium formate (analytical grade) were purchased from 
Fluka (Milan, Italy). Syringe filters with polytetrafluoroethylene membrane 
(PTFE, 15 mm, diameter 0.22 μm) were supplied by Phenomenex (Castel 
Maggiore, Italy). Glass amber vials with septum screw caps were supplied by 
Agilent Technologies (Milan, Italy).  
   The standards of veterinary drugs and mycotoxins (purity >98%) were 
purchased from Sigma Aldrich (Milan, Italy). Veterinary drugs were selected 
from those with lower MRLs or prohibited in milk in accordance with EC 
Regulation No. 37/2010. The standard of veterinary drugs included: 
metronidazole, clenbuterol hydrochloride, meloxicam, dexamethasone, 
amoxicillin, ampicillin, benzylpenicillin procaine, ceftiofur, danofloxacin, 
monensin sodium, sulfadimidine, dapsone, chloramphenicol, abamectin, 
amitraz, cyhalothrin, cipermethrin, trichlorfon, colchicine, imidocarb, 
doramectin, ivermectin, eprinomectin and deltamethrin. The standard of 
mycotoxins included: aflatoxins (AFM1, AFB1, AFB2, AFG1 and AFG2), 
ochratoxin A (OTA), fumonisins (FB1 and FB2), deoxynivalenol (DON), 3-
acetyldeoxynivalenol (3-AcDON), 15-acetyldeoxynivalenol (15-AcDON), 
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nivalenol (NIV), HT-2 toxin, T2 toxin, neosolaniol (NEO), diacetoxyscirpenol 
(DAS), fusarenon-X  (FUS-X), zearalenone (ZON), α-zearalenol (α-ZOL), ß-
zearalenol (ß-ZOL), α-zearalanol (α-ZAL), β-zearalanol (β-ZAL), zearalanone 
(ZAN), beauvericin (BEA), enniatins (ENNA, ENNA1, ENNB and ENNB1), 
alternariol (AOH) and alternariolmonomethyl ether (AME). 
   To lack of analytical standards, the identification of veterinary drug (n=37) 
including: albendazole, betamethasone, carprofen, cefalexin, cefazolin, 
chlorpromazine, chlortetracycline, cloxacillin, cypermethrin, decoquinate, 
diazinon, dicloxacillin, difloxacin, enrofloxacin, febantel, fenbendazole, 
florfenicol, flumequine, levamisole, lyncomycin, marbofloxacin, 
mebendazole, methylprednisolone, oxacillin, oxfendazole, oxolinic acid, 
oxytetracycline, prednisolone, rifaximin, ronidazole, spiramycin, tetracycline, 
thiamphenicol, tilmicosinand mycotoxins (n=16) including: chaetoglobosin a, 
cyclopiazonic acid, deoxynivalenol-3-glucoside, gliotoxin, hydrolyzed 
fumonisin B1, hydrolyzed fumonisin B2, penicillic acid, tentoxin, AFM2, 
OTAb, α-OTA, sterigmatocystin, FB3, deepoxy-deoxynivalenol (DOM), t2-
trialwere carried out by a post-target screening. 
   Individual standard solutions were prepared by diluting 1 mg of each 
analyte in 1 mL of solvent (MeOH, EtOH, ACN or DMSO) based on the 
specifications of the supplier. Three stock solutions were prepared:stock 
solution 1 (including all the mycotoxins, except aflatoxins), stock solution 2 
(including aflatoxins, clenbuterol hydrochloride and prohibited substances in 
milk) and stock solution 3 (including the rest of the studied veterinary 
drugs), were prepared by taking a defined volume from each one of the 
individual standard solutions and then performing adequate dilution to 
reach appropriate working standard solutions for spiking experiments. The 
working standard solutions were prepared at 25, 250, 1250 ng/L (from stock 
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1), at 2.5, 5, 10 ng/L (from stock 2), and at 0.2, 2, 10 mg/L (from stock 3). All 
solutions were stored at −20°C in screw-capped glass vials. 
UHPLC-Q-Orbitrap HRMS analysis 
Analysis were performed by using an UHPLC instrument (Dionex 
Ultimate 3000, Thermo Fisher Scientific, Waltham, Ma, USA) coupled to a Q 
Exactive Orbitrap mass spectrometer (Thermo Fischer Scientific, Waltham, 
Ma, USA). The UHPLC system consisted of a degassing system, a 
Quaternary UHPLC pump working at 1250 bar, an auto sampler device and 
a thermostated Luna Omega column (50 x 2.1 μm, 1.6 μm, Phenomenex) held 
at 30 °C. The mobile phase consisted of (A) water with 0.1% formic acid 
containing 5 mM ammonium formate and (B) methanol with 0.1% formic 
acid containing 5 mM ammonium formate.  A linear gradient elution 
program was applied as follows: initial 0% B was held for 1 min and then 
increased to 95% B in 1 min and held for 0.5 min. Then, the gradient was 
linearly decreased to 75% in 2.5 min, and decreased again to 60% B in 1 min. 
Finally, gradient was reduced to 0% in 0.5 min and held for 1.5 min for re-
equilibration, giving a total run time of 8 min. The flow rate was 0.4 mL/min.  
Detection was performed using a Q-Exactive Orbitrap mass 
spectrometer. The mass spectrometer was operated in positive and negative 
ion mode by setting two scan events: full ion MS and data-dependent 
fragmentation, dd-MS2. Full scan data were acquired at a resolving power of 
70000 FWHM at 200 m/z. Mass range in the Full scan experiments was set at 
m/z 100–1000. The conditions in positive ionization mode (ESI +) were: spray 
voltage 4000 V; capillary temperature 290°C; S-lens RF level 50; sheath gas 
pressure (N2>95%) 35, auxiliary gas (N2 >95%) 10, and auxiliary gas heater 
temperature 305°C. The conditions in negative ionization mode (ESI -) were: 
spray voltage - 4000 V; capillary temperature 290°C; S-lens RF level 50; 
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sheath gas pressure (N2>95%) 35, auxiliary gas (N2 >95%) 10, and auxiliary 
gas heater temperature 305°C. The parameters for the scan event of dd-MS2 
were as follow: a mass resolving power of 17 500 FWHM (m/z 200), AGC 
target at 2E5, maximum IT at 50 ms and isolation window at 2.0 m/z. 
   A theoretical database including the chemical formula, the extracted mass, 
the polarity of acquisition and the expected adducts was built and used for 
post-run retrospective screening (Table 4). To create the database, two 
spectral libraries were taken: Antibiotics and veterinary drugs Spectral 
Library v1.0 1.0 for Use in MasterView™ Software, and LibraryView™ 
Software, AB SCIEX, Mycotoxin Spectral Library for LibraryView™ 
Software, AB SCIEX. For an accurate mass measurement, the identification 
and confirmation approach was performed setting a mass tolerance of 5 ppm 
for the molecular ion and for the fragments; an intensity threshold of 1000. 
Data analysis and processing were evaluated by the Quan/Qual Browser 
Xcalibur software, v. 3.1.66. (Xcalibur, Thermo Fisher Scientific). 
 
Table 4. Chromatographic retention time, optimized MS/MS parameters for untarget analytes. 
 
 
Compound Chemical 
 Formula 
Extracted Mass 
(m/z) 
Adduct  
ion 
Veterinary drugs: (37) 
Albendazole C12H15N3O2S 266.09577 [M+H]+ 
Betamethasone C22H29FO5 451.21266 [M+H3C2O2]- 
Carprofen C15H12ClNO2 272.04838 [M-H]- 
Cefalexin C16H17N3O4S 348.10125 [M+H]+ 
Cefazolin C14H14N8O4S3 455.03729 [M+H]+ 
Chlorpromazine C17H19ClN2S 319.10302 [M+H]+ 
Chlortetracycline C22H23ClN2O8 479.12157 [M+H]+ 
Cloxacillin C19H18ClN3O5S 453.09939 [M+NH4]+ 
Cypermethrin C22H19Cl2NO3 433.10802 [M+NH4]+ 
Decoquinate C24H35NO5 418.25880 [M+H]+ 
Diazinon C12H21N2O3PS 305.10833 [M+H]+ 
Dicloxacillin C19H17N3Cl2O5S 470.03387 [M+H]+ 
Difloxacin C21H19F2N3O3 400.14672 [M+H]+ 
Dimetridazole C5H7N3O2 142.06110 [M+H]+ 
Enrofloxacin C19H23FN3O3 360.17179 [M+H]+ 
Febantel C20H22N4O6S 447.13328 [M+H]+ 
Fenbendazole C15H13N3O2S 300.08012 [M+H]+ 
Florfenicol C12H14Cl2FNO4S 355.99318 [M-H]- 
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Flumequine C14H12FNO3 262.08739 [M+H]+ 
Levamisole C11H12N2S 205.07939 [M+H]+ 
Lyncomycin C18H34N2O6S 407.22103 [M+H]+ 
Marbofloxacin C17H19FN4O4 363.14630 [M+H]+ 
Mebendazole C16H13N3O3 296.10296 [M+H]+ 
Methylprednisolone C22H30O5 433.22207 [M+H3C2O2]- 
Oxacillin C19H19N3O5S 419.13837 [M+NH4]+ 
Oxfendazole C15H13N3O3S 316.07503 [M+H]+ 
Oxolinic acid C13H11NO5 262.07099 [M+H]+ 
Oxytetracycline C22H24N2O9 461.15550 [M+H]+ 
Prednisolone C21H28O5 419.20642 [M+H3C2O2]- 
Rifaximin C43H51N3O11 786.35960 [M+H]+ 
Ronidazole C6H8N4O4 201.06183 [M+H]+ 
Spiramycin C43H74N2O14 843.52128 [M+H]+ 
Tetracycline C22H24N2O8 445.16050 [M+H]+ 
Thiamphenicol C12H15Cl2NO5S 353.99752 [M-H]- 
Tilmicosin C46H80N2O13 869.57331 [M+H]+ 
Tolfenamic acid C14H12ClNO2 262.06293 [M+H]+ 
Toltrazuril C18H14F3N3O4S 424.05843 [M-H]- 
Mycotoxins: (16) 
Chaetoglobosin A C32H36N2O5 529.26970 [M+H]+ 
Cyclopiazonic acid C20H20N2O3 337.15467 [M+H]+ 
Deoxynivalenol-3-glucoside C21H30O11 459.18609 [M+H]+ 
Gliotoxin C13H14N2O4S2 327.04678 [M+H]+ 
Hydrolyzed fumonisin B1 C22H47NO5 406.35270 [M+H]+ 
Hydrolyzed fumonisin B2 C22H47NO4 390.35778 [M+H]+ 
Penicillic acid C8H10O4 171.06518 [M+H]+ 
Tentoxin C22H30N4O4 415.23398 [M+H]+ 
Verruculogen C27H33N3O7 512.23913 [M+H]+ 
AFM2 C17H14O7 331.08123 [M+H]+ 
OTA B C20H19NO6 370.12851 [M+H]+ 
α-ota C11H9N5Cl                    247.06192 [M+H]+ 
Sterigmatocystin C18H12O6 325.07066 [M+H]+ 
FB3 C34H59NO14 706.40083 [M+H]+ 
DOM C15H20O5 281.13835 [M+H]+ 
T2-trial C20H30O7 383.20643 [M+NH4]+ 
 
Results and discussion  
Optimization of the UHPLC-Q-Orbitrap HRMS conditions 
   Chromatographic conditions were studied to achieve the best separation of 
the analyzed compounds. In the present study, methanol was chosen as the 
organic phase because it achieved a better resolution and sensitivity than 
acetonitrile for the studied compounds as previously reported in literature 
(Xie et al. 2015). 
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   The addition of formic acid and ammonium formate in mobile phases 
could promote the formation of adduct ions, thereby improving the detection 
sensitivity, especially for fumonisins and some drugs, which could hardly 
ionize under the neutral or alkaline conditions (Mao et al. 2018). For instance, 
the addition reported help in the separation of the Zearalenone isomers 
without which, these isomers overlapped and could not be quantified 
separately (Jia et al. 2014). In this study, the UHPLC Luna Omega column (50 
x 2.1 μm, 1.6 μm, Phenomenex) was used and several gradient profile were 
tested to optimize the chromatographic separation of the studied 
compounds. The tested gradients were: 
Gradient 1:  
   The following gradient was tested: initial 10% B was held for 2 min and 
then increased to 100% B in 3 min and held for 1.5 min. Then, the gradient 
was linearly decreased to 10% B in 1 min and held for 2 min for re-
equilibration, giving a total run time of 9.5 min. 
Gradient 2:  
   The following gradient was tested: initial 5% B was held for 1 min and then 
increased to 95% B in 1.5 min and held for 1 min and decreased again to 70% 
B in 2 min. Then, the gradient was linearly decreased to 5% B in 1 min and 
held for 2 min for re-equilibration, giving a total run time of 9.5 min. 
Gradient 3:  
   The following gradient was tested: initial 0% B was held for 1 min and then 
increased to 95% B in 1 min and held for 0.5 min. Then, the gradient was 
linearly decreased to 75% in 2.5 min, and decreased again to 60% B in 1 min. 
Finally, the gradient was reduced to 0% in 0.5 min and held for 1.5 min for 
re-equilibration, giving a total run time of 8 min.  
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   Starting the gradient program with 10% B, some of the target analytes 
peaks were eluted in the column dead time and the peak response was 
irregular. With the second tested gradient, there was a decrease in the 
number of analytes no retained from the chromatographic column, but 
satisfactory results in terms of retention time and good peak shape were 
achieved using 0% B in the initial condition of the gradient. In the latter, a 
good separation of all fifty-four target analytes was obtained in 8 min which 
allowed also a reduction in solvent consumption. Under the condition, 
retention times of the analytes were constant, ranging from 3.84 (Amoxicillin) 
to 7.10 (Doramectin) min, as shown in Table 5. 
Table 5. Chromatographic retention time, optimized MS/MS parameters for target analytes. 
 
 
Compound Retention 
time (min) 
Chemical 
Formula 
Adduct 
ion 
Theoretical 
mass (m/z) 
Measured 
mass (m/z) 
Accuracy 
( Δ ppm) 
Veterinary drug: (24)       Amoxicillin 3.84 C16H19N3O5S [M+H]+ 366.11182 366.11173 -0.25 
Metromidazole 3.86 C6H9N3O3 [M+H]+ 172.07167 172.07152 -0.87 
Procaine Benzylpenicillin 4.03 C13H20N2O2 [M+H]+ 237.15975 237.15936 -1.64 
Imidocarb 4.10 C19H20N6O [M+H]+ 349.17714 349.17679 -1.00 
Danofloxacin 4.15 C19H20FN3O3 [M+H]+ 358.15615 358.15552 -1.76 
Dapsone 4.23 C12H12N2SO2 [M+H]+ 249.06922 249.06886 -1.45 
Ampicillin 4.27 C16H19N3O4S [M+H]+ 350.11693 350.11633 -1.63 
Sulfadimidine 4.27 C12H14N4O2S [M+H]+ 279.09102 279.09064 -1.36 
Clenbuterol 4.35 C12H18Cl2N2O [M+H]+ 277.08690 277.08658 -1.15 
Trichlorfon 4.40 C4H8Cl3O4P [M+H]+ 256.92985 256.92966 -0.74 
Ceftiofur 4.48 C19H17N5O7S3 [M+H]+ 524.03629 524.03558 -1.35 
Colchicine 4.50 C22H25NO6 [M+H]+ 400.17546 400.17471 -1.87 
Dexamethasone 4.70 C22H29FO5 [M+H]+ 393.20718 393.20639 -2.01 
Meloxicam 4.79 C14H13N3O4S2 [M-H]- 350.02747 350.02710 -1.06 
Chloramphenicol 5.11 C11H12Cl2N2O5 [M-H]- 321.00505 321.00476 -0.90 
Ivermectin 5.60 C48H74O14 [M+NH4]+ 892.54168 892.54028 -1.57 
Amitraz 5.75 C19H23N3 [M+H]+ 294.19647 294.09150 -1.36 
Cyhalothrin 5.77 C23H19ClF3NO3 [M+NH4]+ 467.13438 467.13361 -1.65 
Cypermethrin 5.80 C22H19Cl2NO3 [M+NH4]+ 433.10802 433.10724 -1.80 
Deltamethrin 5.87 C22H19Br2NO3 [M+NH4]+ 521.00699 521.00627 -1.38 
Eprinomectin 6.07 C50H75NO14 [M+H]+ 914.52603 914.52417 -2.03 
Abamectin 6.15 C48H72O14 [M+NH4]+ 890.52603 890.52411 -2.16 
Monesin 6.50 C36H61NaO11 [M+H]+ 693.41843 693.41663 -2.60 
Doramectin 7.10 C50H74O14 [M+NH4]+ 916.54168 916.53955 -2.32 
Mycotoxins: (30) 
    
NIV 3.98 C15H20O7 [M+Na]+ 335.11012 335.06511 -1.22 
DON 4.10 C15H20O6 [M+H]+ 297.13326 297.13327 0.03 
FUS-X 4.28 C17H22O8 [M+Na]+ 37712073 377.12057 -0.42 
NEO 4.32 C19H26O8 [M+NH4]+ 400,19659 400.19662 0.07 
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DAS 4.41 C19H26O7 [M+H]+ 367.17513 367.17554 1,12 
3-ADON 4.45 C17H22O7 [M+H]+ 339.14383 339.14331 -1.53 
15-ADON 4.48 C17H22O7 [M+H]+ 339.14383 339.14331 -1.53 
AFM1 4.51 C17H12O7 [M+H]+ 329.06558 329.06511 0.09 
AFG2 4.52 C17H14O7 [M+H]+ 331.08123 331.08032 -2.75 
AFG1 4.55 C17H12O7 [M+H]+ 329.06558 329.06553 -0,15 
AFB2 4.60 C17H14O6 [M+H]+ 315.08631 315.08521 -3.49 
AFB1 4.64 C17H12O6 [M+H]+ 313.07066 313.06958 -3.45 
FB1 4.75 C34H59NO15 [M+H]+ 722.39575 722.39539 -0.50 
HT-2 4.77 C22H32O8 [M+NH4]+ 442.24354 442.24323 -0.70 
α-ZAL 4.81 C18H26O5 [M-H]- 321.17044 321.17136 2.86 
AOH 4.85 C14H10O5 [M-H]- 257.04555 257.04623 2.65 
α-ZOL 4.87 C18H24O5 [M-H]- 319.15510 319.15561 1.60 
T-2 4.88 C24H34O9 [M+NH4]+ 484.25411 484.25418 0.14 
β-ZAL 4.94 C18H26O5 [M-H]- 321.17044 321.17136 2.86 
OTA 4.97 C20H18NO6Cl [M+H]+ 404.08954 404.08801 -3.79 
FB2 4.97 C34H59NO14 [M+H]+ 706.40083 706.40192 1.54 
β-ZOL 4.98 C18H24O5 [M-H]- 319.15510 319.15549 1.22 
ZAN 5.00 C18H24O5 [M-H]- 319.15510 319.15549 1.22 
ZEA 5.02 C18H22O5 [M+H]+ 317.13945 317.1391 -1.10 
AME 5.14 C15H12O5 [M-H]- 271.06120 271.06131 0.41 
ENN B 5.61 C33H57N3O9 [M+NH4]+ 657.44331 657.44299 -0.49 
ENN B1 5.73 C34H59N3O9 [M+NH4]+ 671.45986 671.45923 -0.94 
BEA 5.77 C45H57N3O9 [M+NH4]+ 801.44331 801.44318 -0.16 
ENN A1 5.89 C35H61N3O9 [M+NH4]+ 685.47461 685.47351 -1.60 
ENN A 6.07 C36H63N3O9 [M+NH4]+ 699.49026 699.48926 -1.43 
 
   The optimum MS/MS parameters for the identification and quantification 
of the fifty-four analytes were obtained infusing directly each analyte 
standard (1 μg/mL)into the Q-Orbitrap system using a syringe injection at a 
flow rate of 8 μL/min in order to obtain all the characteristic molecular ions 
signals and investigating on operational parameters such as flow gas, 
temperatures, capillary voltage and collision energy. Sensitivity of target 
analytes was checked by recording chromatograms in full scan method in 
both positive and negative ionization mode.   
   Positive and negative ionization full scan mode were monitored to 
determine the parameters that lead to the optimal response. The responses of 
adduct protonate [M+H]+ ions were much more intense than the adduct 
deprotonate [M−H]− ions for the studied analytes. After full scan analysis, the 
accurate mass of the characteristic ion (precursor ion) was listed in a 
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inclusion list. In dd-MS2 mode, a product ion spectrum was obtained 
automatically. With respect to mass analyzer used by others authors like a 
triple-quadrupole, the chosen mode offers a higher level of confidence in 
analyte identification. In table 6 are shown the analytical methods for the 
simultaneous determination of mycotoxins and veterinary drugs reported to 
date by other authors. 
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Table 6. Analytical methods for the simultaneous determination of mycotoxins and veterinary drugs reported to date by other authors. 
Matrix n. analytes                     
detected 
Extraction/                                     
Clean-up 
Separation Determination References 
Column Mobile phase Detection Sensitivity (ng/g ng/L) 
Egg 15 veterinary drugs                  6 mycotoxins QuEChERS 
LC                                                               
ACE silica C18                                      
(150 mm×2.1 mm, 3   μm ) 
A: 0.1% FA in water                                           
B: 0.1% FA in acetonitrile                                                                   
Flow:0.2 mL/min                               
QqQ (API 3000 triple)                                         
(ESI)  MRM mode 
LOQ 1.3-28.9                                       
LOQ n.r. Capriotti et al. 2012 
Milk                                              
Cereal-based 
products 
8 veterinary drugs                 
12 mycotoxins QuEChERS 
UHPLC                                                     
BEH C18                                                     
(100mm x 2.1mm,  1,7  μm) 
A:1 mM NH4OAc  and 
0.05% AcOH                                                                                            
B:0.05% AcOH in 
methanol                              
Flow: 0.2 mL/min 
Q-Orbitrap  (Exactive, 
Thermo Fisher 
Scientific)                                                  
(ESI +) and (ESI -)  
HRMS 
LOD 1-100 Dominicis et al. 2012 
Milk 255 veterinary drugs                          6 mycotoxins 
Ethanol–acetonitrile 
(1:5, v/v)- Based 
UPLC                                                    
Acquity HSS-T3 column                      
(100mm x 2.1mm,  1,8  μm) 
A: 0.1% FA  and 0.5 
mmol/LNH4OAc in water   
B: 0.1% FA in methanol  
C: 2.5 mmol/LNH4OAc in 
water 
D: Methanol                                                                
Flow:0.4 mL/min 
QqQ (Xevo TQ-S)                                                 
(ESI +) and (ESI -) MRS 
mode 
LOQ 0.05- 5 Zhan et al. 2012 
Milk                                       
Dairy products 
27 veterinary drugs               
16 mycotoxins SPE 
LC                                                           
Agilent ZORBAX SB-C18  
(100 × 2.1 mm, 3.5 μm) 
A: 0.1% FA and  5 mM 
NH4OAc  in water                                                                                        
B: Methanol                                                                               
Flow: 0.4 mL/min 
 QqQ (Agilent 6460)                                     
(ESI +) and (ESI -) MRM 
mode 
LOQ 0.02-1.0  Xie et al. 2015 
Fruits                             
Baby Food 
 117 veterinary drugs            
21 mycotoxins QuEChERS 
UHPLC                                             
Eclipse-Plus C18                                    
(50 mm × 2.1 mm, 1.8 μm) 
A: 0.1 % FA in water                                                       
B: 0.1 % FA in acetonitrile                                               
Flow:  0.5 mL/min 
Q-TOF MS (Agilent  
6530)                                    
(ESI +) and (ESI -) MRM 
mode 
LOQ 1-100 Pérez-Ortega et al. 2016 
Vegetable                    
Fruits                            
Cereals                          
Meat                              
Milk        
14 veterinary drugs                     
4 mycotoxins 
Acidified methanol-
Based 
LC                                                                                                                
ZIC-HILIC-Philic                                                     
(150 mm × 4.6 mm, 5 μm) 
A:  50 mM NH4HCO2 in 
water                                  
B: water/acetonitrile 
10/90 (v/v).                                
Flow: 0.5 mL/min 
QqQ (Varian model
1200L)                                     
(ESI +) MRM mode 
LOQ 1-10 Danezis et al. 2016 
Milk                                               
Egg              
65 veterinary drugs                     
39 mycotoxins QuEChERS 
UPLC                                                        
Acquity  CORTECS                                 
(3.0 mm × 150 mm, 1.6 μm) 
A: 0.1% FA in water                                                                            
B:0.1% FA in acetonitrile                                                                             
Flow:  0.4 mL/min                               
QqQ (Xevo TQ-S)                                         
(ESI +) and (ESI -) MRM
mode
LOQ 0.01-31                                                                      
LOQ 0.01-10 Zhou et al. 2017 
Milk 24  veterinary drugs             26 mycotoxins QuEChERS 
UHPLC                                                          
Luna Omega column                               
(50 mm x 2.1 μm, 1.6 μm) 
A: : 5 mM NH4HCO2 and 
0.1% FA in water                                                                                      
B: 5 mM NH4HCO2 and 
0.1% FA in methanol                                                           
Flow: 0.4 mL/min 
Q-Orbitrap  (Exactive, 
Thermo Fisher 
Scientific) (ESI +) and 
(ESI -)  HRMS 
LOQ 0.00001-0.03                                                                                                                   
LOQ 0.001-0.5 This work 
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SPECIFIC OBJECTIVES 2: 
   Development of a multi-residue method based on QuEChERS procedure 
for the extraction and purification of veterinary drug residues  and 
mycotoxins in milk. 
Materials and Methods 
Chemicals and materials 
   Methanol (MeOH), acetonitrile (AcN) and water(LC-MS grade) were 
acquired from Merk (Darmstadt, Germany). Formic acid (mass spectrometry 
grade) was purchased from Fluka (Milan, Italy). Syringe filters with 
polytetrafluoroethylene membrane (PTFE, 15 mm, diameter 0.22 μm) were 
supplied by Phenomenex (Castel Maggiore, Italy). Sodium chloride (NaCl), 
anhydrous sulphate sodium (Na2SO4) andanhydrous sodium acetate (NaAc), 
were acquired from Sigma Aldrich (Milan, Italy). C18 (analytical grade) and 
primary secondary amine (PSA) sorbent were acquired from Supelco (Milan, 
Italy). 
Sampling 
A total of 56 commercially available milk samples were randomly 
purchased between January and February 2018 from different supermarkets 
located in the Campania region, Southern Italy. Samples were shipped to the 
laboratory in their original packages and stored at 4°C until analysis. Milk 
analysis was carried out within two days after arrival of samples. 
Sample preparation 
   A QuEChERS-based procedure developed by Zhou et al .2018 was selected 
as a starting point and then slightly modified. Briefly, 10 mL sample were 
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introduced into a 50 mL Falcon tube, and 2.5 mL of distillate water and 5 mL 
of acetonitrile containing 3.35% of formic acid (v/v) were added. The sample 
was vortexed for 1 min and sonicated for 15 min (vortexed in every five-
minute interval). Then, the tube involved the addition of 4.0 g of Na2SO4, 1.2 
g of NaCl, and 0.5 g of anhydrous NaAc, which was shaken by hand for 1 
min and then centrifuged for 3 min at 4000 rpm and 4°C. The supernatant (3 
mL) was collected into a 15 mL Falcon tube containing 300 mg of C18 
sorbent, 140 mg of PSA and 1.5 g of Na2SO4. Subsequently, the mixture was 
vortexed for 1 min and centrifuged for 1 min at 1500 rpm and 4°C. The 
supernatant (2 mL) was transferred into a new glass tube and then dried 
under gentle nitrogen flow at 45°C. Finally, the residue was reconstituted 
with 0.5 mL of MeOH:H2O (70:30, v/v), filtered through a 0.22 μm filter, and 5 
μL were injected into the UHPLC-Q-Orbitrap HRMS instrument. 
 
 
Figure 1. Schematic flow of the sample preparation procedure. 
 
Results and discussion 
Optimization of the sample preparation procedure 
   In the multi-residual determination, sample preparation is a critical step 
given the different chemical-physical properties of the compounds, the 
different levels of contaminants to detect and the complexity of the matrix 
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(Martos et al. 2010; Kabir et al. 2017). To date, a limited number of 
information about the simultaneous determination of veterinary drugs and 
mycotoxins in milk were reported in literature as shown in table 7. 
   To obtain the optimal experimental conditions different optimization steps 
were performed. Critical extraction parameters such as different ratios 
between the amount of sample and the extraction solvent and the ultrasonic 
treatment were evaluated. 
Table 7. Available studies on simultaneous determination of veterinary drugs and 
micotoxins in milk. 
 
n.  analysed 
milk 
samples 
n. Analytes 
% 
positive 
samples 
Analyte                     
detected 
Concentration 
reported ng/mL  References 
20 255 veterinary drugs                          6 mycotoxins 
25                   
70 
Lincomycin                   
Ciprofloxacin 
  0.14–13.7                   
0.59–25.4 
Zhan  
et al. 2012 
1 8 veterinary drugs                 12 mycotoxins n.r. n.r. n.r. 
De Dominicis 
et al. 2012 
32 27 veterinary drugs               16 mycotoxins 3 
Chloramphenicol               
Flunixin                       
Cimeterol 
0.027                                 
0.452                                       
0.053- 
Xie 
et al. 2015 
n.r. 14 veterinary drugs                     4 mycotoxins n.r. n.r. n.r. 
Danezis 
et al. 2016 
30 65 veterinary drugs                 39 mycotoxins 
10                                  
43.3                                    
30                               
36.7                        
Enoxacin                        
Danofloxacin                   
Ofloxacin                              
Aflatoxin M1 
0.5–0.8                               
0.1–2.7                            
0.01–1.1                        
0.002-0.03 
Zhou  
et al. 2018 
56 61 veterinary drugs             46 mycotoxins 
17.5                     
1.7                                
1.7                             
5.3                          
21                           
8.8                              
1.7                          
Amoxicillin                          
Ampicillin                           
Imidocarb                    
Ivermectin                       
Meloxicam              
Benzylpenicillin 
procaine   
Dexamethasone 
1.2-1.68                                 
0.860                                          
0.080                                           
0.380-4.240                 
0.007-0.220                                                   
1-4.530                                                      
0.140                       
This work 
   The ultrasonic treatment is an important extraction-influencing 
experimental parameter. In order to improve the extraction efficiency, 
different ultrasonic times in the extraction process was tested and compared 
(5, 15 and 25 min). A sonication time of 5 min was not suitable  (mean 
recovery=50%, RSD=22%,n=9), whereas mean recoveries of 75% (RSD=12%, 
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n=9) and 77% (RSD=13%, n=9) were obtained using 15 and 25 minutes of 
ultrasonic treatment, respectively. No significant statistical differences were 
found between the different time of treatment. Therefore, to keep the sample 
preparation procedure as short as possible, protocol with 15 minutes of 
ultrasonic treatment was selected. 
   After the optimization of ultrasonic treatment, another parameter was 
streamlined. As regarding the different ratios between the amount of sample 
and the extraction solvent, three different concentration factors (CF) were 
tested. Starting to main extraction procedure in which 5 mL of sample was 
extracted using 10 mL of solvent, a reducing of the solvent volume was 
performed from 10 to 5 mL (FC 4). To further concentrate, the use of 10 mL of 
sample (FC 8)  leaving unchanged the solvent volume (5 mL) was tested. 
   Better recoveries (in the range from 52 to 87%) and lower quantification 
level (LOQ <0.001 ng/L) were obtained with the lower extraction solvent 
volume tested. With an additional sample concentration (FC8), an important 
improvement concerning the values of recoveries (from 72 to 93%; RSDs<9%; 
n=9)and a decrease of LOQ (0.0001-0.05 ng/L) were obtained.  
All experiments were performed in blank milk samples fortified with studied 
veterinary drugs and mycotoxins at different levels as reported in the 
previous section. The analysis was performed in triplicate and the extraction 
recoveries were expressed as recovery ± RSD (%).  
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SPECIFIC OBJECTIVES 3 
   Validation of the analytical method in accordance with the regulation 
2002/657/CE on the performance of analytical method. 
Materials and methods 
Validation of the method 
   The method was in-house validated according to the guidelines established 
by the EU Commission Decision 2002/657/EC. The parameters evaluated 
were: linearity, matrix effect, specificity, trueness, precision and sensitivity. 
All parameters were performed in triplicate.  For confirmation criteria, 
retention times of analytes in standards and samples were compared at a 
tolerance of ± 2.5%. 
   Data quality was monitored using a comprehensive range of Quality 
Assurance/Quality Control (QA/QC) procedures. A rigorous and systematic 
control of blanks including: a reagent blank, a procedural blank, a replicate 
sample, and a matrix-matched external calibration were included in each 
batch of samples. Three spiking levels for each stock solution were used for 
analytical quality control (QC). 
Statistical data 
   All method performance experiments were conducted in triplicate and data 
were expressed as mean ± RSD. The statistical analysis of the results was 
performed by Student’s t test. The level of p ≤ 0.05 was considered 
statistically significant.  
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Results and discussion  
Analytical features of the proposed method  
   The proposed method was in-house validated according to the EU 
Commission Decision 2002/657/EC. Table 8 shows the performance of 
optimized method. Standard calibration curves and matrix-matched 
calibration of each analyte were performed at six concentration levels. Each 
calibration curve was prepared in triplicate. Regression coefficients (R2) 
greater than 0.990 were obtained for all studied compounds. To evaluate 
matrix effects, the matrix-matched calibration curves (A) were compared to 
the standard calibration curves (B) and expressed as the ratio percentage 
between these slopes. Thus, the ratio (A/B × 100) was defined as the matrix 
effect (%). A value of ME  100% means that no matrix effect occurred. There 
was signal suppression if the value was lower than 100% and signal 
enhancement if the value was higher than 100%. Matrix effects obtained were 
in the range of 75-97%. The specificity was determined by analyzing ten 
times a blank milk extract, to confirm the absence of possible sample 
interferences at the same retention time of the analyte. For all of the target 
analytes, the specificity of the HRMS led to no significant interfering 
substances which could interact with the quantification. To ensure the 
quality of results, QA/QC criteria were verified. When the recoveries were in 
the range from 70% and 120% (RSD < 20%) extraction process was considered 
satisfactory. To evaluate method trueness, recoveries were calculated at 
different spiking levels. Spiking levels were 0.05, 0.5, 2.5 μg/L for those 
analytes included in stock 1 solution, 0.005, 0.01, 0.05 μg/L for those analytes 
included in stock solution 2 and 0.5, 5, 25 μg/L for those analytes included in 
stock solution 3. The method provided satisfactory recoveries at all spiking 
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levels, ranging from 74% to 105%. The precision of the method was evaluated 
in terms of repeatability (intra-day precision, n=3) and reproducibility (inter-
day precision, n=3) of milk samples spiked at the levels above reported. The 
precision data, expressed as percentage relative standard deviation (%RSD), 
showed that the method was reproducible (RSD<14%) and repeatable 
(RSD<7%). Sensitivity was determined by calculating the limit of detection 
(LOD) and limit of quantification (LOQ) for each target compound. LOD was 
established as the lowest concentration tested that allows to identify the 
molecular ion with a mass error below 5 ppm. LOQ was established as the 
lowest concentration of the analyte that generate a chromatographic peak 
with acceptable accuracy and precision results(<20%).  
   Table 6 are shown the available multi-residue methods for the 
simultaneous determination of mycotoxins and veterinary drugs reported by 
other authors in the last decade. Even though the analysis of contaminants is 
becoming more attractive for food safety purposes in food, the presence of 
methods which include compounds from a high variety of different chemical 
classes is still scarce. A comparison of the analytical methods demonstrated 
that the proposed method has the higher sensitivity and thus allowed to 
detect lower levels of analytes. In particular, the value of LOQ achieved with 
the proposed method allowed to quantify levels ten times lower for 
mycotoxins and twenty times lower for veterinary drugs compared to 
available methods in literature. The optimized method, compared to 
methods used in previous studies turns out to be more sensitive, quick and 
efficient.  
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Table 8. Method performance. 
Analyte Linearity (r2) SSE (%) 
Recovery ± RSD (%, n=9) 
LOQ (pg/mL) 
0.5 ng/mL 5 ng/mL 25 ng/mL 
Abamectin 0.9966 93 80 ± 9 96 ± 3 101 ± 5 30.00 
Amitraz 0.9936 76 80 ± 4 86 ± 6 91 ± 6 30.00 
Amoxicillin 0.9937 88 86 ± 5 92 ± 5 96 ± 5 15.00 
Ampicillin 0.9986 84 79 ± 6 84 ± 7 87 ± 4 1.00 
Ceftiofur 0.9995 95 87 ± 6 95 ± 2 98 ± 3 30.00 
Cyhalothrin 0.9903 97 80 ± 9 87 ± 6 92 ± 6 30.00 
Cypermethrin 0.9966 75 74 ± 9 80 ± 4 85 ± 4 5.00 
Danofloxacin 0.9978 94 84 ± 10 86 ± 4 88 ± 7 0.5 
Deltamethrin 0.9968 86 81 ± 8 91 ± 3 94 ± 3 5.00 
Dexamethasone 0.9993 94 91 ± 10 96 ± 4 105 ± 3 30.00 
Doramectin 0.9993 89 87 ± 8 91 ± 4 97 ± 2 30.00 
Eprinomectin 0.9968 98 84 ± 9 92 ± 6 98 ± 6 5.00 
Imidocarb 0.9982 82 90 ± 8 95 ± 9 97 ± 8  1.00 
Ivermectine 0.9987 97 89 ± 7 95 ± 5 105 ± 4 0.05 
Meloxicam 0.9955 90 90 ± 7 94 ± 6 101 ± 5 5.00 
Monesin 0.9981 98 88 ± 11 93 ± 5 95 ± 3 30.00 
Procaine Benzilpenicillin 0.9974 75 84 ± 6 93 ± 5 99 ± 4 0.05 
Sulfadimidine 0.9906 93 86 ± 9 95 ± 7 99 ± 6 1.00 
Trichlorfon 0.9981 85 77 ± 14 83 ± 5 87 ± 5 5.00 
       
Analyte 
Linearity (r2) SSE (%) Recovery ± RSD (%, n=9) LOQ (pg/mL) 
    0.05 ng/mL 0.5 ng/mL 2.5 ng/mL   
DON 0.9985 94 94 ± 4 87 ± 10 83 ± 11 25.00 
FUS-X 0.9945 89 96 ± 8 89 ± 9 80 ± 8 25.00 
NEO 0.9935 86 92 ± 7 90 ± 8 88 ± 9 25.00 
DAS 0.9957 84 97 ± 5 94 ± 11 85 ± 13 50.00 
3-ADON 0.9985 90 88 ± 7 87 ± 9 75 ± 15 50.00 
15-ADON 0.9901 94 84 ± 6 94 ± 4 88 ± 6 50.00 
FB1 0.9926 97 91 ± 3 84 ± 4 80 ± 10 12.50 
HT-2 0.9973 91 95 ± 5 91 ± 7 83 ± 6 12.50 
α-ZAL 0.9992 81 86 ± 6 84 ± 9 95 ± 11 25.00 
AOH 0.9908 85 90 ± 8 84 ± 10 77 ± 12 50.00 
α-ZOL 0.9946 86 91 ± 7 93 ± 12 80 ± 14 25.00 
T-2 0.9984 87 87 ± 9 90 ± 10 93 ± 7 12.50 
β-ZAL 0.9937 94 82 ± 5 85 ± 8 84 ± 9 25.00 
OTA 0.9910 93 96 ± 8 93 ± 7 92 ± 10 2.50 
FB2 0.9909 97 93 ± 9 90 ± 8 89 ± 6 12.50 
β-ZOL 0.9997 85 98 ± 4 84 ± 9 77 ± 8 25.00 
ZAN 0.9932 89 88 ± 5 82 ± 7 74 ± 9 25.00 
ZEA 0.9974 87 84 ± 3 94 ± 7 84 ± 12 25.00 
AME 0.9937 94 89 ± 8 93 ± 6 87 ± 11 50.00 
ENN B 0.9954 86 96 ± 6 95 ± 6 91 ± 9 12.50 
ENN B1 0.9967 97 94 ± 7 87 ± 4 92 ± 6 12.50 
BEA 0.9909 86 84 ± 8 89 ± 8 82 ± 7 25.00 
ENN A1 0.9949 97 96 ± 9 93± 8 88 ± 11 12,50 
ENN A 0.9943 95 93 ± 4 91± 9 86 ± 13 12,50 
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Analyte 
Linearity (r2) SSE (%) Recovery ± RSD (%, n=9) LOQ (pg/mL) 
    0.005 ng/mL 0.01 ng/mL 0.05 ng/mL   
AFG2 0.9934 96 94 ± 6 93 ± 9 90 ± 10 4.00 
AFG1 0.9912 89 86 ± 7 89 ± 8 95 ± 12 2.00 
AFM1 0.9953 87 93 ± 5 97 ± 7 89 ± 8 2.00 
AFB2 0.9940 95 88 ± 7 100 ± 6 91 ± 9 4.00 
AFB1 0.9961 83 86 ± 7 96 ± 8 84 ± 8 2.00 
Clenbuterol 0.9948 73 98 ± 3 91 ± 4 84 ± 8 0.01 
Chloramphenicol 0.9950 82 104 ± 2 96 ± 6 81 ± 9 2.00 
Colchicine 0.9957 93 96 ± 2 91 ± 5 83 ± 11 7.5 
Dapsone 0.9981 86 88 ± 4 84 ± 8 76 ± 7 0.05 
Metronidazole 0.9996 81 94 ± 3 89 ± 5 82 ± 4 1.00 
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SPECIFIC OBJECTIVES 4: 
   Application of validated method to investigate the occurrence of the before 
mentioned compounds in 56 milk samples purchased in Campania, Italy. 
Results and discussion 
Application of the method to milk samples 
   The validated method was applied to the analysis of 56 milk samples 
acquired from different supermarkets located in the Campania region, 
Southern Italy. Results obtained were listed in Table 9. 
Table 9. Results obtained applied the validated methods to the 56 milk samples (target 
analysis). 
Milk 
samples 
(ng/mL) 
Amoxicillin Ampicillin Imidocarb Ivermectin Meloxicam Procaine 
Benzylpenicillin 
Dexamethasone 
1 1.600 n.r. n.r. n.r. n.r. n.r. n.r. 
2 n.r. n.r. n.r. n.r. 1.540 n.r. n.r. 
3 n.r. n.r. n.r. 1.600 n.r. n.r. n.r. 
4 1.540 n.r. n.r. n.r. n.r. n.r. n.r. 
5 n.r. n.r. n.r. n.r. 0.015 n.r. n.r. 
6 n.r. n.r. n.r. n.r. 0.018 n.r. n.r. 
7 n.r. n.r. n.r. n.r. 0.012 n.r. n.r. 
6 n.r. n.r. n.r. n.r. 0.008 n.r. n.r. 
10 n.r. n.r. n.r. 0.380 n.r. n.r. n.r. 
11 1.200 n.r. n.r. n.r. n.r. n.r. n.r. 
12 1.640 n.r. n.r. n.r. n.r. n.r. n.r. 
15 n.r. n.r. n.r. n.r. 0.014 n.r. n.r. 
19 n.r. n.r. n.r. n.r. 0.008 n.r. n.r. 
23 n.r. 0.860 n.r. n.r. 0.010 n.r. n.r. 
25 1.660 n.r. n.r. n.r. n.r. n.r. n.r. 
28 n.r. n.r. 0.080 n.r. n.r. n.r. n.r. 
29 n.r. n.r. n.r. n.r. n.r. 1.020 n.r. 
33 n.r. n.r. n.r. n.r. 0.020 n.r. n.r. 
36 1.680 n.r. n.r. n.r. 0.060 n.r. n.r. 
38 n.r. n.r. n.r. n.r. n.r. 1.000 n.r. 
43 n.r. n.r. n.r. n.r. n.r. 3.365 n.r. 
45 n.r. n.r. n.r. n.r. n.r. 4.530 n.r. 
46 1.450 n.r. n.r. n.r. n.r. n.r. n.r. 
48 1.500 n.r. n.r. n.r. n.r. n.r. n.r. 
49 n.r. n.r. 0.007 n.r. n.r. n.r. n.r. 
50 1.480 n.r. n.r. n.r. n.r. n.r. n.r. 
51 n.r. n.r. n.r. 4.240 0.220 1.000 n.r. 
55 1.510 n.r. n.r. n.r. n.r. n.r. n.r. 
 71  
 
Section I Chapter 2 - Specific objectives 4 
   None of the analyzed samples were contaminated by mycotoxins. As 
regarding the occurrence of mycotoxins in milk, most of the studies reported 
in the literature are focused on AFM1 investigation. The here reported data, 
are in agreement with previous monitoring studies carried out in milk. For 
instance, Tsiplakou et al. did not detect AFM1 (LOQ: 0.002 μg/L) in any of 
Greek milk analyzed samples (n=21). Similarly, Flores-Flores et al. 2018, who 
conducted a monitoring of AFM1 in Spanish milk samples (n=191) did not 
found AFM1 contamination (LOD: 0.025 ng/g). Boudra et al. have detected 
AFM1 contamination in 3.4% of French milk samples analyzed (n=264) at 
levels below the EU Regulation. In contrast, Duarte et al. 2013 reported that 
5% of Croatian milk samples (n=40), presented AFM1 values that surpassed 
the legal maximum limit (0.05 μg/L). As regards the incidence of AFB1 in 
milk, may be due to contaminated feedstuffs not completely metabolized by 
cow to AFM1, the occurrence of AFB1 was reported in 1.2% (n=80) [Carvajal 
et al. 2003], 1.4% (n=290) [Nassib et al. 2005], 12.4% (n=250) [Mao et al. 2018] 
and 17.5% (n=40) [Scaglioni et al. 2014] of Mexican, Egyptian, Chinese, and 
Brazilian milk samples, respectively. In agreement with previous studies 
reported in the literature, the absence of AFB1 was found in the here 
analyzed milk samples (Flores-Flores et al. 2017; Flores-Flores et al. 2018, 
Rodriguez et al. 2018). As reported in table 7, among the authors that 
examined the simuntaneous occurrence of mycotoxins and veterinary drug 
residues in milk, the presence of AFM1 was reported by just  Zhou et al. 2018.  
   Even though aflatoxins (especially AFM1) are the mycotoxins of greater 
incidence in milk and dairy products, have been reported that other 
mycotoxins, such as fumonisin, ochratoxin A, trichothecenes, zearalenone, T-
2 toxin, and deoxynivalenol, can also be found in these products (Flores-
Flores et al. 2015). 
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   As far as OTA, Pattono et al. 2011 reported the occurrence of OTA in 3 
Italian milk samples (n=63) in concentrations ranging from 0.07 to 0.11 μg/L 
(LOQ 0.05 μg/L). Also, Boudra et al. 2007 reported the occurrence of OTA in 
2.3% of French milk samples (n=132) above the LOQ of the method (0.005 
μg/L). On the contrary, Flores et al. 2018 did not found OTA in 191 milk 
samples (LOD 0.2 μg/L). Over the past decade, attention to the risk to human 
health has also been extended at Fusarium mycotoxins (Gruber et al. 2016). 
Notwithstanding, no presence of Fusarium mycotoxins (fumonisins, ZEN, 
trichothecenes) were found in herein reported data, Gazzotti et al. 2009 have 
found FB1 above the LOQ in eight out of ten analysed Italian samples at a 
contamination range from 0.26 to 0.38 μg/kg. Furthermore, our results 
regarding the incidence of ZEN are in agreement with the results reported by 
Zhan et al. 2012 who analyzed seven mycotoxins without detecting samples 
contamination. Even though ZEN is not one of the higher mycotoxins of 
occurrence in milk and its derivatives, some studies have reported ZEN 
contamination (Meucci et al. 2011, Signorini at al. 2012, Hang et al. 2014). 
Regarding trichothecenes, although have been reported the possibility of 
milk contaminated toward animals ingesting feed contaminated (Danicke 
and Brezina, 2013), no available studies reported this occurrence in milk. In 
fact, Flores et al. 2018 who analyzed 22 mycotoxins including DON, 3-DON, 
15-ADON, HT2 and T2 did not detected contamination of samples (LOD: 0.4-
2.5 μg/L). 
   Concerning the occurrence of veterinary drugs residues, the contamination 
was detected in 50% of analyzed samples ata concentration levels from 0.007 
ng/mL to 4.53 ng/mL. Among the studied VDs, up to seven analytes, 
belonging to antibiotic drugs (amoxicillin, ampicillin, benzylpenicillin 
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procaine), NSAIDs (meloxicam), corticosteroids (dexamethasone), 
antiprotozoans (imidocarb) andanthelmintics (ivermectina) were detected. 
   Amoxicillin was found in ten milk samples (17.8%) in a concentration range 
from 1.200 to 1.680 ng/mL (LOQ: 0.015). Ampicillin was detected in one of 
the analyzed samples (n=56) at a concentration of 0.860 ng/mL (LOQ: 0.001). 
None of the analyzed veterinary drug residues had a concentration level 
higher than their permitted limits, except for benzylpenicillin procaine, 
which was detected in 5 out of 56 analyzed samples (8.9%) in a concentration 
range from 1.000 to 4.530 ng/mL (EU 4 ng/mL). The occurrence of amoxicillin 
was reported in 3% of Chinese milk samples (n=33) analyzed by Zhu et al. 
2016 at an average concentration of 22.9 ng/mL, the latter percentage is out of 
MRL permitted by the legislation in force (EC: 4 ng/mL; China: 10 ng/mL). 
As shown in table 7, no occurrence of β-Lactams residues were found in 
milk, whereas, the occurrence of ciprofloxacin (quinolones) and lincomycin 
(lincosamides) were reported by Zhan et al. 2012 in 70% and 25 % of analyzed 
samples, respectively. Also the incidence of ampicillin did not detect in 
twenty milk samples (LOQ 0.5 ng/g) analysed by Li et al. 2018, and 108 milk 
samples (LOQ <10 μg/L) analyzed by Stolker et al. 2008. 
   Among the anti-inflammatory veterinary drugs, meloxicam (NSAIDs) was 
the most commonly detected (21%, n=12) in the analyzed milk samples in a 
concentration range of 0.007-0.220 ng/mL. As regards dexamethasone 
(glucocorticoids), the occurrence was found in one of the analyzed samples 
(n=56) at a concentration of 0.140 ng/mL (LOQ: 0.030 ng/mL). Despite the 
prevalence, the levels detected were lower than the MRLs provided by EC 
Regulation no. 37/2010 in all cases (15 μg/Kg and 0.3 μg/Kg for meloxicam 
and dexamethasone, respectively). Also, Zhan et al. 2012 have investigated 
anti-inflammatory veterinary drug residues (n=46) in twenty milk 
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samplesbut did not report the occurrence of this classes of drugs (LOQ 0.2-1 
μg/kg). Similarly, Xie et al. 2015 did not found NSAIDs drugs in analysed 
(n=32) milk samples (LOQ 0.12-1 μg/kg). The absence of dexamethasone in 
(n=20 ) milk samples was reported also by Li et al. 2018. 
   No presence of prohibited veterinary drug residues in milk such as, 
chloramphenicol, dapsone, metronidazole, colchicine was reported although 
the low detection level (LOQ: 0.00001μg/L). According to our results, Stolker 
et al. 2008, did not find the occurrence of prohibited drugs in (n=100) Dutch 
analyzed milk samples (LOQ <10 μg/L). Similarly, Alcántara-Durán et al. 
2018, who conducted a study of the incidence of (n=87) VDs in four Spanish 
milk samples did not found prohibited drugs (LOD: 0.1-1 μg/kg). On the 
contrary, as shown in table 7, the presence of chloramphenicol was found in 
3% of Chinese milk sample (n=32) by Xie et al. 2015. In the same study, the 
absence of metronidazole (LOQ: 0.2 μg/kg) and dapsone (LOQ: 0.04 μg/kg) 
were reported. Furthermore, Bilandžić et al. 2011 detected the occurrence of 
chloramphenicol in 63.6% of Croatian milk sample (n=1259), at a 
concentration range from 0.001 to 0.118 ng/mL.  
   Of special toxicological interest is the occurrence of veterinary drug 
residues in the same sample. In 4 out of 56 milk analyzed samples in this 
study, the coexistence of veterinary drug residues was detected: three 
samples contained simultaneously two analytes and one sample three 
analytes. In the latter, the simultaneous presence of: ivermectin (4.240 
ng/mL), meloxicam (0.220 ng/mL) and benzylpenicillin procaine (1 ng/mL) 
was detected. Even though the individual concentrations of the veterinary 
drug residues detected in the samples were within the MRL, the possible 
toxic effects derived from the additive or synergistic action of different 
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chemical substances coexisting in the same sample should be taken into 
consideration in the risk assessment studies. 
Retrospective screening analysisof real samples  
   The post-target screening approach has enabled us to detect 26 out of 37 
veterinary drugs and 12 out of 16 mycotoxins in 56 real samples, 
reprocessing the raw data. The results of the retrospective analysis of data 
are shown in the Figure 2. As regards the incidence of mycotoxins, AFM2 
contamination, was displayed in >70% of analyzed samples. Also Lee et al. 
2015 have studied AFM2 contamination in dairy products reporting a 
percentage of contamination in the range between 2-10% of the fifty analyzed 
samples. After ingestion, AFB1 and AFB2 are metabolized by the liver to 
their hydroxylated metabolites M1 (AFM1) and M2 (AFM2), which can be 
excreted in urine, feces, transferred to milk. In a recent study conducted by 
Tozzi et al. 2016 individual milk samples were analyzed for AFM1 and AFM2 
contamination for 15 days after the contaminated feed administration. 
Amounts of AFM1 and AFM2 were detected in the analysed milk samples. 
Concerning the other eleven mycotoxins investigated, a low incidence (<35%) 
were found. 
   The main part of the texted samples shown a VDs contamination (>40%) by 
drugs frequently use in food producing animals, like antibiotics and anti-
inflammatories presuming an inappropriate use of drugs or no respect of 
withdrawal period (Masiá et al. 2016). A significant percentage (>80%) have 
shown by betamethasone, prednisolone and oxfendazole. Special focus 
should be paid to these latter, considering that the maximum residue limit 
permitted in EC 37/2010 is really low, 0.3; 6; 10 ug/Kg, respectively. In 
addition, others veterinary drug residues identified in analyzed milk 
 76  
 
Section I Chapter 2 - Specific objectives 4 
samples are prohibited in milk in accordance with regulation in force (EC 
37/2010). Table 10 shown the maximum limits permitted by regulation in 
force for VDs investigate with a post target analysis. 
Table 10. In table the maximum limits permitted by regulation in force for VDs 
investigate with a post target analysis were reported. 
 
 
Veterinary drug 
residues 
μg/kg permitted by 
regulation in force 
Betamethasone 0.3 
Carprofen Prohibited in milk  
Cefazolin 50 
Chlorpromazine Prohibited in milk  
Cloxacillin 30 
Decoquinate Prohibited in milk  
Dicloxacillin 30 
Dimetridazole Prohibited in milk  
Enrofloxacin 100 
Febantel 10 
Florfenicol Prohibited in milk  
Flumequine 50 
Levamisole Prohibited in milk  
Lyncomycin 150 
Marbofloxacin 75 
Mebendazole Prohibited in milk  
Methylprednisolone Prohibited in milk  
Oxfendazole 10 
Oxolinic acid Prohibited in milk  
Prednisolone 6 
Rifaximin 60 
Ronidazole Prohibited in milk  
Thiamphenicol 50 
Tilmicosin 50 
Tolfenamic acid 50 
Toltrazuril Prohibited in milk  
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Figure 2. Retrospective screening analysis
 
 
Deepoxy-deoxynivalenol
Deoxynivalenol-3-glucoside
Penicillic acid
Verruculogen
Hydrolyzed fumonisin B2
Chaetoglobosin A
Hydrolyzed fumonisin B1
Cyclopiazonic acid
Chapter 2 - Specific objectives 4
 of real samples (untarget analysis).
 
0 10 20 30 40 50 60
AFM2
T2-trial
OTA B
Tentoxin
% 
Mycotoxins
Section I  
 
70 80
 78  
 
 
Carprofen
Dicloxacillin
Levamisole
Rifaximin
Tolfenamic acid
Toltrazuril
Cefazolin
Mebendazole
Ronidazole
Tilmicosin
Febantel
Oxolinic acid
Chlorpromazine
Lyncomycin
Cloxacillin
Marbofloxacin
Betamethasone
Enrofloxacin
Flumequine
Dimetridazole
Thiamphenicol
Florfenicol
Decoquinate
Oxfendazole
Methylprednisolone
Prednisolone
Chapter 2 - Specific objectives 4
 
0 10 20 30 40 50 60 70
%
Veterinary drug residues
Section I  
80 90
  
79  
 
Section I References 
References: 
 Alcántara-Durán, J., Moreno-González, D., Gilbert-López, B., Molina-Díaz, A., & 
García-Reyes, J. F. (2018). Matrix-effect free multi-residue analysis of veterinary 
drugs in food samples of animal origin by nanoflow liquid chromatography high 
resolution mass spectrometry. Food chemistry, 245, 29-38. 
 Bilandžić, N., Varenina, I., & Solomun, B. (2010). Aflatoxin M1 in raw milk in 
Croatia. Food Control, 21(9), 1279-1281. 
 Boudra, H., Barnouin, J., Dragacci, S., & Morgavi, D. P. (2007). Aflatoxin M1 and 
ochratoxin A in raw bulk milk from French dairy herds. Journal of Dairy 
Science, 90(7), 3197-3201. 
 Carvajal, M., Rojo, F., Méndez, I., & Bolaños, A. (2003). Aflatoxin B1 and its 
interconverting metabolite aflatoxicol in milk: the situation in Mexico. Food additives 
and contaminants, 20(11), 1077-1086. 
 Dänicke, S., & Brezina, U. (2013). Kinetics and metabolism of the Fusarium toxin 
deoxynivalenol in farm animals: Consequences for diagnosis of exposure and 
intoxication and carry over. Food and chemical toxicology, 60, 58-75. 
 Duarte, S. C., Almeida, A. M., Teixeira, A. S., Pereira, A. L., Falcão, A. C., Pena, A., & 
Lino, C. M. (2013). Aflatoxin M1 in marketed milk in Portugal: Assessment of 
human and animal exposure. Food Control, 30(2), 411-417. 
 Flores-Flores, M. E., & González-Peñas, E. (2017). An LC–MS/MS method for multi-
mycotoxin quantification in cow milk. Food chemistry, 218, 378-385. 
 Flores-Flores, M. E., & González-Peñas, E. (2018). Analysis of mycotoxins in Spanish 
milk. Journal of dairy science, 101(1), 113-117. 
 Flores-Flores, M.E.; Lizarraga, E.; de Cerain, A.L.; González-Peñas (2015). E. 
Presence of mycotoxins in animal milk: A review. Food Control,53, 163–176. 
 Gruber-Dorninger, C., Novak, B., Nagl, V., & Berthiller, F. (2016). Emerging 
mycotoxins: Beyond traditionally determined food contaminants. Journal of 
agricultural and food chemistry, 65(33), 7052-7070. 
 Huang, L. C., Zheng, N., Zheng, B. Q., Wen, F., Cheng, J. B., Han, R. W., & Wang, J. 
Q. (2014). Simultaneous determination of aflatoxin M1, ochratoxin A, zearalenone 
and α-zearalenol in milk by UHPLC–MS/MS. Food chemistry, 146, 242-249. 
 80  
 
Section I References 
 Lee, D., & Lee, K. G. (2015). Analysis of aflatoxin M1 and M2 in commercial dairy 
products using high-performance liquid chromatography with a fluorescence 
detector. Food Control, 50, 467-471. 
 Li, J., Ren, X., Diao, Y., Chen, Y., Wang, Q., Jin, W., & Liu, H. (2018). Multiclass 
analysis of 25 veterinary drugs in milk by ultra-high performance liquid 
chromatography-tandem mass spectrometry. Food chemistry, 257, 259-264. 
 Mao, J., Zheng, N., Wen, F., Guo, L., Fu, C., Ouyang, H., & Lei, S. (2018). Multi-
mycotoxins analysis in raw milk by ultra high performance liquid chromatography 
coupled to quadrupole orbitrap mass spectrometry. Food Control, 84, 305-311. 
 Masiá, A., Suarez-Varela, M. M., Llopis-Gonzalez, A., & Pico, Y. (2016). 
Determination of pesticides and veterinary drug residues in food by liquid 
chromatography-mass spectrometry: a review. Analytica chimica acta, 936, 40-61. 
 Meucci, V., Razzuoli, E., Soldani, G., & Massart, F. (2010). Mycotoxin detection in 
infant formula milks in Italy. Food Additives and Contaminants, 27(1), 64-71. 
 Nassib, T. A., Guergues, S. N., & Motawee, M. M. (2005). Survey For Detection and 
Determination of Aflatoxins M1 and B1 in local Milk and Certain Dairy Products by 
Thin Layer Chromatographic Method. Egyptian Journal of Hospital Medicine, 18, 29-36. 
 Pattono, D., Gallo, P. F., & Civera, T. (2011). Detection and quantification of 
Ochratoxin A in milk produced in organic farms. Food Chemistry, 127(1), 374-377. 
 Rodríguez-Carrasco, Y., Izzo, L., Gaspari, A., Graziani, G., Mañes, J., & Ritieni, A. 
(2018). Simultaneous Determination of AFB1 and AFM1 in Milk Samples by Ultra 
High Performance Liquid Chromatography Coupled to Quadrupole Orbitrap Mass 
Spectrometry. Beverages, 4(2), 43. 
 Scaglioni, P. T., Becker-Algeri, T., Drunkler, D., & Badiale-Furlong, E. (2014). 
Aflatoxin B1 and M1 in milk. Analytica chimica acta, 829, 68-74. 
 Signorini, M. L., Gaggiotti, M., Molineri, A., Chiericatti, C. A., De Basílico, M. Z., 
Basílico, J. C., & Pisani, M. (2012). Exposure assessment of mycotoxins in cow’s milk 
in Argentina. Food and chemical toxicology, 50(2), 250-257. 
 Stolker, A. A. M., Rutgers, P., Oosterink, E., Lasaroms, J. J. P., Peters, R. J. B., Van 
Rhijn, J. A., & Nielen, M. W. F. (2008). Comprehensive screening and quantification 
of veterinary drugs in milk using UPLC–ToF-MS. Analytical and Bioanalytical 
Chemistry, 391(6), 2309-2322. 
 81  
 
Section I References 
 Tozzi, B., Liponi, G. B., Meucci, V., Casini, L., Dall’Asta, C., Intorre, L., & Gatta, D. 
(2016). Aflatoxins M1 and M2 in the milk of donkeys fed with naturally 
contaminated diet. Dairy Science & Technology, 96(4), 513-523. 
 Tsiplakou, E., Anagnostopoulos, C., Liapis, K., Haroutounian, S. A., & Zervas, G. 
(2014). Determination of mycotoxins in feedstuffs and ruminant׳ s milk using an 
easy and simple LC–MS/MS multiresidue method. Talanta, 130, 8-19. 
 Xie, J., Peng, T., Zhu, A., He, J., Chang, Q., Hu, X., & Li, J. (2015). Multi-residue 
analysis of veterinary drugs, pesticides and mycotoxins in dairy products by liquid 
chromatography–tandem mass spectrometry using low-temperature cleanup and 
solid phase extraction. Journal of Chromatography B, 1002, 19-29. 
 Zhan, J., Yu, X. J., Zhong, Y. Y., Zhang, Z. T., Cui, X. M., Peng, J. F., & Zhu, Y. (2012). 
Generic and rapid determination of veterinary drug residues and other 
contaminants in raw milk by ultra performance liquid chromatography–tandem 
mass spectrometry. Journal of Chromatography B, 906, 48-57. 
 Zhou, J., Xu, J. J., Cong, J. M., Cai, Z. X., Zhang, J. S., Wang, J. L., & Ren, Y. P. (2018). 
Optimization for quick, easy, cheap, effective, rugged and safe extraction of 
mycotoxins and veterinary drugs by response surface methodology for application 
to egg and milk. Journal of Chromatography A, 1532, 20-29. 
 Zhu, W. X., Yang, J. Z., Wang, Z. X., Wang, C. J., Liu, Y. F., & Zhang, L. (2016). Rapid 
determination of 88 veterinary drug residues in milk using automated TurborFlow 
online clean-up mode coupled to liquid chromatography-tandem mass 
spectrometry. Talanta, 148, 401-411. 
 
  
82  
 
Section I Conclusions 
3. CONCLUSIONS 
   A multi-residue method was optimized for the simultaneous determination 
of veterinary drug residues and mycotoxins in milk. The method has been 
validated according to Decision 2002/657/CE. In terms of linearity, matrix 
effect, specificity, trueness, precision and sensitivity, satisfactory 
characteristics of analytical method has been obtained. The method 
developed herein, compared to methods used in previous studies turns out 
to be more sensitive, quick and efficient. The validated UHPLC-Q-Orbitrap 
HRMS methodology was applied to 56 milk samples commercially available 
in Italy. Results showed that any analyzed sample was contaminated with 
mycotoxins whereas 50% of the samples were positive in the presence of 
veterinary drugs at a concentration range from 0.007 to 4.530 ng/mL 
Meloxicam was the most commonly detected drugs (21%). Of particular 
toxicological interest is the co-occurrance of veterinary drug residues in the 
same milk sample. In herein data reported, co-occurrance of up to three 
veterinary drug residues was found in four analyzed samples. In addition, 
retrospective screening analysis of real samples have demostated an high 
incidence of prohibited VDs in milk (37/2010) and AFM2 contamination in 
>70% of the analysed samples. Thus, the latter results obtained show the 
need for constant controls in breeding farms to guarantee food safety for 
consumers. 
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 SECTION II  
 
CHAPTER 1 – Whey 
   Whey, the liquid residue of cheese, casein and yoghurt production, is one 
of the biggest reservoirs of food protein available today. Of the total world 
milk output, the 11.4% is used for manufacturing cheese and approximately 
the 85% is discarded as whey. Whey is considered a waste product with very 
important nutritional properties, because it contains 55% milk nutrients. The 
annual production of whey is more than 120 million tonnes, with an 
estimated growth rate of 1–2% yearly. The majority of world whey 
production is not treated, the 20% is employed for the livestock feeding and 
only a small percentage, the 6.5% is utilized in the production of ‘ricotta’ 
(ISTAT/CLAL 2016). The amount of worldwide whey obtained from cheeses 
in the last years is shown in Table 11. 
 
Table 11. Amount of worldwide whey obtained from cheeses (tons).   
WORLD: AMOUNT OF WHEY OBTAINED FROM CHEESES (TONS)   
Year Milk                        
production 
Milk  
equivalent 
Whey 
obtained 
from cheese 
Powder whey 
obtained  
from cheese 
2018 (forecast) 17.595 151.910 129.124 8.135 
2017 17.444 150.607 128.016 8.065 
2016 17.533 151.375 128.669 8.106 
2015 17.351 149.160 126.786 7.988 
2014 16.889 145.157 123.383 7.773 
2013 7.094 61.050 51.892 3.269 
2012 7.036 60.266 51.226 3.227 
Sorce: CLAL PROCESSING ON FAS-USDA DATA 
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   Whey can be classified into two categories as sweet whey and acidic whey. 
Sweet whey is produced during the making of rennet type of cheese like 
cheddar and Swiss cheese whereas acidic whey is a co-product from the 
process for the manufacture of certain acidic dairy products such as, cottage 
cheese and strained yoghurt. As reported by Tsakali et al. 2010, whey 
composition is widely dependent on the source of milk (cow, sheep, goat), 
the feed of the milk-producing animal, the processing method used and the 
stage of lactation. 
 
1.1.Functional role of caseins and whey proteins  
   Milk proteins fraction can be divided into soluble and insoluble proteins. 
The soluble fraction of milk proteins is represented by whey proteins and the 
insoluble fraction by caseins. Traditionally, milk proteins consist of 80% 
casein and 20% whey proteins. 
   Casein is a phosphoprotein classified in five kinds of casein micelles that 
are different in molecular composition but are similar in structure (alpha S1 
(αs1-CN), alpha S2 (αs2-CN), beta (β-CN), kappa (κ-CN) and (γ- CN) casein). 
Typically, they have a molecular weight between 14 and 25 kDa (Thorn, 
2015). The principal role attributed to the insoluble fraction is the transport of 
calcium and phosphate due to their capacity to act as carriers. Furthermore, 
they are also responsible to support efficient stomach digestion of calcium 
and phosphorus. Additionally, caseins give origin to several bioactive 
peptides that have shown benefits in human health (Atamer et al. 2017). 
These include antioxidant, cytomodulatory, immunomodulatory, 
antihypertensive, and antithrombotic actions in the cardiovascular, nervous, 
immune, and digestive systems (Bhat et al. 2015). 
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   Whey proteins are globular proteins having excellent nutritional properties 
which can be isolated from whey. The soluble fraction proteins include: 
 
 β-lactoglobulin (β-Lg) is the main protein found in whey which 
represents 50% of whey proteins and also 12% of total proteins in 
milk. β-Lg has a molecular weight of 18 kDa and it is well-known 
protein for their capability to bind to fatty acids and retinol (vitamin 
A) and because of this, it has great foaming and gelation properties 
(Boland et al. 2014). 
 α-lactalbumin (α–La) is the second most important protein content  in 
whey and milk with a molecular weight of about 14 kDa. It comprises 
20 % of total whey proteins and also 3.5 % of total proteins in milk. α–
La has a high tryptophan (Trp) content which is useful for human 
brain function. α–La is known as a metalloprotein correlated on 
calcium (Ca2+) ions (Derek et al. 2006). 
 Lactoferrin (LF)  is an 80 kDa member of the transferrin family of non-
heme iron-binding monomeric glycoproteins (Arnold et al. 1980). LF is 
normally found in various liquids including milk, nasal, saliva. 
Lactoferrin is a crucial element in iron absorption and in exerting 
antioxidant, antimicrobial and anticarcinogenic effects (Giansanti et al. 
2016, Orso et al. 2004, Tsuda et al. 2000). 
 Bovine serum albumin (BSA) is another cow milk proteins with a 
molecular weight of 66 kDa. BSA has a significant biological effect on 
human health but it role in food and milk are not well known. BSA 
has only a slight effect on whey physiochemical properties due to its 
low concentration in milk. It is sometimes used as a protein standard 
in some experiments (Aguero et al. 2017). 
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 Immunoglobulin (Ig) has a molecular weight of 150-1000 kDa and 
represents the immunological part of the milk which can protect 
people against a wide range of bacteria and viruses. The highest 
amount of Ig is found in human milk whereas the low level is present 
in cow’s milk. The immunoglobulins, most commonly found in the 
colostrum are essential to guarantee immunity to infants after birth 
(Hanson et al. 2003, Tovar Jiménez et al. 2012). 
    The amino acid profile is really different between the two milk fractions, in 
fact, whey is especially rich in branched chain amino acids, such as, leucine, 
isoleucine, and valine as well as lysine, whereas casein has a higher 
percentage of histidine, methionine, and phenylalanine (Wolfe et al. 2017). In 
addition to high-quality and biological effect, milk protein and bioactive 
compounds have shown the possible protective action in human health, 
include antibacterial, antiviral, antifungal, antioxidant, antihypertensive, 
antimicrobial, antithrombotic, opioid, and immunomodulatory effects (Bhat 
et al. 2015, Nongonierma et al. 2015, Park et al. 2015). 
1.2. Possibility to whey reuse 
   Nowadays huge quantities of whey are one of the considerable disposal 
problems in the dairy industry which creates several environmental 
concerns, especially in developing countries. An investigation carried out in 
11 cheese industry in Serbia has shown that 78.8 % of whey is discharged 
into river systems, contributing to the organic pollution of the environment. 
In recent years, environmental and economic problems associated with food 
waste have induced industries to reuse these materials in other preparations 
in order to minimize waste (Ostojic et al. 2005).  
   Over the past few decades, there has been an increased interest in the 
utilization of whey for the production of value-added products like whey 
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proteins. Several methods have been proposed for whey valorization, an 
interesting way to upgrade this effluent could be subjecting the whey to 
fermentation process because the biological wastewater treatment 
technologies is an expensive alternative (Arvanitoyannis & Giakoundis, 
2006). Lactic acid bacteria (LAB) have the property of producing proteolytic 
enzymes that hydrolyze large milk protein producing small peptides and 
free amino acids, with several functional properties for human health (Wang 
et al. 2015). 
1.3. Lactic acid bacteria in fermentation process 
   LABs are a heterogeneous group of microorganisms belonging to the 
Lactobacillales, Propionibacterium and Bifidobacterium strains. According to 
their hexose metabolic pathways, LABs are classified into two groups: 
homofermentative and heterofermentative. In the first case, lactic acid is the 
principal products and in the second case, others end products include acetic 
acid, carbon dioxide, or aroma compounds are produced in addition to lactic 
acid (Stanton et al. 2005). The production of lactic acid preserves foods by 
inhibition of the proliferation of undesirable microorganisms. In addition, 
lactic acid contributes to the formation of flavour and in the coagulation of 
caseins, contributing to modify the texture of fermented milk products 
(Papagianni et al. 2012).  
   LABs have been employed as a long time for fermentation of foods and 
underlie one of the oldest methods employed for food preservation. These 
microorganisms are suitable for dairy fermentation process because they 
have a proteolytic system, which decomposes casein and lactose digestive 
enzymes to obtain various products with numerous biological and 
antimicrobial activity. Furthermore, they have been known to produce 
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antagonistic compounds which inhibit food spoilage moulds and bacteria. 
Given the significant quantity of lactose contained in this by-product, it can 
be used directly as a substrate for the growth of different microorganisms. 
During fermentation, LAB releases a range of secondary metabolites, some of 
which have been associated with beneficial health effects (Panesar et al. 2012). 
The US Food and Drug Administration Agency has defined LAS as 
“generally recognized as safe GRAS status” (Burdock et al. 2004, FDA 2018).  
1.4. Biological activity of compounds of fermented whey 
   Different bioactivities have been associated with whey proteins. Despite 
biological activities are present in the intact proteins, in various cases whey 
proteins act as precursors of bioactive peptides released during the 
hydrolysis of proteins through fermentation or enzymatic processes.   
(Yalcin, 2006; Hernández-Ledesma et al. 2008; Madureira et al. 2010).  Among 
the bioactivities known so far,  angiotensin-converting enzyme (ACE) 
inhibitory properties have received special attention due to their potential 
beneficial effects in the treatment of hypertension. Several published reports 
on ACE-inhibitory are associated with peptides derived from bovine milk 
(Hernández-Ledesma et al. 2002).  
   Gobbetti et al. 2000 have studied two different types of milk fermented by 
L. delbrueckii subsp. bulgaricus SS1 and L. lactis subsp. Cremoris FT4 which 
produced angiotensin-I-converting-enzyme inhibitory peptides. The 
antihypertensive activity of the milk fermented by L. delbrueckii subsp. 
bulgaricus SS1 was associated with sequences of β-casein (β-CN) fragments: 
f6–14, f7–14, f73–82, f74–82, and f75–82. Those from the milk fermented by L. 
lactis subsp. cremoris FT4 contained the sequences of β-CN: f7–14, f47–52, 
and f169–175 and k-CN: f155–160 and f152–160. Most of these sequences 
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showed analogies with antihypertensive sequences present in the literature. 
In particular, the β-CN f47–52 sequence had high homology than 
angiotensin-II (Nguyen et al. 2015).  
   As regard antioxidant activity, Xiao et al. 2015 have studied the antioxidant 
activity of soy whey after fermentation by L. plantarum in order to find out 
their nutraceutical potential. The analysis showed that the fermentation of 
whey has an effect on the total phenolic content (TPC), antioxidant activity 
and DNA damage protection. The results showed an increase in these 
activities compared with unfermented whey.  In a study conducted by Qian 
et al. 2011 was evaluated the antioxidant, antihypertensive and 
immunomodulatory activity derived from milk fermented by two strains of 
bacteria: L. delbrueckii ssp. bulgaricus LB34. Bioactive compounds in the range 
from 5 to 3 kDa showed an appreciable antioxidant activity. The data 
obtained exhibited the potential of the milk fermented by L. delbrueckii ssp. 
bulgaricus LB340 as a functional food. 
   The antimicrobial effect obtained from the bioactive compounds of whey 
may be releated to the different active molecules relased during fermentation 
process as reported by scientific studies. Acids are in general responsible for 
the antimicrobial effect due to their interfering nature with the maintenance 
of the cell membrane potential, the capability to inhibit a variety of metabolic 
functions or supply an hostile acid environment for the growth of pathogenic 
and deteriorating microorganisms (Reis et al. 2012). In addition, the 
production of phenolic acids could have a secondary synergistic effect on the 
inhibition of fungal growth of whey fermented by LABs. Peyer et al. 2016 
studied the effect of carboxylic acids, composed of both organic and phenolic 
acids, released in a barley malt substrate fermented by LAB highlighting the 
inhibitory effect of these compounds on fungal growth. 
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   Hati et al. 2018 have studied growth, proteolysis and antimicrobial activity 
of LAB in a skimmed milk medium supplemented with different 
concentrations of whey protein. Finally, the antimicrobial peptide in the 
fermented milk was identified as lactoferrin by RP-LC/MS analysis. Several 
scientific studies have shown that lactoferrin exerts several beneficial health 
effects on humans and animals such as antimicrobial, antiinfective, anti-
cancer and anti-inflammatory effects (El-Loly et al. 2011). 
    Gerez et al. 2013 have evaluated the potential of ninety-one LAB strains; 
ten out of the total of tested strains were selected due to their high inhibitory 
effect in fungal growth. In the cell-free supernatants, lactic, acetic and 
phenyllactic acids were identified as metabolites responsible for an 
antifungal effect. The antifungal activity was lost after the neutralization 
treatment determining the acidic nature of the antifungal metabolites. 
Inactivation of fungal growth by lactic, acetic and other organic acids is a 
well-known fact. This piece of evidence has also been reported by other 
researchers (Stanojević-Nikolićet al. 2016). 
   The traditional view of whey as a by-product of dairy industry with little 
value has disappeared, and now the whey is seen as a potential source of 
bioactive components that can be used in the formulation of multiple 
functional foods. 
1.5. Application of bioactive compounds of whey to increase the shelf-life 
of bread 
  Nowadays, research efforts are generally aimed at improving quality with 
respect to a longer shelf-life. There is a significant need to improve food 
preservation method. Several bacterial species that contaminate foodstuffs 
and crops are pathogenic and may cause a range of food-borne illnesses 
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(Behravesh et al. 2012). Fungal spoilage can also lead to serious economic 
losses. It has been estimated that about one quarter of the world’s food 
supply is lost as a result of microbial spoilage, and food-borne microbial 
infections represent a constant and serious threat to human health. Indeed, 
the most common type of microbial spoilage is mould growth that 
contributes to the shortening of products’ shelf life (Garnier et al. 2017). 
  The traditional method of preserving food from the effect of microbial 
growth include thermal processing,  freezing, refrigeration, drying, 
irradiation and addition of antimicrobial agents or salts in food. 
Antimicrobials are used to enhance the quality and safety of food by 
reducing surface contamination of processed food. Antimicrobials reduce the 
population of microorganism by extending the lag phase of the 
microorganism or through their inactivation (Sharif et al. 2017, Hintx et al. 
2015, Charozo et al. 2015).  
   Among different food products, bakery products comprise an important 
part of a balanced diet and for this reason, a wide variety of such products 
can be found on food market shelves. Fungi are the most common spoilage 
organisms in baked products such as bread; the shelf life without 
preservatives is 3–4 days.  Like many processed foods, bakery products are 
subjected to physical, chemical and microbial spoilage. Physical and 
chemical spoilage limits the shelf-life of low and intermediate moisture 
bakery products, whereas microbial spoilage is the concern in high moisture 
products (aw > 0.85) (Smith et al. 2004). 
   In wheat based bakery products, deteriorations have been attributed to the 
following fungi genus: Penicillium, Aspergillus, Cladosporium and Neurospora.  
In wheat bread, P. commune, P. solitum, P. Corylophilum, and A. flavus are the 
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most dominant. P. Roqueforti, P. Corylophilum, and Eurotium species are more 
dominant in rye bread. Microorganisms may be present in raw materials, 
developed in the products or contaminate it during processing and 
packaging  (Garcia et al. 2018). 
   Microbiological shelf-life of bread is generally prolonged by the use of the 
chemical preservative like calcium propionate (Belz et al. 2012). In Europe, 
the maximum limits for propionic acid and propionate have been established 
at 3000 mg/kg in pre-packed sliced bread and rye bread, 2000 mg/kg in 
energy reduced bread, partially/pre-baked bread, pre-packed rolls and buns 
and 1000 mg/kg in pre-packed bread (EFSA, 2014). 
   However, as a result of increasing signs of negative effects on consumer 
health, biopreservation strategies are given further attention (Dengate & 
Ruben, 2002). The rationale of incorporating antimicrobials into bread 
preparation is to prevent surface growth in foods where a large portion of 
spoilage and contamination occurs. There is a clear trend toward preventing 
or delaying microbial growth in foodstuffs by means of natural 
preservatives. Due to its unique properties, whey can be an excellent 
medium for bacteria and enzymes in the laboratory (Karwowska et al. 2014; 
Ribes et al. 2018, Jideani et al. 2016). 
1.6. Identification of phenolic compounds 
For the identification of the phenolic compounds, I used a mass spectrometer 
with a Q-TOF detector. TOF is a relatively mature technology proposed at 
the first time by Stephens in 1946 and subsequently developed by Cameron 
and Eggers two years later (Cameron & Eggers, 1948). TOF instrument 
allows of ions separation based on mass-to-charge (m/z) ratio which travels 
through a flight tube: the lighter ions on will fly faster and reach the detector 
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earlier. At the moment, there are two principal types of TOF analyzers: linear 
and of orthogonal acceleration, even if linear time-TOFs is the most 
commonly used configuration nowadays. The TOF technique has been 
employed for various years in different areas, particularly for quantification 
of large molecules. The analysis in TOF-MS mode gives the greatest 
flexibility and throughput due to its speed of acquisition, high resolution, 
and its ability to acquire large scan windows (>20000 amu). On the other 
hand, the use of TOF-MS is limited by the sensitivity. The main weaknesses 
of TOF detectors are correlated with saturation from a threshold intensity 
which affects the measured signal amplitude and also can result in a relevant 
mass shift of the ions being affected by saturation. Even if this mode 
produces the highest signal, and no signal loss due to the poor fragmentation 
efficiency of most compounds, chromatograms are usually affected with high 
chemical noise, which reduces the signal-to-noise ratio (S/N)(Ramagiri et al. 
2012, García-Reyes et al. 2017). 
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CHAPTER 2 - Objectives section II 
 
2.1. General Objectives section II 
 
   The present study aims to evaluate the antifungal activity of fermented 
whey containing lactic acid bacteria and to apply the latter to the preparation 
of pita bread, in order to extend the storage time of the product. I have also 
evaluated the biological activities of this by-product for use it in a 
formulation of a potential nutraceutical as shown in Figure 3 (work in 
progress). 
 
 
Figure 3. General objective of the second part of my thesis work: whey treatments; 
fermentation at three different times (24, 48, 72h), purification on centricon amicon with cut-
off <3kDa and evaluation of biological and antimicrobial proprieties of this particular 
fraction. 
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2.2. Specific Objectives section II 
 
1. Sample preparation: determination of macronutrient composition of by-
product (protein, fat, lactose, humidity and ash), pasteurization and 
fermentation; 
2. Qualitative evaluation of the antifungal activity of cell-free supernatant 
(CFS) obtained from fermented whey with lactic acid bacteria and 
quantitative determination of the antifungal activity of CFS by defining the 
MIC and the MFC; 
3. Evaluation of inhibition of fungal growth in bread, by inserting fermented 
whey with lactic acid bacteria in its preparation. 
4. Evaluation of biological activities including ACE-inhibitory, antioxidants 
and Fe-binding in order to use this by-product for the formulation of a 
nutraceutical. 
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SPECIFIC OBJECTIVE 1 
   Sample preparation: determination of macronutrient composition of by-
product (protein, fat, lactose, humidity and ash), pasteurization and 
fermentation. 
Materials and methods 
Chemicals and reagents 
   Potassium iodide solution, sodium thiosulphate, bradford reagent, 
chloramine T, tungstate acid, phenylmethanesulfonyl fluoride, starch and 
glycerol were purchased from Sigma Aldrich (Milan, Italy). Hydrochloric 
acid was acquired from Merck (Darmstadt, Germany). All other chemicals 
and reagents were of analytical grade. Deionized water (<18 MX cm 
resistivity) was obtained from a Milli-Q water purification system (Millipore, 
Bedford, MA, USA). Standard of bovine serum albumin (BSA), was acquired 
from Sigma Aldrich (Milan, Italy). Buffered peptone water, potato dextrose 
agar (PDA), potato dextrose broth (PDB), De Man Rogosa-Sharpe medium 
(MRS Broth), were provided by Oxoid (Madrid, Spain). 
Microorganisms and culture conditions 
L. plantarum (CECT 220; 221; 223; 748) were obtained by Colección Espanola 
de Cultivos Tipo (CECT) and stored at −80°C in glycerol 25%. The cultures 
were defrosted under sterile conditions, diluted in sterile MRS broth and 
finally incubated at 37 °C during 48 h. 
Freeze-dried whey was provided by the Nutriops company, S.L. (Murcia, 
Spain). This powder whey was obtained from cow’s milk without chemical 
preservatives. Liquid sweet whey was provided by the ALCLIPOR company, 
S. A. L. (Benassal, Spain). This whey was obtained from goats’s milk without 
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chemical preservatives. Sample were stored at 4 °C until analysis carried out 
within 48 h after arrival of sample.  
Pasteurization of whey 
   The standard method was simulated by heating sweet whey in a water 
bath to 63 °C and maintaining that temperature for 30 min with continuous 
mixing, followed by rapid cooling according to standardized guidelines 
(Roth-Walteret al .2008). 
Whey fermentation 
   Freeze-dried whey was fermented with three different species of 
lactobacilli (L. plantarum CECT 220; 221; 748) for 24, 48 and 72 hours at 37 
°Cusing the method of Luz&Izzo et al. 2018 with some modifications. Whey 
was reconstituted with distilled water to a 10% (w/v) final concentration. 
After pasteurization at 65 °C for30 minutes, 30 mL were fermented in sterile 
conditions with1 mL of previously activated bacteria of L. plantarum (CECT 
220; 221; 748). Liquid sweet whey was fermented with four different strains 
of lactobacilli (L. plantarum CECT 220; 221; 223; 748) only for 72 h at 37 °C. 
The suspension of each LAB at concentration of 108 CFU/mL were added to 
40 mL of sterile pasteurized sweet whey. 
After then, fermented whey was centrifuged at 4000 rpm for 10 min to 
remove bacteria (Eppendorf 5810R, Hamburg, Germany).  The cell-free-
supernatant (CFS) was collected in the tube and lyophilized after adding to 
protease inhibitor 1mM PMSF (phenylmethanesulfonyl fluoride). The CFS 
were lyophilized and stored at −80 °C for further analysis. A schematic 
representation of fermentation process for obtaining the cell-free supernatant 
is shown in figure 4. 
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Figure 4. Schematic representation of fermentation process for obtaining the cell-free 
supernatant. 
Characterization of raw material 
   The determination of macronutrient composition (protein, fat, lactose, 
humidity and ash) was performed according to the guidelines instructions 
listed below.  
Soxhlet extraction 
   Freeze-dried sweet whey (5.00 g) was extracted with n-hexane in a Soxhlet 
apparatus by a continuous series of cycles of boiling and condensation of 
solvent for 6 h (Teixeira et al. 2018). 
Protein determination 
   Protein determination was performed using the method of Bradford with a 
slight modification to the original assay (Zor et al. 1996). A volume of 0.1 mL 
of dye reagent was added to 0.1 mL of appropriately diluted sample. After 
mixing and incubated in the dark, the absorbance readings at 595 nm were 
taken between 5 and 60 min. The mean of replicate solvent blanks was 
subtracted from the mean of replicate samples. The BSA (3.12-15 μg/mL) was 
used as standard to quantifie the proteins in the sample. 
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Lactose determination 
Lactose determination was carried out using the chloramine T assay. A ten 
mL aliquot of sweet whey was added 25 mL of water and 40 mL of 
deproteinization reagent (tungstate acid) and making up to 100 mL with 
water. The mixture was vortexed vigorously and filtrated after 1 h of the 
pose in the dark conditions. Briefly, ten mL of sample were introduced into a 
flask of 250 mL and five mL of 10 % (w/v) potassium iodide solution and 20 
mL of chloramine T 0.040M were added. The mixture was shaken for 90 min 
in dark conditions. Then, five mL of 2M hydrochloric acid were added to the 
flask and titrated with 0.04M sodium thiosulphate to a starch (1%) end point. 
A blank titration was performed under same conditions. The amount of the 
lactose present in the measured aliquot was accurately calculated from the 
volume of chloramine that has reacted with the sample (Silvestre et al. 2014). 
Humidity and ash 
   Humidity were measured after drying 40 mL aliquots of thoroughly mixed 
samples at 100±2 °C for 3 h in porcelain crucibles until reaching the constant 
weight. Ash was further incinerated at 450 °C for 12 h for determination of 
ash content. Results were expressed in mg/100 mL (Ranganna et al.  1986). 
Density and pH measurement 
   Density value was assessed using a lactodensimeter (Lactometer 
Quevenne, Brannan Thermometers). pH value was determined using a basic 
20 pHmeter (Crison, Spain). 
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Results and discussion 
Pasteurization and fermentation processes 
   The process of milk pasteurization is intended to ensure the safety of the 
product reducing the number of viable spoilage microorganisms, and 
inactivating several milk enzymes, as consequence of this process an increase 
in the shelf-life was obtained. Shelf life is influenced by multiple factors such 
as the quality of raw milk, post-pasteurization contamination especially 
during packaging, light exposure, and temperature control during storage 
and distribution.  Post-pasteurization contamination is caused by improperly 
cleaned and sanitized cooling sections, process lines, valves, tanks, and 
packaging materials (Schmidt et al. 2008).  
   Pasteurization is a mild type of heat treatment which causes only minor 
changes in milk flavor and nutritional quality. Raw milk spoils within a few 
days even when stored at refrigeration temperature, whereas pasteurized 
milk can have a shelf life between 7 and 28 days, or even longer. The goal of 
pasteurization is to achieve 99.999% reduction in viable microorganisms. 
Pasteurization should not be confused with sterilization, where the objective 
is to kill all microorganisms (pathogenic and spoilage) in the food (Claeys et 
al. 2013).  
   However, in view of the above I performed pasteurization of goat’s whey 
before the fermentation process using LAB. As reported by other authors,  
the bioconversion of lactose present in whey to valuable products has been 
actively explored. Since whey contains significant quantities of lactose, as 
also reported of the macronutrients analysis, an interesting way to upgrade 
this effluent could be as a substrate for fermentation (Panesar et al. 2007). 
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Evaluation of compositional analysis 
   The nutritional composition of two typologies of whey is shown in Table 
12. The protein fractions of bovine and goat’s milk are qualitatively very 
similar, and the major difference among these is related to the proportions 
and classes of caseins. In the protein profile of goat’s whey low concentration 
or absence of α-s1 casein was reported. Studies involving milk from various 
animal species, including goats, indicate that milk and whey proteins, as well 
as the peptides generated from these proteins, have important biological 
activities, such as antimicrobial, immunomodulatory, antioxidant, 
antithrombotic, hypocholesterolemic and antihypertensive activities. Milk 
proteins and its derivates maybe an important source of antimicrobial 
peptides, natural agents having potential application as biopreservatives in 
food matrices (Hejtmánková et al. 2012; da Costa et al. 2014). As reported by 
da Costa, who analyzed protein composition of goat’s milk in order to 
evaluate the antibacterial activity of its protein fractions, only the protein 
fraction containing the largest amounts of casein (60–90%) are able to inhibit 
bacterial growth, with MIC values between 50 and 100 mg/mL. 
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Table 12. Macronutrient composition of goat’s liquid whey and cow’s freeze dried whey 
utilized in fermentation process with Lactobacillus plantarum. 
 
 
Macronutrient composition 
of whey 
 GOAT’S LIQUID  
SWEET WHEY  
COW’S FREEZE 
DRIED WHEY 
 g/100 g g/100g 
Lipids 0.9 0.9 
Carbohydrates 
  
 - Lactose 69.8 71.5 
Proteins 14.7 12.2 
Ash 0.7 2 
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SPECIFIC OBJECTIVE 2 
Qualitative evaluation of the antifungal activity of cell-free supernatant (CFS) 
obtained from fermented whey with lactic acid bacteria and quantitative 
determination of the antifungal activity of CFS by defining the MIC and the 
MFC of two different type of whey: 
1. Freeze-dried cow’s whey (FDW); 
2. Liquid sweet goat’s whey (SW). 
Materials and methods 
Chemicals and reagents 
   Sodium chloride, magnesium sulfate were purchased from Sigma Aldrich 
(Milan, Italy). Acetonitrile, methanol, formic acid, HPLC grade were 
acquired from Merck (Darmstadt, Germany). All other chemicals and 
reagents were of analytical grade. Syringe filters with nylon membrane (NY, 
15 mm, diameter 0.22 μm) were supplied by Phenomenex (Castel Maggiore, 
Italy). 
   Standard of gallic, protocatechuic, chlorogenic, caffeic, syringic, vanillin, p-
coumaric, ferulic, hydroxibenzoic, vanillic, sallicilic, hydrocinnamic, sinapic, 
benzoic, DL-3-phenyllactic, 1-2 dihydroxybenzene, 3,4- 
dihydroxyhydrocinnamic, DL-p-hydroxyphenyllatic acids (purity >98%) 
were acquired from Sigma Aldrich (Milan, Italy). Buffered peptone water, 
potato dextrose agar (PDA), potato dextrose broth (PDB), De Man Rogosa-
Sharpe medium (MRS Broth), were provided by Oxoid (Madrid, Spain). 
   Deionized water (<18 MX cm resistivity) was obtained from a Milli-Q water 
purification system (Millipore, Bedford, MA, USA). Buffered peptone water, 
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potato dextrose agar (PDA), potato dextrose broth (PDB), De Man Rogosa-
Sharpe medium (MRS Broth), were provided by Oxoid (Madrid, Spain). 
Microorganisms and culture conditions 
   L. plantarum (CECT 220; 221; 223; 748) were obtained from Colección 
Espanola de Cultivos Tipo (CECT) and stored at −80 °C in glycerol 25%. The 
cultures were defrosted under sterile conditions, diluted in sterile MRS broth 
and finally incubated at 37 °C for 48 h. 
   For the evaluation of the antifungal activity, the mycotoxigenic strains used 
P. expansum CECT 2278, P. brevicopactum CECT 2316, P. camemberti CECT 2267, 
P. roqueforti CECT 2905, P. verrucosum VTT D-01847, P. digitatum CECT 2954, 
P. nordicum CECT 2320, P. pinophilum CECT 2912, P. commune CECT 20767, P. 
solitum CECT 20818; A. parasiticus CECT 2681, A. flavus ITEM 8111, A. niger 
CECT 2088, A. steynii CECT 20510, A. carbonarius ITEM 5010, A. brasiliensis 
CECT 2574, A. sclerotioniger CECT 20583, A. tubingensis CECT 20543, A. 
tubingensis CECT 20544, A. lacticoffeatus CECT 20581; F. moniliforme CECT 
2987, F. moniliforme CECT2152, F. moniliformis CECT2982, F. graminearum 
CECT2049, F. graminearum ITEM 6415, F. proliferatum ITEM 12072, F. 
verticillioides ITEM 12052, F. verticillioides ITEM 12043, F. verticillioides CECT 
20926, F. verticillioides ITEM 12044, F. sporotrichioides ITEM 12168,  F. 
langsethiae ITEM 11031, F. poae ITEM 9151 were purchased from the 
Colección Espanola de CultivosTipo (CECT). All strains were maintained in 
PDA at room temperature (25 °C) until use. 
Antifungal activity test 
   Antifungal activity of fermented whey was assessed by using Kirby-Bauer 
test according to Varsha et al. 2014 with slight modifications. The analysis 
was performed against three different strains of fungi belonging to the 
  
112  
 
Section II Chapter 2 – Specific objectives 2 
Penicillium, Aspergillus and Fusarium genera at 24, 48 and 72 h for freeze-dried 
whey and after 72 h of fermentation time for goat’s whey. Briefly, 70 μL of 
sample (0.5 g/L) solubilized in potato dextrose broth (PDB) were added to 
the wells (5 mm diameter) cut on potato dextrose agar which was previously 
spread plated with 1×104 fungal spores and kept at 26 °C for 3 days (Figure 
5). Following incubation, the zones of inhibition were measured. Overall, 
halos equal to or greater than 8-10 mm were considered positive for 
antifungal activity (Nascimento et al. 2000). 
 Determination of minimum inhibitory concentration and minimum 
fungicidal concentration (MIC–MFC)  
  The antifungal activity of fermented whey by L. plantarum strains at 72 h 
was determined using the method of Fothergill et al. 2012 with some 
modifications. The 96-well sterile microplates were utilized to perform the 
experiment. A negative control without adding of spores and a positive 
control in the presence of spores were included (Figure 5). The assay was 
performed by a micro-dilution technique to obtain serial dilution 
concentrations. First, 0.5 g/L of the sample was diluted in the same volume 
(100 μL) of spores at a concentration of 5 × 104 to obtain a final concentration 
range from 250 g/L to 1.95 g/L. The microplates were incubated at 26 °C for 
72 h. The micro-assay were performed in triplicate. The lowest 
concentration of sample capable to inhibit the visible growth of 
microorganisms is known as MIC.  The minimum fungicidal concentration 
(MFC) was determined by planting 10 μL of each different concentrations 
with a visible growth of the subculture of the sample in the PDA plate. The 
MFC value was determined after 72 h of incubation at 26 °C. 
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Figure 5. In the picture is shown a 96-well sterile microplate utilized to perform the 
experiment of antifungal activity. 
LC-ESI-qTOF-MS separation and identification of phenolic acids 
   The extraction of the phenolic compounds was performed using the 
method described by Brosnan et al. 2014 with some modifications. Ten 
milliliters of fermented whey were extracted with 10 mL of 1% of formic acid 
in ethyl acetate, 4 g of MgSO4 and 1 g NaCl using vortex VWR international 
(Barcelona, Spain) for 2 minutes. The extract was centrifuged at 3000 rpm 
(Eppernord AG 22331, Hamburg, Germany) for 10 minutes, and the 
supernatant was treated and mixed using vortex for 2 minutes with 150 mg 
C18 and 900 mg MgSO4. The samples were centrifuged at 3000 rpm 
(Eppernord AG 22331, Hamburg, Germany) for 10 minutes and the 
supernatant was completely dried using a continuous flow of nitrogen 
(Turbovap LV, Zymark Runcorn, UK). Finally, the sample was suspended in 
1 mL of water : acetonitrile (90 : 10 v/v), filtered through a 0.22 μm nylon 
filter (Phenomenex, California, Stati Uniti) and stored for chromatographic 
analysis.  
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   An Agilent 1200-LC system (Agilent Technologies, Palo Alto, CA, USA) 
equipped with a vacuum degasser, auto-sampler, and binary pump was used 
for the chromatographic determination. Chromatography separation was 
performed using a Gemini (C18 50 × 2 mm, 100 A, 3 μm) column 
(Phenomenex, Torrance, California, UK). Mobile phases consisting of 1% 
acetic acid as solvent system A and acetonitrile as solvent system B and the 
following gradient elution were used: 0 min, 0.8% B; 5.5 min, 6.8% B; 16 min, 
20% B; 20 min, 25% B; 25 min, 35% B; 29 min, 100% B; 32 min, 100% B; 34 
min, 0.8% B; 36 min, 0.8% B. The column was equilibrated for 3 min prior to 
every analysis. The sample volume injected was 20 μL and the flow rate used 
was 0.8 mL/min.  
   MS analyses were carried out using a 6540 Agilent Ultra- High-Definition 
Accurate-Mass q-TOF-MS coupled to the HPLC, equipped with an Agilent 
Dual Jet Stream electrospray ionization (Dual AJS ESI) interface in negative 
ionization mode with the following conditions: drying gas flow (N2), 12.0 L/ 
min; nebulizer pressure, 50 psi; gas drying temperature, 370 °C; capillary 
voltage, 3500 V; fragmentor voltage, and scan ranges were 3500 V and m/z 
50–1500, respectively. Automatic MS/MS experiments were carried out using 
the following collision energy values: m/z 100, 30 eV; m/z 500, 35 eV; m/z 
1000, 40 eV; and m/z 1500, 45 eV. Integration and data elaboration were 
performed using Mass Hunter Work station software (Agilent Technologies). 
Statistical analysis 
  Analysis of variance was carried out to assess whether the different 
experiments led to statistically different results for those variables evaluated. 
Statistical analysis of data was performed using the Tukey’s test. Results are 
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expressed as mean values ± s.e. mean. The chosen significance level was P < 
0.01. 
Results and discussion 
Antifungal activity, MIC–MFC of freeze-dried fermented whey obtained 
by fermentation with different strains of Lactobacillus plantarum 
correlation with organic compounds 
   The use of LAB in the food industry is widespread because of its positive 
contribution to the flavour, texture and nutritional value in food products, 
besides its natural antimicrobial properties that extend their shelf life. The 
proteolytic systems of LAB, which include proteinases and peptidases, are a 
considerable means to produce peptides and amino acids from milk proteins 
during fermentation (Ström et al. 2002, Lavermicocca et al. 2002, 
Lavermicocca et al. 2003). Proteinases are located in the cell wall and belong 
to the serine protease group, and they are able to make peptides starting 
caseins. Peptidases can be both extra and intra-cellular and are responsible 
for cleaving large peptides into small peptides (Kenny et al. 2003). Probably, 
secondary metabolites produced during fermentation by LAB, including 
organic acids, supply an unfavorable acid environment for the growth of 
pathogenic and deteriorating microorganisms. Acids are generally 
responsible for the antimicrobial effect due to their interfering nature with 
the maintenance of the potential cell membrane, reducing intracellular pH, 
inhibiting active transport and a variety of metabolic functions (Taylor et al. 
2014). 
   In Table 13, the results associated with the antifungal activity of freeze-
dried fermented whey by different strains of L. plantarum against 9 strains of 
mycotoxigenic Aspergillus, Penicillium and Fusarium strains are plotted. The 
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results highlight that whey fermentedby different strains of L. plantarum do 
not have activity against mycotoxigenic Penicillium and Aspergillus strains at 
different fermentation times (24, 48, 72 h). As regards Fusarium genera, an 
antifungal activity of fermented whey by L. plantarum 220 and 221 was 
observed. In particular, a clearing zone of 8–10 mm against mycotoxigenic 
fungi F. graminearum, F. verticilliodes at 24 hours of fermentation time, 
respectively were exhibited. The highest antifungal activity was observed for 
whey fermented by L. plantarum 220 against the Fusarium strains. 
Whey fermented by L. plantarum 748 showed an antifungal activity on F. 
verticilliodes exhibiting a clearing zone of 8 mmat 24 hours of fermentation 
time. The antifungal activity increased with fermentation time (48, 72 h), 
showing a clearing zone of 10 mm on F. moniliformis, F. graminearum and F. 
verticilliodes at 72 h of fermentation. In Table 14, it is possible to observe the 
results related to the Minimum inhibitory Concentration and the Minimum 
Fungicidal Concentration (MIC–MFC) of fermentedwhey by different strains 
of L. plantarumat 72 h of fermentation time. In particular, as regards the 
Fusarium generum, the MIC ranged from 31.3 to 250 g/L, whereas the MFC 
data ranged from 125 to 250 g/L for whey fermented by three strains of L. 
plantarum (220, 221, 748). For Penicillium strains, the MIC ranged from 62.5 to 
250 g/L, while the MFC presented the value of 250 g/L necessary to obtain the 
minimum fungicidal concentration. Whey fermented by L. plantarum 748 
evidenced the slightest antifungal activity, showing a MIC of 250 g/L. The 
antifungal activity of whey fermented by LAB has not yet been extensively 
studied. In particular, Gamba et al. 2015 investigated the antifungal activity 
of permeate fermented whey by Kefir grain against A. parasiticus, acommon 
fungal contaminant in food, which has the capability to produce aflatoxin B1. 
A fungicidal effect was obtained with 65% v/v of cell free supernatant in the 
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culture medium at pH 4.55. In these conditions, aflatoxin production was not 
detected. 
   Tulini et al. 2016 investigated the role of LAB strains isolated from different 
dairy products (milk and cheese samples), in order to evaluate the 
correlation with the antimicrobial activity. Among the strains studied, L. 
plantarum FT723 presented the most antifungal activity able to inhibit P. 
expansum in a modified MRS agar and fermented milk model. LAB 
couldproduce several antimicrobial compounds which make these bacteria 
interesting for food bio-preservation. 
 
Table 13. Antifungal activity of freeze-dried whey obtained from fermentation with three 
different Lactobacillus in three different times of fermentation (24, 48, 72h)  using the 
antimicrobial assay on solid medium of PDA. Clearing zone (+) corresponding to 8 mm, (++) 
corresponding to 10 mm. 
Fungi L.plantarum 220 L.plantarum 221 L.plantarum 748 
  24h 48h 72h 24h 48h 72h 24h 48h 72h 
P. camemberti CECT 2267 - - - - - - - - - 
P. expansum CECT 2278 - - - - - - - - - 
P. roqueforti CECT 2905 - - - - - - - - - 
A. parasiticus CECT 2681 - - - - - - - - - 
A. flavus   ITEM  8111 - - - - - - - - - 
A. niger CECT 2088 - - - - - - - - - 
F. moniliformis CECT 2982 - ++ ++ - ++ ++ - ++ ++ 
F. verticilliodes CECT 20926 ++ ++ ++ ++ ++ ++ - ++ ++ 
F. graminearum CECT 20490 + ++ ++ + ++ ++ + ++ ++ 
 
Table 14. Minimum inhibitory concentration and minimum fungicidal concentration 
expressed in g/L (MIC-MFC) evidenced by freeze-dried whey obtained by  fermentation 
with three different  Lactobacillus at 72h of fermentation time, on several mycotoxigenic 
fungi; (a= g/L). 
Fungi   L.plantarum 220 L.plantarum 221 L.plantarum 748 
  MICa MFC MIC MFC MIC MFC 
P. camemberti 62.5 250 125 125 nd nd 
P. expansum 62.5 250 62.5 250 250 250 
P. roqueforti  125 125 125 125 125 125 
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A. parasiticus  250 250 250 250 250 125 
A. flavus   250 250 250 250 250 nd 
A. niger 250 250 nd nd nd nd 
F. moniliformis 62.5 125 125 250 250 250 
F. verticilliodes 62.5 62.5 125 125 250 250 
F. graminearum  31.3 250 62.5 250 125 125 
 
 
Antifungal activity, MIC–MFC of sweet fermented whey obtained by 
fermentation with different strains of Lactobacillus plantarum  
   The qualitative antifungal activity of SFW against the tested fungi is 
detailed in Table 15. Sweet whey fermented by four different LABs were 
active against Aspergillus, Penicillium and Fusarium genera. In the analysis of 
data, it was observed that sweet whey fermented by L. plantarum 220, L. 
plantarum 221, L. plantarum 223 were more active than sweet whey fermented 
by L. plantarum 748. The most satisfying inhibitory effect was shown against 
A. flavus, A. carbonarius, P. verrucosum, P. nordicum, P. pinophilum and all the 
Fusarium species. The diameters of the inhibition zones toward the 
pathogenic strains varied between 8.0 and 10.0 mm. The lowest inhibitory 
activity was obtained against A. lacticoffeatus from all four type of bacteria 
utilized in the fermentation process. In figure 6 is reported an example of 
antifungal activity in the solid medium. 
Table 15. Antifungal activity of sweet fermented whey by four different strains of L. 
plantarum using the antimicrobial assay on solid medium of PDA. The diameters of 
the inhibition zones toward the pathogenic strains varied between 8 and 10 mm: 
clearing zone (+) corresponding to 8 mm, (++) corresponding to  9mm, (+++) 
corresponding to  10 mm. 
 
Fungi  CECT/     
 ITEM 
SFW    
CECT 
220 
SFW            
CECT 
221 
SFW         
CECT 
223 
SFW          
CECT 
748 
Aspergillus parasiticus CECT 2681 ++ + ++ + 
Aspergillus steynii CECT 20510 ++ + ++  - 
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Aspergillus flavus 
Aspergillus carbonarius 
Aspergillus niger 
Aspergillus brasiliensis 
Aspergillus sclerotioniger 
Aspergillus tubingensis 
Aspergillus tubingensis 
Aspergillus lacticoffeatus 
  
Penicillium camamberti 
Penicillium roqueforti 
Penicillium verrucosum 
Penicillium digitatum 
Penicillium nordicum 
Penicillium commune 
Penicillium expansum 
Penicillium brevicompactum
Penicillium solitum 
Penicillium pinophilum 
 
Fusarium moniliforme 
Fusarium moniliforme 
Fusarium graminearum 
Fusarium proliferatum 
Fusarium verticillioides 
Fusarium verticillioides 
Fusarium verticillioides 
Fusarium sporotrichioides 
Fusarium langsethiae 
Fusarium poae 
 
Figure 6. An example of antifungal activity of sweet fermented whey  in the  solid medium
on three different strain of mycotoxigenic fungi.
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ITEM 8111 +++ ++ 
ITEM 5010 +++ ++ 
CECT 2088 + + 
CECT 2574 ++ + 
CECT 20583 ++ + 
CECT 50543 ++ ++ 
CECT 50544 ++ + 
CECT 20581 - - 
      
CECT 2267 +++ ++ 
CECT 2905 + + 
VTT D-01847 +++ +++ 
CECT 2954 +++ ++ 
CECT 2320 +++ +++ 
CECT 20767 +++ ++ 
CECT 2278 +++ +++ 
 CECT 2316 +++ +++ 
CECT 20818 +++ ++ 
CECT 2912 +++ ++ 
   
CECT 2987 +++ +++ 
CECT 2152 +++ +++ 
ITEM 6415 +++ +++ 
ITEM 12072 +++ +++ 
ITEM 12052 +++ ++ 
ITEM 12043 +++ +++ 
ITEM 12044 +++ +++ 
ITEM 12168 +++ +++ 
ITEM 11031 +++ +++ 
ITEM 9151 +++ +++ 
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The antifungal activity of goat’s  fermented whey in liquid medium against 
the tested fungi allowed us to determine the Minimum Inhibitory 
Concentration and the Minimum Fungicidal Concentration (MIC–MFC). In 
picture 4 is reported an example of antifungal activity in the liquid medium. 
The values of MIC–MFC of goat’s whey fermented by different strains of L. 
plantarum at 72 hours of fermentation time was contained between 1.95 and 
250 g/L and are detailed in table 16. The value of MIC for Aspergillus and 
Fusarium genera was contained between 1.95 and 62.5 g/L whereas for 
Penicillium genera was contained between 3.9 and 125 g/L. The value of MFC 
was included in a range of: 15.6-250 g/L for Aspergillus, 62.5-250 g/L for 
Penicillium and 3.9-250 g/L for Fusarium. The lowest MIC values (1.95 g/L) 
was shown from goat’s whey fermented by L. plantarum 223 against A. 
steynii, F. moniliforme, F. verticillioides, F. sporotrichioides, F. langsethiae, F. poae 
species and whey fermented by L.plantarum 220 against A.stenyii, F. 
langsethiae, F. poae species. Less active SFW show higher MIC and MFC 
values (250 g/L) as reported by sweet whey fermented by L. plantarum 748 
against Penicillium and Aspergillus genera. Particularly interesting were the 
results of sweet whey fermented by L. plantarum 220, 221, 223 against P. 
pinophilum. For the Aspergillus genera, satisfying inhibitory effect were 
obtained against A. steynii for sweet whey fermented by L. plantarum 220 and 
against A. cabonarius, A. lacticoffeatus for goat’s whey fermented by L. 
plantarum 223. Regarding Fusarium genera, all species have shown a good 
inhibition effect after fermentation process using L. plantarum 220 and L. 
plantarum 223 strains. 
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Figure 7. An example of antifungal activity of sweet fermented whey  in the  liquid medium 
on mycotoxigenic fungi. 
 
Table 16. Minimum inhibitory concentration and minimum fungicidal 
concentration  (MIC–MFC) obtained by sweet whey after fermentation process with 
four different Lactobacillus at 72 h of fermentation time, on 28 mycotoxigenic fungi; 
(a = g/L) 
 
Fungi  
CECT/                       
ITEM 
MIC 
g/L
MFC 
g/L 
MIC 
g/L 
MFC 
g/L 
MIC 
g/L 
MFC 
g/L 
MIC 
g/L 
MFC 
g/L 
SFW CECT 
220 
SFW CECT 
221 
SFW CECT 
223 
SFW CECT 
748 
Aspergillus parasiticus CECT 2681 31.2 125 15,6 125 62.5 250 125 250 
Aspergillus steynii CECT 20510 1.95 62.5 7.8 62.5 1.95 125 31.2 250 
Aspergillus flavus ITEM 8111 31.2 62.5 31.2 62.5 7.8 62.5 62.5 250 
Aspergillus carbonarius ITEM 5010 31.2 31.2 31.2 62.5 3.9 31.2 62.5 125 
Aspergillus niger CECT 2088 31.2 31.2 31.2 31.2 7.8 15.6 62.5 125 
Aspergillus brasiliensis CECT 2574 31.2 125 31.2 125 15.6 31.2 62.5 125 
spergillus sclerotioniger CECT 20583 31.2 62.5 31.2 62.5 7.8 31.2 62.5 125 
Aspergillus tubingensis CECT 50543 31.2 31.2 31.2 31.2 7.8 15.6 62.5 62.5 
Aspergillus tubingensis CECT 50544 31.2 31.2 31.2 62.5 7.8 15.6 62.5 125 
Aspergillus lacticoffeatus CECT 20581 31.2 62.5 31.2 62.5 3.9 15.6 62.5 250 
          
Penicillium camemberti CECT 2267 62.5 250 125 250 15,6 - 31.2 - 
Penicillium roqueforti CECT 2905 62.5 - 62.5 - 62.5 - 125 - 
Penicillium verrucosum VTT D-01847 15.6 62.5 15.6 125 7.8 125 31.2 125 
Penicillium digitatum CECT 2954 62.5 - 62.5 - 125 - 125 - 
Penicillium commune CECT 2320 62.5 125 31.2 250 31.2 125 62.5 125 
Penicillium solitum CECT 20767 31.2 125 31.2 125 31.2 125 62.5 250 
Penicillium nordicum CECT 20818 7.8 62.5 31.2 62.5 62.5 125 62.5 250 
Penicilliun expansum CECT 2278 7.8 62.5 7.8 62.5 3.9 62.5 31.5 250 
Penicillium brevicompactum CECT 2316 7.8 62.5 7.8 62.5 7.8 62.5 31.2 250 
Penicillium pinophilum CECT 2912 7.8 62.5 7.8 62.5 3.9 62.5 15.6 250 
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Fusarium moniliforme CECT 2987 7.8 125 7.8 125 3.9 15.6 31.2 125 
Fusarium moniliforme CECT 2152 7.8 31.2 7.8 125 1.95 62.5 31.2 62.5 
Fusarium graminearum ITEM 6415 7.8 31.2 7.8 62.5 3.9 62.5 31.2 62.5 
Fusarium proliferatum ITEM 12072 15.6 31.2 15.6 31.2 3.9 7.8 31.2 62.5 
Fusarium verticillioides ITEM 12052 7.8 62.5 7.8 250 1.95 7.8 31.2 125 
Fusarium verticillioides ITEM 12043 7.8 62.5 15.6 62,5 3.9 31.2 31.2 250 
Fusarium verticillioides ITEM 12044 7.8 62.5 7.8 31.2 3.9 7.8 31.2 125 
Fusarium sporotrichioides ITEM 12168 7.8 31.2 15.6 31.2 1.95 15.6 31.2 62,5 
Fusarium langsethiae ITEM 11031 1.95 3.9 7.8 15.6 1.95 3.9 7.8 15.6 
Fusarium poae ITEM 9151 1.95 31.2 7.8 15.6 1.95 3.9 7.8 62.5 
 
   The antifungal activity of goat’s whey fermented by LAB has not yet been 
extensively studied.  Londero et al. 2014 have studied the antifungal activity 
of whey fermented with kefir grains for 24 h at 20 °C. After 24 h of 
fermentation, the kefir grains were separated from the fermentation products 
by filtration through a plastic sieve.  The grains showed a high percentage of 
inhibition of the conidium germination (≥ 70%) in the species of Aspergillus, 
Penicillium and Fusarium. Also Gamba et al. 2016 have studied the antifungal 
capacity of cell-free-supernatants from whey permeate obtained after 
fermentation of kefir grains against Fusarium graminearum growth and the 
production of zearalenone (ZEA). It was observed that, the fermented 
supernatants of pH 3-5 produced the highest percentages of inhibition of the 
conidial germination.  Alkalinization led to the gradual loss of antifungal 
activity. Results shown that the supernatants of kefir had antifungal activity 
against the strains of F. graminearum investigated and inhibited the 
production of mycotoxins. 
   Several potential health or nutritional benefits could be possible using 
some species of LAB on fermentation process in dairy products (Borresen et 
al. 2012, Swain et al. 2016). The production of antimicrobial substances by the 
use of starter cultures, for instance, LABs led to rapid acidification of the raw 
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material, providing an unfavourable environment for microorganism growth 
(Soro-Yao et al. 2014). In a recent study conducted by Juodeikiene et al. 2018, 
was investigated the treatment with LABs in malting wheat grains to finding 
a strategy for reduction of Fusarium mycotoxin. LABs strains (Lactobacillus 
sakei KTU05-6, Pediococcus acidilactici KTU05-7, and Pediococcus pentosaceus 
KTU05-8, KTU05-09, KTU05-10) have revealed a broad spectrum of 
antimicrobial activity against Fusarium culmorum and Fusarium poae. The 
treatment of wheat grains with permeate previously fermented with P. 
acidilactici KTU05-7 and P. pentosaceus KTU05-10 strains resulted in increased 
germination of wheat grains by 9.5 and 7.9% respectively comparing with 
grains that were not pre-treated.  Also Fernandez et al. 2017 have screened 88 
strains of food-grade bacteria for their inhibition effect on four spoilage 
moulds commonly isolated from cheese. Strains of Propionibacterium and 
Lactobacillus were the most active. Particularly, Lactobacillus rhamnosus A238 
alone or in combination with Bifidobacterium animalis subsp. lactis A026 was 
able to inhibit mold growth for at least 21 days at 6°C, due probably to the 
production of secondary metabolites or competition for nutrients. The use of 
different strains of LAB in the fermentation process of whey allowed to 
obtain good results in antifungal activity tests. In fact, as demonstrated that, 
fermentation process using LAB impacted on the phenolic profile (Kwaw et 
al. 2018, Sánchez-Maldonado et al. 2011). 
Identification of phenolic compounds  
   Antimicrobial activity of LAB is associated with the production of different 
active molecules such as peptides, antifungal compounds and organic acids 
(Kralik et al. 2018, Rodríguezet et al. 2009). However, there are other 
preservation mechanisms, such as bacteriocins production, that are 
suspected of being involved in the inactivation or inhibition of the growth of 
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other associated species of pathogens. A large number of bacteriocins 
produced by LABs have been identified, although their potential application 
as bio-preservatives has not been fully developed. (Cheikhyoussef et al. 2009, 
Tremonte et al. 2017, Dinev et al. 2018). The analysis of total phenolic 
compounds connected with freeze-dried fermented whey after 72 h of 
treatment led to the identification of ten different compounds that are shown 
in Table 16. In particular, in the FDW fermented by L. plantarum 220, the 
following were detected: hydroxibenzoic acid, sinapic acid, benzoic acid and 
DL-3-phenillactic acid, whereas in the FDW fermented by L. plantarum 221, 
ferulic acid, hydroxibenzoic acid, sinapic acid, benzoic acid and DL-3-
phenillactic acid were discovered. Finally, in the FDW fermented by L. 
plantarum 748, caffeic acid, p-coumaric acid, salicilic acid, hydrocinnamic 
acid, DL-3-phenillactic and 1,2-dihydroxibenzene were detected.  
   Benzoic acid and sodium benzoate are antifungal agents and they are 
employed in industries to contribute to preservationof foods. Strains of L. 
acidophilus, L. casei and L.s helveticus used for milk fermentation can produce 
benzoic acid infermented milk (Garmiene et al. 2010, Schnürer, et al. 2005).          
Recently, Kwaw et al. 2018 investigated the effect of LAB strains on the 
phenolic profile and antioxidant activities of mulberry juice. The 
fermentation process using L. plantarum demonstrated that LABs impacted 
on the phenolic profile. In addition, Valerio et al. 2009 studied the organic 
acids in the LAB from semolina in order to find a correlation with the 
antifungal activity of bacterial strains. All strains isolated acidified the 
medium, leading to pH values ranging from 3.05 to 3.85, and they have the 
capability to produce organic acids. The inhibitory effect of pure lactic and 
acetic acids was tested. Results indicated an inhibitory effect of the medium 
composed of both organic acids of 99.9%, 75.5% and 97.4% inhibition against 
A. niger, P. roquefortiand E. fibuliger, respectively. Phenolic compounds 
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showed microbicidal properties against different microorganisms (Gañan et 
al. 2009). 
   The phenolic acids studied in the SFW are summarized in Table 18 
including molecular formula, experimental and calculated m/z, and 
fragments. The analysis of phenolic compounds connected with SFW after 72 
h of treatment led to the identification of the predominant one: DL 3-
phenillactic (PLA). This phenolic compound was found in all SFW by 
different strains of L. plantarum. The results were expressed as mg/L of PLA 
compared to the control. The quantitative of PLA obtained in SFW by L. 
plantarum strains were: 1.18±0.03, 0.68±0.04, 1.21±0.02 and 0.003±0.01 for L. 
platarum 220, 221, 223 and 748, respectively.  
   These phenolic compounds, present in all whey fermented by different 
strains of L. plantarum, have been widely studied by researchers for their 
fungal inhibition capability (Ansari et al. 2013, Carvalho et al. 2018, Alves et 
al. 2014).   PLA is an important phenolic acid, produced during microbial 
fermentation using the strains of LAB. Due to the metabolism of 
phenylalanine in LAB, the latter was transaminated to phenylpyruvic acid 
(PPA) and PPA further reduced to PLA (Vermeulen et al. 2006; Li et al.2007, 
Chaudhari, et al. 2016).  The fermentation production of PLA with different 
microorganisms has been investigated by researchers in the past years. 
Previous studies have reported that PLA is an antimicrobial compound with 
a wide activity spectrum against some yeast and moulds including 
mycotoxigenic species such as Aspergillus and Penicillium (Dieuleveux et al. 
1998, Valerio et al. 2004 Lavermicocca, Valerio, & Visconti, 2003; Yoo et al  
2010). A wide variety of LAB has been screened by researchers for their 
antifungal potential and their capability to produce PLA (Cortés-Zavaleta et 
al. 2014, Gerez et al. 2009, Crowley et al. 2013, Gerez et al. 2013). 
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Table 17. Phenolic compounds identified in freeze-dried whey obtained from 24, 48, 
72h of fermentation with three different Lactobacillus by LC-qTOF-MS”. 
 
 
   
 Valerio et al. 2004 reported that the organic acids: PLA and 4-
hydroxyphenyllactic acid (HPLA), could be produced by a wide range of 
LAB species such as Lactobacillus, Enterococcus, Weissella, and Leuconostoc. It is 
presumed that the behaviour of the antifungal activity of whey was caused 
by acidic compounds like PLA or organic acids rather than proteins or 
peptides molecules (Martins et al. 2012, O’connell et al. 2001, Li et al. 2015, 
Ryan et al. 2011, Mu et al. 2009). 
   Rodriguez et al. 2011 have studied the ability to produce PLA from five 
different LABs. The highest amount of PLA was produced by L. plantarum 
CECT 221, the same strain used in our study. A GC-FID analysis of the 
metabolites obtained in the phenylalanine metabolism were showed the 
Compound Molecular formula m /z  Calculated (M-H)- m /z  Detected (M-H)- Fragments L. plantarum 220 L. plantarum 221 L. plantarum 748
Caffeic acid C9H8O4 790.1629 179.0323 135.0447/89.0404/107.0506 - - +
p-Coumaric acid C9H8O3 163.1611 163.0378 119.0497/93.0349 - - +
Ferulic acid C10H10O4 193.1828 193.0475
134.0364/ 178.0251/ 
106.0428/ 78.9589/ 
152.8921
- + -
Hydroxibenzoic acid C7H6O3 137.1233 137.0233 93.0351/ 65.0408 + + -
Sallicilic acid C7H6O3 137.1211 137.0235 93.0351/ 65.0405 - - +
Hydrocinnamic acid C9H10O2 149.1711 149.0593
63.0047/ 78.9609/ 84.9856/ 
96.9594/ 133.8511/ 
128.5397/ 58.3563
- - +
Sinapic acid C11H12O5 223.2156 223.0568
193.0118/ 93.0350/ 
121.0292/ 149.0232/ 
163.0393/ 208.0348/ 
135.0446/ 126.9043/ 
89.0244
+ + -
Benzoic acid C7H6O2 121.1212 121.5028
87.9241/ 64.6394/ 97.9436/ 
67.5325/ 105.8440/ 78.9786/ 
43.8011/ 50.4725
+ + -
DL-3-phenyllactic acid C9H10O3 165.1750 165.0532
103.0556/ 72.9940/ 
119.0500/ 147.0447/ 
77.0403/ 91.0563/ 44.9996
+ + +
1-2 dihydroxybenzene C6H602 109.1145 109.0288
108.0218/ 65.0042/ 91.0195/ 
53.0407/ 81.0349 - - +
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presence of small amounts of benzaldehyde and phenylacetaldehyde. 
Exhausted broths containing mixtures of PLA and other organic acids 
resulted to be an effective antimicrobial against the pathogen Salmonella 
reducing his growth in 63.2% in 24 h of incubation.  
   Lavermicocca et al. 2000 have evaluated the antifungal activity of PLA 
obtained during fermentation of wheat flour by L. plantarum 21B strain.  The 
high concentration of the phenolic compound in the bacterial culture filtrate, 
allowed to inhibit all fungi tested belonging to the Aspergillus, Penicillium 
genera at a concentration of 50 mg/mL. For P. roqueforti IBT18687 and P. 
corylophilum IBT6978 the inhibitory effect was obtained at a concentration of 
166 mg/mL.  Also in our study, SFW did not show adequate inhibitory 
results against P. roqueforti strain.  A subsequent study conducted by 
Lavermicocca et al. 2003 reported that fermentation process with 
Saccharomyces cerevisiae and the PLA-producing LAB strain, L. plantarum 21B, 
delayed for 7 days the fungal growth in bread. 
   So, this interesting organic acid provides new perspectives for the 
possibility of using this natural antimicrobial compound as a fungicide or as 
food preservative, feed additive, pharmaceutical agent and therefore, has 
potential applications in chemical, pharmaceutical, biotechnological and food 
industries.
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Table 18. Phenolic compounds identified in sweet whey obtained from 72h fermentation with different Lactobacillus by LC-qTOF-MS”. 
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SPECIFIC OBJECTIVE 3 
    Evaluation of inhibition fungal growth in pita bread, by inserting 
fermented whey with lactic acid bacteria in its preparation. 
Materials and methods 
Chemicals and reagents 
   Wheat flour, sugar, salt, instant yeast and extravirgin olive oil were 
purchased in a shop market. Deionized water (<18 MX cm resistivity) was 
obtained from a Milli-Q water purification system (Millipore, Bedford, MA, 
USA. Buffered peptone water, potato dextrose agar (PDA), potato dextrose 
broth (PDB), De Man Rogosa-Sharpe medium (MRS Broth), were provided 
by Oxoid (Madrid, Spain). 
Microorganisms and culture conditions 
   For bread contamination, the mycotoxigenic strains of P. expansum CECT 
2278 and P. brevicopactum CECT 2316 purchased from the Colección Espanola 
de Cultivos Tipo (CECT) were used. All strains were maintained in PDA at 
room temperature (25 °C) until use. 
Preparation of pita bread dough, inoculation and packaging 
The experiment was conducted in the following steps: 
1) Preparation of pita bread; 
2) Contamination of the surface of bread with P. expansum and P. 
brevicompactum; 
3) Packaging; 
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4) Observation of fungal growth. 
1) Preparation of pita bread 
Pita bread was prepared by adapting the method reported by Saladino et al. 
2016. Commercial wheat flour 250 g, was mixed with 2.5 g of sugar, 20 mL 
extra virgin olive oil, 5 g of salt, 15 g of instant yeast and the quantity of 
water required to reach the recommended graphic consistency necessary to 
obtain a good quality of pita bread (125 mL). The dough was mixed for 12 
minutes in the Simon extensometer mixer and the obtained dough was left 
rising for 30 min at 30°C in dark conditions. The formed dough was divided 
into 40 g portions and unrolled to the desired thickness of approximately 6 to 
7 mm, and  4 cm in diameter. In total, the 9 dough of pita bread for each test 
were placed on a perforated greased plate and baked at 180 °C for 7 minutes 
in a muffle furnace (Memmert ULE 500 AO BARLOWORLD scientific S.A. , 
Madrid, Spagna). After baking, pita bread samples were cooled up to reach 
room temperature (20-22 °C, 1 h approximately) and then immediately 
prepared to be inoculated with fungi. The different steps of bread 
preparation are shown in the Figure 8. 
 
Figure 8. In the picture are shown the different steps of breads preparation. 
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Eight different typologies of bread were prepared: 
 27 replicas ofbread without synthesis additives: positive control; 
 27 replicas ofbread with calcium propionate 0.2%: negative control; 
 27 replicas ofbread with a concentration of 1% freeze-dried whey 
fermented by L. plantarum 220: test 1; 
 27 replicas ofbread with a concentration of 1% freeze-dried whey 
fermented by L. plantarum 221: test 2; 
 27 replicas ofbread with a concentration of 1% freeze-dried whey 
fermented by L. plantarum 223: test 3; 
 27 replicas of bread with the replacement of 100% of water used in 
bread preparation with whey fermented by L. planatrum 220: test 4; 
 27 replicas of bread with the replacement of 100% of  water used in 
bread preparation with whey fermented by L. planatrum 221: test 5; 
 27 replicas of bread with the replacement of 100% of  water used in 
bread preparation with whey fermented by L. planatrum 223: test 6; 
2) Artificial contamination with Penicillium expansum and Penicillium 
brevicopactum and natural contamination of bread 
The antifungal activity of fermented whey has been tested both in pita bread 
artificially contaminated with the chosen fungal spores that on pita bread 
exposed at natural contamination condition. The impact of antifungal 
inhibition of fermented whey on bread was evaluated following the method 
used by Ryan et al. 2011 with some modifications. Table 19 summarized all 
the experiments performed. 
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Table 19. In the table are shown the different experiments performed for the 
artificial and natural contamination of bread. 
 
 
   After baking, 9 replicas for each typologies of pita bread were inoculated in 
9 spots with 100 μl of a suspension containing 1x107conidia/mL of the chosen 
fungi and 9 replicas for each typologies have followed a natural 
contamination (Figure 9). Conidial concentration was measured by optical 
density at 600 nm and adjusted to 107conidia/mL in PDB as reported (Kelly et 
al. 2006). For the evaluation of inhibition of fungal growth in bread, 
Penicillium expansum CECT 2278 and Penicillium brevicopactum CECT 2316 
were used because are the most common species. Penicillium species were 
previously cultured in PDB liquid medium following the manufacturer's 
Experiments performed Mycotoxigenic fungi used for 
inoculation of bread 
Pita bread without synthesis additives 
P. expansum
 CECT 2278 
P. brevicopactum
 CECT 2316 
W
ithout fungi: N
atural contam
ination 
Pita  bread with calcium propionate 0.2%: 
Pita  bread with a concentration of 1% freeze-dried 
whey fermented by L. plantarum 220 
Pita  bread with a concentration of 1% freeze-dried 
whey fermented by L. plantarum 221 
Pita  bread with a concentration of 1% freeze-dried 
whey fermented by L. plantarum 223 
Pita bread with the replacement of 100% of  water 
used in bread preparation with whey fermented by L. 
planatrum 220 
Pita bread with the replacement of 100% of  water 
used in bread preparation with whey fermented by L. 
planatrum 221 
Pita bread with the replacement of 100% of  water 
used in bread preparation with whey fermented by L. 
planatrum 223 
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specifications (27 g of product per 1 L of distilled water) and sterilization of 
the Selecta autoclave medium (Barcelona, Spain) at 121 ° C for 20 min. 
 
 
Figure 9. Inoculation of bread with Penicillium fungi. 
3) Packaging 
Finally, they were packed in sealed low-density polyethene bag with the help 
of a Sammic TS-150 (Basarte, Spain). All plastic bag was closed hermetically 
and incubated at room temperature during 10-20 days.  
4) Observation of fungal growth 
During that time, a visual control of the surface of the inoculated bread was 
carried out daily, identifying at a glance the possible growth or not of fungus 
and to establish the effect of the treatment on the shelf-life. 
Antimicrobial activity of bread: determination of the fungal load of bread 
treated with fermented whey   
   Once the period of preservation of the bread samples was exceeded, a 
microbiological study was carried out, in order to determine the fungal 
contamination present in one of the bread samples. After 10 or 20 days for 
the artificially or natural contaminated of pita bread respectively, 10 g of 
bread were homogenized together with 90 mL of peptone water, previously 
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autoclaved, in a Stomacher IUL (Barcelona, Spain) for 30 seconds. From that, 
3 serial decimal dilutions were prepared in glass tubes with 9 mL of peptone 
water. After 100 μL were plated out of each tube in PDA culture medium 
plates. The plates were incubated at 26 ° C, and the number of viable colonies 
counted after 72 h of incubation (Figure 10). 
 
 
Figure 10. Antimicrobial activity of bread samples after the period of preservation. 
Evaluation of the sensorial acceptability of bread produced with the 
fermentates 
   Sensorial evaluation of the different typologies of bread was performed by 
means of a nine-point Hedonic scale. The scale ranges from dislike (1) and 
extremely to like (9). The sensory evaluation of the bread was performed by 
25 assessors to whom were presented coded samples in random order and 
were asked to evaluate the flavour of each sample in the order provided. The 
responses of the assessors to the flavour of the bread were then tallied, after 
which the averages and standard deviations were calculated.  
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Statistical analysis  
   Statistical analysis of data was performed using the Tukey’s test. Results 
are expressed as mean values ± s.e. mean. The chosen significance level was 
P < 0.01. 
Results and discussion  
Artificial contamination with Penicillium expansum and brevicopactum 
   In recent years, the interest in food biopreservation has increased. Based on 
previous performed experiments, mycotoxigenic strains of P. expansum and 
P. brevicompactum were employed for studying the shelf-life improvement of 
bread. To simulate a real situation in which the products enter in contact 
only with the spores naturally present in the environment, an experiment 
without inoculation by fungi was performed. The results of the different 
experiments are shown in table 20. 
   In the positive control (bread prepared without additives), the visual 
growth of P. expansum and P. brevicompactum in the surface of pita bread 
started in the second day of the preservation period, whereas in the negative 
control (bread prepared with additives), the period of visual fungal growth is 
increased to sixth day. An important increment of the shelf-life was observed 
in the pita bread preparated adding whey fermented by L. plantarum. In this 
case, the visual fungal growth of P. brevicompactum in pita bread prepared 
adding 1% of freeze-dried fermented whey started on the fourth day of 
storage, whereas in pita bread prepared replacing water with sweet 
fermented whey, the fungal growth was observed between the ninth and 
tenth days, obtaining a total shelf life of eighth-nine days. 
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   Similar results were observed also for the mycotoxigenic fungi P. expansum 
with the only difference that the fungal growth of pita bread prepared 
adding 1% of the freeze-dried whey, started at the third day. The 
experiments carried out using L. plantarum during the fermentation process 
of whey, evidenced an increment of the shelf life of pita bread, compared 
with the positive control, of 1-2 and 7-8 days for freeze-dried and liquid 
fermented whey, respectively. 
   As regards the results obtained from the natural contamination of bread, a  
visual fungal growth was obtained on the fifth day for positive control and 
on the sixth day for negative control.  An appreciable increase in the shelf life 
was obtained from pita bread prepared with the fermented whey. In the case 
of freeze dried whey, a visual fungal grown was reached at the seventh and 
eighth day, whereas in pita bread prepared replacing water with liquid 
sweet whey, a slight fungal growth was observed at nineteenth and 
twentieth day.Visual representation of pita bread inoculated with P. 
brevicompactum and P. expansum after 10 days of the period of preservation 
and pita bread subject to natural contamination at 20th day are shown in 
figure 11,12. 
   The results obtained in this work are according to contents reported by 
Gerez et al. 2009, in which the ability of lactic acid bacteria (LAB) to inhibit 
Aspergillus, Fusarium, and Penicillium was evaluated in bread preparation. 
Using LAB in bread preparation, an increase in the shelf-life of bread of 5 
days compared to bread without LAB was observed. In addition, LAB in 
bread preparation cause a 50% reduction in the concentration of calcium 
propionate, a synthetic preservative. These results are also in agreement with 
a recent study carried out by Le Lay et al. 2016. In the latter work, different 
LAB led to delayed fungal growth after incorporation in milk bread rolls 
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preparation. Also Dal Bello et al .2007 have screened Lactobacillus plantarum 
for in vitro antimicrobial activity, and it was resulted to be active against 
spoilage moulds and bacteria. This LAB were tested for the ability to produce 
the antifungal compounds during sourdough fermentation and to produce 
bread of good quality and increased shelf-life. 
   Fungal spoilage is the main cause of substantial economic losses in 
packaged bakery products and might also be cosidered a source of 
mycotoxins, involving public health problems. In this context, LAB may be 
considered as an alternative for bio-conservation. 
Table 20. Shelf-life of pita bread contaminated with P. expansum, P. brevicompactum 
and natural contamination.  
 
Pita Bread Sample P. 
expansum 
Shelf-Life (days) 
1 2 3 4 5 6 7 8 9 10 
Positive control - + + + + + + + + + 
Negative control - - - - - + + + + + 
Test 1 - - - + + + + + + + 
Test 2 - - - + + + + + + + 
Test 3 - - - + + + + + + + 
Test 4 - - - - - - - - - + 
Test 5 - - - - - - - - + + 
Test 6 - - - - - - - - + + 
 
Pita Bread Sample P. 
brevicompactum 
Shelf-Life (days) 
1 2 3 4 5 6 7 8 9 10 
Positive control - + + + + + + + + + 
Negative control - - - - - + + + + + 
Test 1 - - + + + + + + + + 
Test 2 - - + + + + + + + + 
Test 3 - - + + + + + + + + 
Test 4 - - - - - - - - - + 
Test 5 - - - - - - - - + + 
Test 6 - - - - - - - - - + 
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Pita Bread Sample 
without fungi 
Shelf-Life (days)             
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Positive control + + + + + + + + + + + + + + + + 
Negative control - + + + + + + + + + + + + + + + 
Test 1 - - - + + + + + + + + + + + + + 
Test 2 - - + + + + + + + + + + + + + + 
Test 3 - - + + + + + + + + + + + + + + 
Test 4 - - - - - - - - - - - - - - - + 
Test 5 - - - - - - - - - - - - - - + + 
Test 6 - - - - - - - - - - - - - - + + 
 
 
 
 
Figure 11. Visual representation of pita bread inoculated with P.brevicompactum and 
P.expansum after 10 days of the period of preservation. 
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Figure 11. Visual representation of pita bread inoculated with P.brevicompactum and 
P.expansum after 10 days of the period of preservation. 
 
 
Figure 12. Visual representation of pita bread  without inoculation with fungi after 20 days 
of the period of preservation.  
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Antimicrobial activity of bread: determination of the fungal load of bread 
treated with fermented whey   
   Exceeded the period of preservation of bread, a microbiological study was 
performed to determine the fungal contamination present in each one of the 
bread samples. Firstly, the value of pH of bread after homogenization in the 
stomacher was measured and the average with relative deviation standard 
are shown in table 21. A drop in pH was observed in the pita bread with the 
addition of fermented whey in the dough. A significative percentage of pH 
reductionwas observed in pita bread prepared totally replacing water with 
fermented whey of 100% of water used in bread preparation with fermented 
whey. The percentage of decrease was ranged between 17-25%, 18-28% and 
13-20%  for the pita bread contaminated with P. expansum, P. brevicompactum 
and natural contamination, respectively. 
    The antifungal effect would be related to both the nature of the organic 
acid produced during fermentation, such as lactic, acetic and PLA, or/and the 
low pH reached after fermentation. The decrease of pH is caused by 
releasing of weak organic acids such as propionic acid, which are mainly 
dependent on the undissociated molecule, whose fraction increases with a 
decrease in pH. The dependence of the antifungal activity of weak organic 
acids on pH has also been reported in several studies (Smith et al. 2004). 
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Table 21. Pita Bread: pH misured after preservation period. 
 
   As regards the microbiological study of bread, a considerable percentage of 
reduction in fungal growth has been observed as shown in table 22. Adding 
1% of freeze-dried fermented whey in bread preparation, a percentage of 
reduction ranged between 12-23% was obtained, whereas with the 
replacement of 100% of water used in bread preparation with whey 
fermented by LAB the percentage of reduction has a highest peak of increase 
ranged from 42 to 92% for the different typologies of test performed. 
  
Pita Bread: pH misured after preservation 
period  
P.expansum P.brevicompactum Natural 
contamination 
Positive control 5.79±0.072 6.08±0.03 6.11±0.02 
Negative control 5.82±0.130 5.94±0.02 5.71±0.22 
Test 1 5.36±0.015 5.59±0.01 5.51±0.14 
Test 2 5.57±0.066 5.78±0.10 5.64±0.28 
Test 3 5.42±0.010 5.55±0.05 5.54±0.06 
Test 4 4.82±0.056 4.86±0.01 4.95±0.02 
Test 5 4.94±0.038 5.03±0.04 5.08±0.01 
Test 6 4.63±0.026 4.64±0.02 4.76±0.03 
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Table 22. Antimicrobial activity and % reduction of fungal growth 
Pita Bread Sample 
Fungi 
P. expansum P. brevicopactum Without fungi  
log ufc/g % reduction  log ufc/g 
% 
 reduction log ufc/g 
% 
reduction  
Positive control 4.52±0.44a - 3.30±0.07ab - 3.77±0.09a  - 
Negative control 4.37±0.15ab 3 ± 3 2.78±0.44a - 3.11±0.13ab  17 ± 3 
Test 1 4.00±0.16ab 12 ± 4 2.34±0.42ab 16 ± 15 2.91±0.05bc  23 ± 4 
Test 2 4.00±0.27ab 11 ± 6 2.33±0.27ab 16 ± 10 3.00±0.12ab  20 ± 6 
Test 3 3.67±0.25ab 19 ± 6 2.15±0.12b 23 ± 4 2.96±0.13b  21 ± 6 
Test 4 0.57±0.90c 87 ± 20 0.39±0.43c 86 ± 16 1.20±0.90d  68 ± 20 
Test 5 0.31±0.57c 93 ± 13 0.86±1.01c 69 ± 36 2.17±0.50c  42 ± 13 
Test 6 0.73±0.66c 84 ± 15 0.23±0.36c 92 ± 13 0.56±0.53d  85 ± 14 
 
Sensory quality 
   Sensory evaluation of the bread was performed by 25 assessors for the 
different typologies of prepared samples. No significant difference (p>0.05) 
was observed regarding the texture of the different typologies of analyzed 
bread. As regards the flavours, this study showed that the differences 
between pita bread elaborated with various types of fermented whey and 
control bread could be perceived by an untrained panel. In fact, the positive 
control has demonstrated the highest average score for flavour (7.1, like 
slightly), followed by negative control (6.6, neither dislike no like), test 1, 2, 
and 3 (6.5, neither dislike nor like e like slightly), and finally the test 4, 5 and 
6 (6.3, neither dislike no like). According to the one-way ANOVA, significant 
differences (p > 0.05) occurred between the tallied responses of the flavour of 
the bread. 
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SPECIFIC OBJECTIVE 4 
  Evaluation of biological activities including ACE-inhibitory, antioxidants, 
and Fe-binding in order to use this by-product for the formulation of a 
nutraceutical. 
 
Materials and methods 
Chemicals and reagents 
   The compounds 2,2-azinobis (3-ethylbenzothiazoline-6-sulphonic acid) 
diammonium salt (ABTS), N-Hippuryl-His-Leu substrate, angiotensin-
converting enzyme, hippuric acid, ferrozine, ferrous chloride, glutathione, 
were purchased from Sigma-Aldrich Chemical Co. (St Louis, MO, USA). 
Methanol, ethanol, trifluoroacetic acid, ethyl acetate, formic acid and 
acetonitrile. HPLC grade was purchased from Merck (Darmstadt, Germany). 
All other chemicals and reagents were of analytical grade. Deionized water 
(<18 MX cm resistivity) was obtained from a Milli-Q water purification 
system (Millipore, Bedford, MA, USA). Centricon Amicon with a cut-off of 3 
kDa was provided by Microtech Srl (Buccinasco, MI). 
Purification sample 
   An aliquot of 250 mg of freeze-dried fermented whey was solubilized in 1 
mL of 0.1% TFA aqueous solution. The sample was purified on SPE C18 
columns, previously activated, and then eluted with 3 mL of a mixture of 
acetonitrile/0.1% formic acid in water (70:30, v/v). The eluate was further 
purified on Centricon Amicon with a cut-off of 3 kDa to obtain a permeate 
consisting of small bioactive compounds as reported in the literature to show 
greater bioactivity. After purification, the permeate was lyophilized and 
finally re-suspended in 500 μL of water for subsequent analysis 
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(Aschaffenburg 1959). The purified and diluted samples were subjected to 
the biological test for the evaluation of antioxidant activity (ABTS), 
antihypertensive activity (ACE inhibitory) and iron binding activity. 
ABTS radical cation scavenging assay 
   The method reported by Xiao et al .2014 was used to analyze the ABTS 
radical cation (ABTS•+) scavenging activity. ABTS•+ was obtained by the 
reaction of a 7 mM aqueous solution of ABTS with 2.45 mM aqueous solution 
of potassium persulphate which was performed in dark conditions at room 
temperature for 16 h prior to use. The ABTS•+ solution was diluted with 
ethanol to arrive at an absorbance value of 0.70 (±0.02) at 734 nm. ABTS•+ 
solution (1 mL, with an absorbance of 0.700 ± 0.050) was added to the tested 
samples (0.1 mL, opportunely diluted) and mixed thoroughly. The reactive 
mixture was allowed to stand at room temperature for 2.5 min and the 
absorbance was immediately recorded at 734 nm. Ethanolic solutions of 
known trolox concentrations were used for calibration. The results were 
expressed as millimoles of trolox equivalents TE per kg of dry weight. 
ACE inhibitory activity 
  Evaluation of ACE inhibitory activity was assayed using the method 
described by Wu & Ding et al. 2002 with slight modifications. A sample 
solution of 25 μL (500 mg/mL) was mixed with 50 μL of 5 mMN-Hippuryl-
His-Leu substrate HHL solubilized in 0.1 M borate buffer (pH 8.3) containing 
0.3 M NaCl; the mixture was incubated at 37 °C for 10 min. After that, 20 μL 
of ACE solution (100 mU/mL) was added. The mixture was then re-
incubated for 60 min at 37 °C. The reaction was stopped by adding 100 μL of 
1 M HCl, and the mixture was centrifuged at 14 000 rpm (Thermo Fisher 
CL21R, Italy) for 10 minutes. The amount of hippuric acid (HA) in the 
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supernatant was determined by reversed-phase HPLC (Jasco MD-4016, Italy) 
using a Kinetex C18 column (5 μm, 4.6 × 250 mm, Phenomenex, USA) and 
detected using an UV-VIS detector at 228 nm. The mobile phase consisted of 
two solvents: solvent A was water with 0.1% trifluoroacetic acid and solvent 
B was acetonitrile with 0.1% trifluoroacetic acid. A linear gradient was used 
as follows: 0–8 min, 20%–50% B; 8–12 min, 50%–70% B; 12–14 min, 70%–20% 
B; 14–20 min, 20% B. The injection volume was 20 μL and the column 
temperature was 30 °C. The flow rate of the mobile phase was 1 mL/min. The 
percentage of ACE inhibition was calculated according to the following 
equation: 
 
 
where HAcontrol and HAsample are the peak areas corresponding to HA for the 
blank and for an inhibitor sample, respectively. 
 
Ferrous ion chelating ability 
  The ferrous (Fe2+) chelating ability was measured colorimetrically as 
described by Joshi et al. 2013 The solution of ferrous chloride 0.4 M (0.1 mL) 
was added to 1 mL (20 mg/mL) of freeze-dried fermented whey solubilized 
in distilled water followed by the addition of 0.2 mL of ferrozine 5 mM to 
initiate the reaction. The mixture was vortexed and the tubes were kept at 
room temperature for 10 min. The absorbance values were measured at 562 
nm. Glutathione 1 mg/mL was used as positivecontrol. The ferrous ion 
chelating ability was calculated as follows: 
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where Abscontrol and Abssample are the absorbance at 562 nm for the blank and 
for the sample, respectively. 
Results and discussion 
ABTS radical cation scavenging assay 
 
   Scientific research highlights the antioxidant capacity of peptides derived 
from food proteins. These antioxidant compoundsderived from proteins can 
offer a number of potential benefits and are also considered safer alternatives 
to synthetic antioxidants. Some of these peptides possess multiple biological 
activities, which can intensify their physiological efficacy and further reduce 
the disease risk (Meisel et al. 2004). Moreover, peptides can act in synergy 
with non-peptide antioxidants improving their protective effect. The 
recovery of bioactive peptides obtained from whey could be useful for 
production of specific functional or nutraceutical foods (Kitts & Weiler, 
2003). In the present study, ABTS assay was used to measure the antioxidant 
activity on fraction whey obtained after purification through a 3 kDa cut-off 
membrane. Many authors have reported a large number of studies regarding 
the occurrence of antioxidant compounds in the fractions <3 kDa having less 
than 20 amino-acids. For this reason, particular interest was applied to these 
fractions having shown greater bioactivity. The results expressed as 
millimoles of trolox equivalents TE per kg of dry weight (mmol trolox 
equivalent per kg of d.w.) are shown in Figure 13. Considering the ABTS 
assay, whey fermented by the strains of L. plantarum 220 and L. plantarum 221 
resulted in notably significant increases, during the 72 h of treatment. Whey 
fermented by L. plantarum 220 showed anincrease in the antioxidant activity 
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of 34% from 24 to 72 h of treatment and an increase of 27% compared to the 
control, while whey fermented by L. plantarum 221 showed an increase of 
37% from 24 to 72 h of treatment and an increase of 15% compared to control. 
Similar results regarding the increase of antioxidant capacity during 
fermentation were reported in the literature by other authors (Hafeez et al. 
2014). On the other hand, whey fermented with the strain of L. plantarum 748 
showed the highest activity after 24 h of fermentation exhibiting at this 
fermentation time an increase in the antioxidant activity of 20% compared to 
those of the sample at 72 h of fermentation. Comparing the antioxidant 
activity of L. plantarum 748 with no fermented whey an increase of 46% was 
observed at the same fermentation time (24 h). However, it has been reported 
that L. plantarum strains are able to excrete different endopeptidases in 
fermentation media. The activities of various endopeptidases in medium 
containing proteins may result in the generation of different antioxidant 
compounds (Liu et al. 2011). 
   In recent studies conducted by Moreno-Montoro et al. 2017 and Aguilar-
Toalá et al. 2017 the antioxidant activity of milk fermented by L. plantarum 
was analyzed. Their results highlighted, according to the evidence reported 
in the literature, that the highest antioxidant capacity measured by ORAC 
was found in the fraction of fermented milk derived from the cation 
exchange membrane permeate with molecular weight <3 kDa. In another 
study conducted by Osuntoki et al .2010 the antioxidant activity of fermented 
whey by Lactobacillus isolated from Nigerian food products was evaluated 
and the highest level of antioxidant activity was observed in the whey 
fermented with the strain of L. brevis isolated from wara, a dairy product. 
This is probably due to the strain being better adapted to the milk substrate, 
in contrast to the other no dairy isolated. In this experiment, the 
measurement of radical scavenging activity was conducted using the DPPH 
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showed an increase in the antioxidant capacity of whey during fermentation. 
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homeostasis. In RAS, the rennin has the capability to cut the liver-derived 
precursor, angiotensinogen, into a decapeptide: angiotensin I. The enzyme 
ACE catalyzes cleavage of angiotensin I to angiotensin II (a vasoconstrictor 
factor). Furthermore, ACE inactivate the vasodilative peptides bradykinin 
and kallidin, and stimulates the release of aldosterone, which increases blood 
pressure (Campbell, 2003). 
   In this study, ACE inhibitory activity was measured on whey fermented by 
L. plantarum 220, L. plantarum 221 and L. plantarum 748 at the respective 
fermentation times (24, 48, 72 h). The results shown in Figure 14 were 
expressed as the inhibition percentage compared to the control. ACE 
inhibition activity obtained by whey fermented with different strains of L. 
plantarum ranged between 67% and 85%. For all samples, ACE inhibitory 
activity increased proportionally to the fermentationtime (from 24 to 72 h), 
evidencing the highest activity at 72 h by the strain of L. plantarum 220.  
In the literature, Gonzalez-Gonzalez et al. 2011 reported that the ACE-
inhibitory activity of milk fermented with probiotic strains increased with 
fermentation reaching the highest value (85%) after 48 h of incubation. In 
particular, L. plantarum NCIMB 8826 inoculated in milk produces an increase 
in antihypertensive activity from 24 to 48 h. In contrast, Pihlanto et al. 2010 
observed that L. acidophilus ATCC 4356 and L. jensenii ATCC 25258 strains, 
inoculated in milk, showed a high ACE inhibitory activity after 24 h of 
fermentation demonstrating that some strains are capable of producing high 
bioactivity at 24 h of fermentation. For this reason, our experimental protocol 
has provided a fermentation time of up to 72 h in order to monitor the trend 
of this biological activity. The results obtained for the ACE inhibitory activity 
of fermented whey samples were in accordance with the reported literature. 
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Ferrous ion chelating ability 
   It has been recognized that transition metal ions are involved in many 
oxidation reactions in vivo. Ferrous ions (Fe2+) can catalyze Haber–Weiss 
reaction and induce superoxide anion to form more hazardous hydroxyl 
radicals. Hydroxyl radicals react rapidly with the near biomolecules and 
cause severe damage. It has been observed that the scavenging of hydroxyl 
radicals by antioxidant compounds was efficacious mainly via the chelating 
of metal ions (Pignatello et al. 2006). In the herein reported data, the metal 
chelating ability was determined by measuring the reduction rate of red 
color, which was formed by ferrozine with ferrous ions. The iron chelating 
activity was expressed as a percentage compared to the positive control 
represented by glutathione (1 mg/mL). Our results are shown in Figure 15, in 
the whey fermented by L. plantarum 220 and L. plantarum 221 the iron-
chelating activity increased linearly with the fermentation time, reaching a 
maximum value after 72 h of fermentation. Fermentation induces the 
structural breakdown of proteins, leading to the liberation or synthesis of 
various compounds responsible also for iron chelating activity (Mokoonlall et 
al. 2016). This piece of evidence is discussed in a report prepared by Hur et al. 
2014 regarding the effect of fermentation in plant-based foods and the 
correlation of this activity with the fermentation process. Even though 
investigations on whey have been conducted widely by several authors, 
there is limited information about the iron binding capability of this matrix 
after fermentation with microorganisms. Among the studies in the literature, 
the evidence of major iron binding activity correlated to compounds with 
lower molecular weight was reported. More particularly, O’Loughlin et al. 
2015 investigated the iron chelating activity of two fractions of WPI at 
different degrees of hydrolysis (DH). They reported a 1 kDa permeate at 10% 
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DH and a 30 kDa retentate at 5% DH. These results showed that the 
capability of chelating iron was 84.4 μM EDTA and 8.7 μM EDTA for 1 kDa 
and 30 kDa fractions, respectively. Thus, it was suggested, according to our 
results, that the lower molecular weight of the WPI fractions was associated 
with higher iron chelating capability. 
   Regarding our results, whey fermented by L. plantarum 748 showed an 
inverse trend, generating the highest iron chelating activity after 24 h of 
fermentation (55%) and a significant decrease after 72 h (18%). Similar results 
were reported by Abubakr et al. 2012 who evaluated the iron binding activity 
of whey after fermentation by LAB. They showed the highest iron binding 
capacity after 24 h of fermentation, with a decrease from 97.6 to 41.8%in the 
following 48 hours, because of a high number of phosphoseryl serine groups 
which have greater affinity for iron. An interesting result was also obtained 
by Silva et al. 2015 who studied the iron chelation activity of whey protein 
hydrolyzedenzimatically with alcalase, pancreatin or flavourzyme, showing 
an increase of iron solubility at pH 7 following the interaction between 
aminoacid residues of casein derived phosphopeptides with metal irons. The 
main advantages of using LAB against enzymatic solution involves the 
decrease of cost and disposal problem keeping food safety. 
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Figure 15. Iron chelating activity percentage of different samples of <3KDa whey fraction 
fermented by three strains of 
fermentation 24, 48 and 72h is illustrated in the figure.
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3.CONCLUSIONS 
 
   Whey deriving from the dairy industry represents a waste product of great 
impact. Whey fermented by some strains of lactic acid bacteria produce 
inhibition of fungal growth of species belonging to the Penicillium, Aspergillus 
and Fusarium genera both in liquid and solid assay. This study suggests the 
possibility to reuse the fermented whey in the food industry. In particular, 
freeze-dried whey fermented by L. plantarum 220 and sweet whey fermented 
by L.plantarum 220 and 223 gives the best results in terms of antifungal 
activity, suggesting its use as a natural antimicrobial compound to control 
fungal contaminants and extend the shelf-life of foods and/or feedstuffs. It is, 
therefore, desirable to continue to expand our understanding of the 
effectiveness of fermented whey by LAB in order to estimate their efficacy for 
future applications in food model systems. 
   In addition, whey compounds obtained during fermentation process using 
LABs, have shown remarkable bioactivities in term of antioxidant, ACE-
inhibitory and iron-binding activity, particularly the best results were 
obtained using L. plantarum 220 in the fermentation process. Even though,  in 
current literature exists information on the various bioactivities of food 
protein-derived peptides, there is limited information on in vivo health-
promoting effects, bioavailability, pharmacokinetics, molecular mechanisms 
of action and possible use in human disease. So, compounds derived during 
the fermentation process of whey could have potential application in human 
disorder, although future research efforts should be directed toward 
evaluation of risks for consumers prior to commercialization of new 
nutraceutical. 
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